Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
1003-6-1|Control, mean age 463 days,some were designated NCI controls|Sequence:1, Age:463,Type:none (controls),Quantity:0,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:n/a|47 (0 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |No information on individuals available for this study
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3085|2|4462|Carcinoma, malignant,Carcinoma, malignant,Hemangiopericytoma, uncertain whether benign or malignant,Leydig cell tumor, benign,Adenoma, benign,Fibroma, benign,Disease or syndrome of skeletal system,Hyperplasia, lymphoid,Inflammation, acute,Hyperplasia,Atrophy,Inflammation, acute,Inflammation, acute,Polyp,Cyst,Infarct,Inflammation, chronic,Congestion,Hyperplasia,Abscess,Hyperplasia,Hematoma,Degeneration,|Prostate,Iliac lymph node,Subcutaneous tissue of neck,Testis, right,Thyroid gland,Stomach,Prescapular lymph node,Tracheobronchial lymph node,Adrenal gland,Testes, both,Lung,Mesenteric lymph node,Stomach,Thyroid gland,Kidney,Urinary bladder,Liver,Bone marrow,Subcutaneous tissue,Atrioventricular valve,Spleen,Liver,|DEGENERATIVE AREASPMN'S IN VASC.SP,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3087|2|4749|Carcinoma, w/evidence of metastasis,Carcinoma, malignant,Carcinoma, malignant,Hemangioma, benign,Carcinoma, malignant,Adenoma, benign,Fibroma, benign,Leydig cell tumor, benign,Cyst,Hyperplasia, lymphoid,Atrophy,Inflammation, acute,Hyperplasia,Hyperplasia,Inflammation, acute,Hemorrhage,Dilatation,Fibrosis,Hyperplasia,Inflammation, chronic,|Adrenal gland, left,Thyroid gland,Lung,Mandibular lymph node,Liver,Anal gland,Stomach,Testis,Prostate,Retropharyngeal lymph node,Gluteus maximus muscle,Male breast,Prostate,Bone marrow,Prostate,Mesenteric lymph node,Renal pelvis, left,Aorta,Pancreas (Exocrine Pancreas),Kidney, left,|ONLY THIN RIM OF FIBROTIC PARENCH.   LEFT,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3090|2|4672|Mixed tumor, malignant (AFIP 80850),Fibroma, benign,Adenoma, benign,Seizure syndrome,Congestion,Degeneration,Cyst,Autolysis,Congestion,Hyperplasia,Congestion,Congestion,Congestion,Polyp,Inflammation, chronic,Congestion,Congestion,|Mammary gland #4, left,Vagina,Pituitary gland,Brain,Liver,Liver,Kidney,Topography, multiple sites,Retropharyngeal lymph node,Adrenal gland,Brain,Kidney,Spleen,Skin,Uterus,Lung,Prescapular lymph node,|,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3092|2|4650|Reticulosarcoma (Histocytic Lymphosarcoma), malignant,Reticulosarcoma (Histocytic Lymphosarcoma), malignant,Adenoma, benign,Hematoma,Inflammation, acute,Inflammation,Hyperplasia,Inflammation, chronic,Thrombus,Hyperplasia,Hemorrhage,Pigmentation, hemosiderin,Hyperplasia,|Skin,Topography, multiple sites,Thyroid gland,Spleen,Topography, multiple sites,Lung,Prostate,Kidney,Artery,Bone marrow,Lung,Topography, multiple sites,Aorta,|INTIMAL THICKENING,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3102|2|4271|Mixed tumor, malignant (AFIP 80850),Mixed tumor, uncertain whether benign or malignant,Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Leiomyoma, benign,Adenoma, benign,Adenoma, benign,Inflammation, acute,Sepsis,Infarct,Inflammation, acute,Hypoplasia,Congestion,Hemorrhage,Inflammation, acute,Inflamation, acute exudative (suppurative),Disseminated intravascular coagulation (DIC) syndrome,Hemorrhage,Ulcer,Congestion,Hypoplasia,Deposition, calcium,Hyperplasia,Hyperplasia,Hematoma,Hypoplasia,Infarct,Degeneration,Congestion,Cyst,Deposition, calcium,Edema,Congestion,|Mammary gland,Mammary gland #4, right,Iliac lymph node,Axillary lymph node,Prescapular lymph node,Vagina,Adrenal gland,Thyroid gland,Intestine,Blood,Heart,Small intestine,Bone marrow,Liver,Mesenteric lymph node,Parotid gland, right,Uterus,Liver,Ovary,Vaginal mucous membrane,Pancreas (Exocrine Pancreas),Mesenteric lymph node,Epiglottis,Parathyroid gland,Uterus,Spleen,Retropharyngeal lymph node,Kidney,Liver,Lung,Thyroid gland,Lung,Lung,Kidney,|,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3103|2|4170|Adenocarcinoma, w/evidence of metastasis,Adenocarcinoma, malignant,Fibrosarcoma, malignant,Leiomyoma, benign,Fibroma, benign,Degeneration,Inflammation, chronic,Inflammation,Hyperplasia, lymphoid,Metaplasia, myeloid  (extramedulary hematopoesis),Deposition, calcium,Hyperplasia,Hyperplasia, lymphoid,Inflammation,Hyperplasia,Undetermined manner of death,Hyperplasia,|Mammary gland,Mammary gland,Mammary gland,Vagina,Axillary lymph node,Liver,Kidney,Esophagus,Mandibular lymph node,Spleen,Lung,Adrenal gland,Prescapular lymph node,Uterus,Uterus,Topography, multiple sites,Uterus,|ADENOMATOUS HYPERPLASIA.,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3109|2|5189|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenoma, benign,Leydig cell tumor, benign,Inflammation, chronic,Pigmentation, hemosiderin,Inflammation,Hematoma,Inflammation, acute,Congestion,Atrophy,Cyst,Congestion,Autolysis,Hyperplasia,Atrophy,Congestion,|Lung,Aorta,Stomach,Tracheobronchial lymph node,Heart,Adrenal gland,Testis,Lung,Spleen,Kidney,Spleen,Liver,Liver,Axillary lymph node,Kidney,Kidney,Topography, multiple sites,Adrenal gland,Biceps brachii muscle,Brain,|MODERATE,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3115|2|3943|Osteosarcoma, malignant,Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Fibroma, benign,Adenoma, benign,Leiomyoma, benign,Adenoma, benign,Lipoma, benign,Inflammation,Hyperplasia, lymphoid,Hematoma,Hyperplasia, lymphoid,Hyperplasia, lymphoid,Inflammation,Cyst,Congestion,Hyperplasia,Hyperplasia,Inflammation,Hyperplasia,Degeneration,Degeneration,|Rib,Mammary gland,Mandibular lymph node,Liver,Axillary lymph node,Ovary,Prescapular lymph node,Vagina,Parathyroid gland,Vagina,Pituitary gland,Omentum (Abdominal Fat),Retropharyngeal lymph node,Spleen,Spleen,Retropharyngeal lymph node,Tonsil,Lung,Ovary,Mandibular lymph node,Uterus,Cervix uteri (exocervix and endocervix),Kidney,Adrenal gland,Liver,Adrenal gland,|CELLULAR DEGEN/NECROSIS IN CORTEX,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3116|2|4333|Carcinoma, malignant,Adenoma, benign,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Leydig cell tumor, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Metaplasia, myeloid  (extramedulary hematopoesis),Degeneration,Hyperplasia,Hyperplasia,Hyperplasia,Hyperplasia, lymphoid,|Perianal gland,Thyroid gland,Inguinal lymph node,Liver,Colic lymph node,Iliac lymph node,Testis,Testis,Spleen,Liver,Adrenal gland,Prostate,Pancreas (Exocrine Pancreas),Lymph node,|PRESCAP,AXIL,MRPH,MANDIB.,BRONCH.,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3117|2|4981|Seminoma, malignant,Hemangioendothelioma, benign,Leydig cell tumor, benign,Adenoma, benign,Adenoma, benign,Inflammation,Congestion,Hemorrhage,Inflammation, chronic,Metaplasia, myeloid  (extramedulary hematopoesis),Pigmentation, hemosiderin,Congestion,Degeneration,Hematoma,Pigmentation, hemosiderin,Hemorrhage,Degeneration,Pigmentation, hemosiderin,Pigmentation, hemosiderin,Congestion,Congestion,|Testis,Subcutaneous tissue,Testis,Pituitary gland,Perianal gland,Prostate,Kidney,Cerebral cortex,Kidney,Spleen,Axillary lymph node,Axillary lymph node,Biceps brachii muscle,Spleen,Iliac lymph node,Adrenal gland,Liver,Prescapular lymph node,Retropharyngeal lymph node,Liver,Lung,|,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3118|2|4298|Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Mixed tumor (Pleomorphic adenoma), benign,Adenoma, benign,Hemangioma, benign,Leydig cell tumor, benign,Developmental malformation,Cyst,Hyperplasia,Degeneration,Inflammation, chronic,Inflammation,Hyperplasia,Hyperplasia,Mixed tumor (Pleomorphic adenoma), benign,Inflammation,Hyperplasia,|Soft palate,Mandibular lymph node,Tracheobronchial lymph node,Heart,Retropharyngeal lymph node,Lung,Prostate,Perianal gland,Skin of chest,Testis,Urethra,Pituitary gland,Adrenal gland,Liver,Kidney,Prostate,Bone marrow,Liver,Urethra,Urinary bladder,Urinary bladder,|HYPERPLASTIC EPITHELIUM,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3121|2|5213|Mixed tumor, malignant (AFIP 80850),Adenocarcinoma, malignant,Adenocarcinoma, malignant,Leiomyoma, benign,Fibroma, benign,Seizure syndrome,Hyperplasia,Hyperplasia,Hematoma,Undetermined manner of death,Congestion,Inflammation, acute,Edema,Congestion,Congestion,Metaplasia, myeloid  (extramedulary hematopoesis),Congestion,Congestion,Congestion,Cyst,Autolysis,|Mammary gland,Mammary gland #2, right,Axillary lymph node,Uterus,Vagina,Brain,Uterus,Atrioventricular valve,Spleen,Whole body,Liver,Lung,Lung,Brain,Mandibular lymph node,Spleen,Pituitary gland,Kidney,Prescapular lymph node,Ovary,Topography, multiple sites,|PANCREAS, LIVER, GALLBLADDER, THYRO   ID, PARATHYROID, ADRENALS, GI TRACT, MESE LN, BOMA,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3132|2|4434|Lymphoma, malignant,Lymphoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Adenoma, benign,Hemangioma, benign,Lipoma, benign,Papilloma, benign,Inflammation,Inflammation, acute,Hyperplasia,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation, acute,Cyst,Hemorrhage,Metaplasia, myeloid  (extramedulary hematopoesis),Cyst,Inflammation,Cyst,|Skin,Topography, multiple sites,Mammary gland,Mammary gland,Mammary gland,Thyroid gland,Vulva,Mammary gland,Skin,Lung,Lip,Adrenal gland,Rib,Liver,Tongue,Thyroid gland,Adipose tissue,Spleen,Liver,Kidney,Ovary,|,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3134|2|4789|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenoma, benign,Adenoma, benign,Fibroma, benign,Toxic state,Metaplasia, myeloid  (extramedulary hematopoesis),Autolysis,Autolysis,Degeneration,Congestion,Inflammation,Inflammation,Hyperplasia,Inflammation,|Mammary gland #2, right,Lymph node,Axillary lymph node,Iliac lymph node,Lung,Adrenal gland,Thyroid gland,Vagina,Spleen,Pancreas (Exocrine Pancreas),Gallbladder,Liver,Prescapular lymph node,Lung,Uterus,Adrenal gland,Kidney,|MOD TO MARKED GLOMERULAR MEMB THICK,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3135|2|3721|Carcinoma, malignant,Adenocarcinoma, malignant,Carcinoma, malignant,Granulosa cell tumor, uncertain whether benign or malignant,Adenoma, benign,Hemangioma, benign,Toxic state,Sepsis,Abscess,Abscess,Degeneration,Inflammation,Disseminated intravascular coagulation (DIC) syndrome,Hyperplasia,Inflammation,Inflammation,Disseminated intravascular coagulation (DIC) syndrome,Edema,Edema,Disseminated intravascular coagulation (DIC) syndrome,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),|Thyroid gland, left lobe,Kidney,Pituitary gland,Ovary,Ovary,Esophagus,Blood,Liver,Liver,Kidney,Lymph node,Stomach,Uterus,Urinary bladder,Adrenal gland,Lymph node,Heart,Lung,Pancreas (Exocrine Pancreas),Bone marrow,Spleen,|MYELOID AND ERYTHROID CELLS.,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3137|2|2353|Inflammation, acute,Degeneration,Congestion,Deposition of foreign crystalline material,Hyperplasia,Atrophy,Autolysis,Inflammation,Hypoplasia,Deposition of foreign crystalline material,Autolysis,Nephrosis,Inflammation,Necrosis,|Intestine,Adrenal gland,Liver,Brain,Lymph node,Testis,Intestine,Lung,Bone marrow,Liver,Liver,Kidney,Lung,Heart,|SINGLE FIBRE NECROSIS,EDEMA,HEMORGE   MARKED FRAGMENTATION OF FIBRE.ALL THE ABOVE CHANGES ARE CONSISTENT WITH TOXIC SHOCK.,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3138|2|3528|Adenoma, benign,Adenoma, benign,Sepsis,Inflammation, pneumonia, septic,Inflammation, acute,Inflammation, acute,Hyperplasia,Inflammation,Inflammation, acute,Inflammation, acute,Cyst,Hyperplasia,Inflammation, acute,Polyp, fibroepithelial,Hyperplasia,Congestion,Inflammation, acute,|Anal gland,Uterus,Blood,Lung,Heart,Lymph node,Bone marrow,Thyroid gland,Diaphragm,Uterus,Ovary,Parathyroid gland,Lung,Vagina,Spleen,Liver,Adrenal medulla,|NECROSIS,BACTERIA +HEMORRHAGES.,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3140|2|3076|Leydig cell tumor, benign,Degeneration,Hyperplasia,Atrophy,|Testis,Cerebellum,Lymph node,Cerebellum,|CEREBELLAR ATROPHY.,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3141|2|3802|Adenoma, benign,Fibrosis,Necrosis,Infarct,Atrophy,Inflammation,Hyperplasia,Disseminated intravascular coagulation (DIC) syndrome,Hemorrhage,Inflammation,Hyperplasia,Regeneration,Degeneration, fatty,|Pituitary gland,Heart,Liver,Kidney,Testis,Lymph node,Bone marrow,Topography, multiple sites,Topography, multiple sites,Lung,Adrenal gland,Liver,Liver,|,|
1003-6-2|3.8 rad/day, total rad dose 450, (22 hrs/7 days) mean age 463 days,05T0600|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until death|24 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-2-3145|2|5056|Adenocarcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Adenocarcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Leiomyosarcoma, malignant,Fibroma, benign,Leiomyoma, benign,Leiomyoma, benign,Adenoma, benign,Inflammation,Hyperplasia,Morphology unknown,Inflammation, acute,Congestion,Hyperplasia,Ectopia,Inflammation, chronic,Degeneration,Hyperplasia,|Mammary gland #4, left,Mammary gland #1, left,Mammary gland #2, left,Mammary gland #5, right,Adrenal gland,Liver,Lung,Urinary bladder,Vagina,Vagina,Vagina,Stomach,Thyroid gland,Diaphragm,Adrenal gland,Omentum (Abdominal Fat),Uterus,Liver,Kidney,Lymph node of thorax,Kidney,Liver,Urinary bladder,|EPITHELIAL,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2181|3|3836|Mixed tumor, uncertain whether benign or malignant,Mixed tumor, uncertain whether benign or malignant,Adenocarcinoma, malignant,Intraductal papilloma, benign,Intraductal papilloma, benign,Intraductal papilloma, benign,Uremia syndrome,Leiomyoma, benign,Obstruction,Hyperplasia,Hyperplasia,Hyperplasia,Inflammation,Inflammation, chronic,Inflammation, chronic,|Mammary chain, right,Mammary gland #2, left,Skin appendage (Adnexal structure),Mammary gland #2, right,Mammary gland #4, left,Mammary gland #4, right,Kidney,Vaginal muscularis,Urethra,Mammary gland #2, left,Thyroid gland, right lobe,Ureter,Kidney,Urinary bladder,Ureter,| BOTH URETERS,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2182|3|4948|Carcinoma, undifferentiated type, malignant,Carcinoma, undifferentiated type, malignant,Carcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Medullary carcinoma (C-cell carcinoma), malignant,Hemangioendothelioma, benign,Leiomyoma, benign,Papillary adenoma, benign,Islet cell adenoma, benign,Papillary adenoma, benign,Atelectasis,Respiratory failure,Embolus,Infarct,Fibrosis,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Inflamation, acute exudative (suppurative),Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Hyperplasia,|Mammary gland,Topography, multiple sites,Thorax,Mammary chain, left,Thyroid gland, left lobe,Skin,Vaginal muscularis,Duodenal mucous membrane,Pancreas (Exocrine Pancreas),Gastric mucous membrane,Lung,Lung,Lung,Pituitary gland,Lung,Anus,Spleen,Endometrium,Liver,Adrenal cortex,Ovary, left,|SURFACE PAPILLARY HYPERPL,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2186|3|3463|Mixed tumor, uncertain whether benign or malignant,Luteoma, benign,Intraductal papilloma, benign,Adenoma, benign,Adenoma, benign,Pyometra,Inflammation, acute,Inflammation, chronic,Degeneration,Inflamation, acute exudative (suppurative),Inflammation, chronic,Cyst,Inflamation, acute exudative (suppurative),Ulcer,Hyperplasia,|Mammary gland #3, right,Ovary, left,Mammary chain, right,Mammary gland #4, right,Thyroid gland, left lobe,Uterus,Abdomen, peritoneum and retroperitoneum,Kidney,Liver,Uterus,Duodenum,Mammary gland #3, right,Abdomen,Duodenum,Mucosa of gallbladder,|CYSTIC MUCINOUS,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2189|3|4324|Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Leydig cell tumor, benign,Leydig cell tumor, benign,Adenoma, benign,Adenoma, benign,Adenoma, benign,Adenoma, benign,Adenoma, benign,Hypoplasia,Atrophy,Inflamation, acute exudative (suppurative),Ulcer,|Perianal gland,Skin appendage (Adnexal structure),Perianal gland,Lymph node,Abdomen,Lung,Skeletal muscle,Testis, right,Testis,Perianal gland,Perianal gland,Perianal gland,Perianal gland,Perianal gland,Liver,Myocardium,Lung,Epidermis,| SUPERFICIAL,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2193|3|5583|Carcinoma, malignant,Adenocarcinoma, malignant,Uremia syndrome,Adenoma, benign,Adenoma, benign,Leydig cell tumor, benign,Leydig cell tumor, benign,Congestion,Autolysis,Autolysis,Pigmentation, hemosiderin,Autolysis,Fibrosis,Congestion,Inflammation, chronic,Autolysis,Pigmentation, hemosiderin,Congestion,Pigmentation, hemosiderin,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation, acute,Congestion,Inflammation, chronic,Congestion,Pigmentation, hemosiderin,Inflammation, acute,Hyperplasia,Congestion,Cyst,Hyperplasia,Pigmentation, hemosiderin,|Thyroid gland,Gallbladder,Kidney,Adrenal gland,Parathyroid gland,Testis, left,Testis, right,Pituitary gland,Topography, multiple sites,Urinary bladder,Retropharyngeal lymph node,Liver,Testis, left,Stomach,Prostate,Bone marrow,Spleen,Lung,Iliac lymph node,Spleen,Lung,Kidney,Kidney,Liver,Prescapular lymph node,Mandibular lymph node,Adrenal gland,Brain,Parathyroid gland,Prostate,Liver,|MODERATE,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2195|3|5092|Carcinoma, malignant,Leiomyoma, benign,Heart failure, (Congestive),Bacterial endocarditis,Adenoma, benign,Adenoma, benign,Adenoma, benign,Filarioidea,Fibrosis,Inflammation,Atrophy,Hyperplasia,Hyperplasia,Cyst,Atrophy,Necrosis,Inflammation,Edema,Hyperplasia,Hyperplasia,Regeneration,Inflammation,Disseminated intravascular coagulation (DIC) syndrome,Atrophy,Fibrosis,|Thyroid gland,Prostate,Heart,Heart,Parathyroid gland,Testis,Testis,Lung,Testis,Testis,Liver,Bone marrow,Pituitary gland,Muscle,Liver,Lung,Heart,Lymph node,Prostate,Liver,Atrioventricular valve,Brain,Testis,Spleen,|MULTIPLE FIBROUS SCARS.,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2199|3|4255|Carcinoma, malignant,Adenocarcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Carcinoma, undifferentiated type, malignant,Papillary carcinoma, malignant,Intraductal carcinoma, non-infiltrating,Mixed tumor, uncertain whether benign or malignant,Papillary carcinoma, malignant,Intraductal carcinoma, non-infiltrating,Papillary carcinoma, malignant,Hemangioendothelioma, benign,Intraductal papilloma, benign,Hemangiopericytoma, uncertain whether benign or malignant,Carcinoma, undifferentiated type, malignant,Adenoma, benign,Papilloma, benign,Hyperplasia,Hyperplasia,Inflamation, acute exudative (suppurative),Hyperplasia,Inflammation,Cyst,Cyst,Deposition, calcium,Degeneration,Degeneration, fatty,Cyst,Hemorrhage,|Mammary gland #4, right,Mammary gland #4, right,Mammary gland #4, right,Mammary gland,Mammary gland #5, left,Mammary gland #2, right,Mammary gland #2, right,Mammary gland #4, left,Mammary gland #3, right,Lung,Visceral peritoneum,Mammary gland #1, right,Subcutaneous tissue of foot,Topography, multiple sites,Mammary gland #3, right,Vaginal mucous membrane,Mammary gland #1, right,Ovary,Uterus,Mammary gland #3, right,Kidney,Thyroid gland,Parathyroid gland,Skeletal muscle,Liver,Aorta,Liver,Spleen,| HEMATOMA C HEMOSIDEROSIS,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2200|3|3888|Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Hemangioendothelioma, benign,Leiomyoma, benign,Inflamation, acute exudative (suppurative),Hyperplasia,Infarct,Atrophy,Inflamation, acute exudative (suppurative),Chondroblastic osteosarcoma, malignant,Chondroblastic osteosarcoma, malignant,Neoplastic disease, malignant,Neoplastic disease, malignant,Radiation disease,Fibrosis, perivascular,Radiation disease,Fibrosis, perivascular,Fibrosis,Fibrosis,Edema,Edema,Osteoblastic osteosarcoma, malignant,Neoplastic disease, malignant,Neoplastic disease, malignant,Osteoblastic osteosarcoma, malignant,Neoplastic disease, malignant,Osteoblastic osteosarcoma, malignant,Osteoblastic osteosarcoma, malignant,Neoplastic disease, malignant,Hyperplasia, focal,Hyperplasia, focal,Cyst,Cyst,|Lip, lower,Buccal mucosa,Lymph node,Liver,Tonsil, left,Brain,Spleen,Cortex of kidney,Small intestine muscularis propria,Lung,Testis,Cortex of kidney,Testis,Spleen,Cervical vertebra, seventh,Cervical vertebra, seventh,Thoracic vertebra, fifth,Thoracic vertebra, fifth,Lumbar vertebra, second,Lumbar vertebra, second,Lung,Lung,Humerus, right,Humerus, right,Tibia, right,Tibia, right,Hepatic parenchymal cell,Hepatic parenchymal cell,Pituitary anterior lobe (Pars Glandularis),Pituitary anterior lobe (Pars Glandularis),|Pathology performed at ITRI! CYST/PITUITARY, PARS DISTALIS (incidental disease04),|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2354|3|5227|Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Sebaceous adenocarcinoma, malignant,Adenoma, benign,Hemangioma, benign,Fibroma, benign,Adenoma, benign,Islet cell adenoma, benign,Fibroma, benign,Chronic renal disease,Congestion,Inflammation,Hyperplasia,Cyst,Atherosclerosis,Hematoma,Hematoma,Regeneration,Hyperplasia,Hyperplasia,|Kidney,Lung,Mammary gland #5, left,Mammary chain, right,Skin,Thyroid gland,Subcutaneous tissue,Vagina,Parathyroid gland,Pancreas (Exocrine Pancreas),Vaginal muscularis,Kidney,Liver,Kidney,Urinary bladder,Thyroid gland,Blood vessel,Muscle,Spleen,Liver,Adrenal gland,Atrioventricular valve,|NODULAR FIBROUS HYPERPLASIA,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2355|3|2932|Papillary carcinoma, malignant,Hemangioendothelioma, benign,Papilloma, benign,Papilloma, benign,Papillary adenoma, benign,Papillary carcinoma, malignant,Papillary carcinoma, malignant,Papillary carcinoma, malignant,Papillary carcinoma, malignant,Papillary carcinoma, malignant,Inflammation, acute,Inflammation,Hyperplasia,Hyperplasia,Hyperplasia,Hyperplasia,Fibrosis,Fibrosis,Hyperplasia,Infarct,Degeneration, fatty,Hemorrhage,|Mammary gland #4, left,Spleen,Ovary, right,Mucous membrane of urinary bladder,Gastric mucous membrane,Bone marrow,Heart,Capsule of kidney,Mammary gland #5, right,Lung,Renal pelvis, right,Lung,Mammary gland #4, left,Liver,Mucous membrane of urinary bladder,Ureter,Capsule of kidney,Diaphragm,Mammary gland #5, right,Heart,Liver,Capsule of kidney,|& GRANULAT. TISS. ADNEXA,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2356|3|4110|Carcinoma, malignant,Adenocarcinoma, malignant,Carcinoma, malignant,Fibroma, benign,Carcinoma, undifferentiated type, malignant,Carcinoma, undifferentiated type, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Melanoma, (Pigmented nevus), benign,Degeneration, fatty,Hyperplasia,Hypertrophy,Atrophy,Cyst,Hyperplasia,Hemorrhage,|Thyroid gland, left lobe,Mammary gland,Mammary gland,Uterus,Mammary gland,Mammary gland,Aorta,Lymph node,Epidermis,Liver,Bony tissue (bone),Spleen,Skeletal muscle,Ovary,Mammary chain, left,Spleen,| HEMATOMA,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2357|3|5199|Fibrosarcoma, malignant,Adenoma, benign,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Adenoma, benign,Adenoma, benign,Leydig cell tumor, benign,Inflamation, acute exudative (suppurative),Fibrosis,Autolysis,Autolysis,Autolysis,Autolysis,Hyperplasia,Autolysis,Autolysis,Congestion,Inflammation, chronic,Hypoplasia,Hypoplasia,Hyperplasia,Autolysis,Hyperplasia,Inflammation, acute,Congestion,Autolysis,Autolysis,Autolysis,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation,Degeneration,Edema,Hyperplasia,|Cecum,Pituitary gland,Pancreas (Exocrine Pancreas),Iliac lymph node,Thyroid gland, left lobe,Thyroid gland, right lobe,Parathyroid gland,Testis,Prostate,Aortic tunica intima,Colon,Ileum,Thyroid gland,Jejunum,Adrenal gland,Duodenum,Gallbladder,Liver,Kidney,Spleen,Mesenteric lymph node,Atrioventricular valve,Urinary bladder,Pancreas (Exocrine Pancreas),Prostate,Lung,Bone marrow,Salivary gland,Adrenal gland,Spleen,Lung,Liver,Lung,Liver,|BILIARY HYPERPLASIA,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2358|3|3901|Hemangiosarcoma (Angiosarcoma), malignant,Hemangiosarcoma (Angiosarcoma), malignant,Seminoma, malignant,Leydig cell tumor, benign,Leydig cell tumor, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Degeneration,Hyperplasia,Edema,Congestion,Necrosis,Metaplasia, myeloid  (extramedulary hematopoesis),Deposition, calcium,Necrosis,Fibrosis,Pigmentation,|Spleen,Liver,Testis, right,Testis, right,Testis, left,Testis, left,Liver,Bone marrow,Myocardium,Lung,Liver,Spleen,Kidney,Skeletal muscle,Endocardium,Lymph node,|HEMOSID+ERYTHROPHAGOCYTOS,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2359|3|3932|Uremia syndrome,Obstruction,Tubular androblastoma (Sertoli Cell Tumor), benign,Leydig cell tumor, benign,Necrosis,Inflammation, acute,Degeneration,Congestion,Congestion,Cyst,Hemorrhage,|Kidney,Urethra,Testis,Testis, right,Cortex of kidney,Mucous membrane of urinary bladder,Myocardium,Lung,Liver,Pituitary gland,Spleen,|HEMATOMA+HEMOSIDEROSIS.             +,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2360|3|4756|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Carcinoma, malignant,Leiomyoma, benign,Adenocarcinoma, malignant,Basal cell carcinoma, malignant,Adenoma, benign,Leydig cell tumor, benign,Lipoma, benign,Hyperplasia,Inflammation, chronic,Necrosis,Atrophy,Disseminated intravascular coagulation (DIC) syndrome,Degeneration, fatty,Pigmentation,Pigmentation,Pigmentation,Fibrosis,Hyperplasia,Hyperplasia,|Prostate,Bony tissue (bone),Topography, multiple sites,Thyroid gland,Duodenum,Lung,Perianal gland,Perianal gland,Testis,Spleen,Parathyroid gland,Lung,Myocardium,Skeletal muscle,Lung,Liver,Liver,Spleen,Lymph node,Kidney,Skin,Kidney,|S DYSPLASIA,PELVIC EPITHE,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2369|3|4753|Adenocarcinoma, malignant,Fibroadenoma, benign,Adenoma, benign,Adenoma, benign,Leiomyoma, benign,Fibroadenoma, benign,Leiomyoma, benign,Adenoma, benign,Inflammation, pneumonia, septic,Inflammation,Infarct,Embolus,Normal tissue morphology,Abscess,Hyperplasia,Inflammation,Inflammation,Embolus,Hyperplasia,Cyst,Congestion,Osteoporosis,|Mammary gland,Mammary gland,Parathyroid gland,Adrenal gland,Jejunum,Mammary gland,Vaginal muscularis,Thyroid gland,Lung,Urinary bladder,Lung,Lung,Bone marrow,Lung,Adrenal gland,Kidney,Kidney,Kidney,Stomach,Ovary,Liver,Bony tissue (bone),|OSTEOPOROSIS/PARATYROID ADENOMA.   BONES SHOW OSTEOPOROSIS+INCREASED OSTEOCLASTIC RESORPTION OF BONY PLATES.,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2370|3|1333|Lymphoma, lymphocytic, malignant, well differentiated,Anemia,Ulcer,Hyperplasia,Abscess,Inflammation,Inflammation, acute,Inflammation,|Topography, multiple sites,Blood,Stomach,Kidney,Visceral peritoneum,Lung,Visceral peritoneum,Kidney,|SUBAC. GLOMERULONEPHRITIS,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2373|3|4977|Carcinoma, malignant,Adenocarcinoma, malignant,Carcinoma, malignant,Uremia syndrome,Inflammation, chronic, glomerulonephritis,Inflammation,Metaplasia, myeloid  (extramedulary hematopoesis),Deposition, calcium,Deposition, calcium,Hyperplasia,Necrosis,Hyperplasia,Inflammation,Inflammation,Fibrosis,Fibrosis,Regeneration,Inflammation,Cyst,Necrosis,Polyp,Hemorrhage,Hyperplasia,Hyperplasia,|Pancreas (Exocrine Pancreas),Lung,Topography, multiple sites,Kidney,Kidney,Prostate,Spleen,Lung,Brain,Lymph node,Spleen,Bone marrow,Lymph node,Urinary bladder,Liver,Kidney,Liver,Lung,Pituitary gland,Pituitary gland,Stomach,Lung,Spleen,Adrenal gland,|NODULAR CORTICAL HYPERPLASIA.,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2495|3|2150|Inflammation, acute,Congestion,Atrophy,Inflammation, acute,Inflammation, chronic,Hypoplasia,Hypoplasia,Inflammation, acute,Inflammation,Inflammation,Inflammation,Degeneration,|Intestine,Topography, multiple sites,Testis,Lung,Colonic mucous membrane,Mesenteric lymph node,Mesenteric lymph node,Pancreas (Exocrine Pancreas),Kidney,Gastric mucous membrane,Small intestine mucous membrane,Kidney,|NEPHROSIS,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2500|3|2204|Seizure syndrome,Adenoma, benign,Congestion,Inflammation, acute,Inflammation,Undetermined manner of death,Deposition, calcium,Atrophy,Congestion,Inflammation,|Brain,Thyroid gland, right lobe,Liver,Lymph node,Lung,Topography, multiple sites,Artery,Testis,Spleen,Kidney,|SUBACUTE GLOMERULONEPHRIT,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2502|3|4133|Sarcoma, malignant,Carcinomatosis, primary or metastasis?,Atrophy,Traumatic abnormality,Hyperplasia,Cyst,|Spleen,Testis,Lung,Prostate,Pituitary gland,|ALARGE COLLOID CYST.,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2509|3|2112|Inflammation, acute,Hypoplasia,Atrophy,Inflammation, chronic,Hyperplasia,Edema,Hyperplasia,Inflammation,Inflammation,Inflammation,Hemorrhage,Hyperplasia,Inflammation, acute,Congestion,|Intestine,Mucous membrane of urinary bladder,Testis,Lung,Spleen,Lung,Adrenal gland,Colonic mucous membrane,Gastric mucous membrane,Small intestine mucous membrane,Myocardium,Mesenteric lymph node,Kidney,Liver,|CPC- INTRANUCL. AC.IN.BO.,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2520|3|3647|Mixed tumor, uncertain whether benign or malignant,Squamous cell carcinoma, malignant (epidermoid carcinoma),Mixed tumor, uncertain whether benign or malignant,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, malignant, w/evidence of metastasis,Intraductal adenoma, benign,Leiomyoma, benign,Intraductal papilloma, benign,Inflammation,Hyperplasia,Congestion,Deposition, calcium,Ulcer,Inflammation, acute,Inflammation,Hyperplasia,Inflammation, chronic,Cyst,Hyperplasia,Hyperplasia,Inflammation, acute,Hyperplasia,|Mammary chain, right,Mammary gland #2, right,Mammary gland #5, left,Skin,Lung Lobe, right diaphragmatic,Topography, multiple sites,Skin,Vaginal muscularis,Mammary gland #5, left,Spleen,Skin appendage (Adnexal structure),Liver,Lung,Skin,Pericardium,Kidney,Mammary gland #1, left,Lung,Ovary,Vaginal mucous membrane,Bone marrow,Visceral peritoneum,Mammary gland #4, left,| C DUCT ECTASIA,|
1003-6-3|3.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,05T1400|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|16 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-3-2522|3|3337|Hemangiosarcoma (Angiosarcoma), malignant,Hemangiosarcoma (Angiosarcoma), malignant,Hemorrhage, acute,Fibrosis,|Myocardium of right atrium,Lung,Myocardium of right atrium,Myocardium,|FIBROTIC REPL. OF MYOCARD           .,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2499|4|4181|Inflammation, pneumonia, septic,Leydig cell tumor, benign,Papillary adenoma, benign,Degeneration,Seizure syndrome,Lipoma, benign,Hyperplasia,Hyperplasia,Hyperplasia,Hyperplasia,Congestion,Degeneration,Hemorrhage,Hyperplasia,Congestion,|Lung,Testis,Duodenal mucous membrane,Brain,Brain,Spleen,Lymph node,Liver,Gastric mucous membrane,Spleen,Liver,Brain,Spleen,Prostate,Lung,|ACUTE CONGESTION.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2501|4|4151|Sarcoma, malignant,Sarcoma, malignant,Tubular androblastoma (Sertoli Cell Tumor), benign,Adenoma, benign,Jaundice, hepatocellular,Uremia syndrome,Hyperplasia,Hypoplasia,Hyperplasia,Cyst,Atrophy,Cyst,Inflammation, chronic,|Spleen,Liver,Testis,Thyroid gland, right lobe,Liver,Kidney,Testis,Bone marrow,Prostate,Thyroid gland, right lobe,Skeletal muscle,Pituitary gland,Kidney,|CH PYELONEPHRITIS/SCARS.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2508|4|2903|Infarct,Toxic state,Infectious or communicable disease,Infarct,Hemorrhage,Hyperplasia,Inflammation, chronic,|Lung,Clostridium,Lung,Topography, multiple sites,Prostate,Epididymis,|AC&CH EPIDIDYMITIS.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2519|4|3379|Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Intraductal papilloma, benign,Intraductal papilloma, benign,|Mammary chain, left,Lung,Lymph node,Pituitary gland,Mammary chain, right,Mammary gland #4, left,|,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2521|4|4274|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Carcinoma, undifferentiated type, malignant,Transitional cell carcinoma, malignant,Fibroma, benign,Fibroma, benign,Lipoma, benign,Adenoma, benign,Hyperplasia,Hyperplasia,Hyperplasia,Hyperplasia,Hyperplasia,Inflamation, acute exudative (suppurative),Atelectasis,Pigmentation,Fibrosis,|Mammary chain, right,Topography, multiple sites,Urinary bladder,Neck of urinary bladder,Uterus,Skin,Skin,Small intestine,Lymph node,Bone marrow,Uterus,Spleen,Liver,Uterus,Lung,Spleen,Atrioventricular valve,|MARANTIC VEGETATIONS.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2537|4|3653|Mixed tumor, uncertain whether benign or malignant,Intraductal papilloma, benign,Fibroma, benign,Hemostatic function, abnormal,Embolus,Hypoplasia,Hyperplasia,Pigmentation,Pigmentation,Embolus,Hyperplasia,|Mammary gland #5, left,Mammary gland #4, right,Uterus,Peritoneal cavity,Lung,Bone marrow,Abdomen,Retropharyngeal lymph node,Spleen,Lung,Liver,|REGEN NODULES/FATTY CHANG,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2749|4|4749|Carcinoma, malignant,Carcinoma, malignant,Cardiopulmonary disease or syndrome,Death, anesthetic,Leydig cell tumor, benign,Hyperplasia, lymphoid,Hemorrhage,Congestion,Edema,Inflammation,Fibrosis,Hyperplasia, lymphoid,Degeneration,Hyperplasia, lymphoid,Autolysis,Congestion,Inflammation,Inflammation, chronic,Acanthosis,Metaplasia, myeloid  (extramedulary hematopoesis),|Adrenal gland,Thyroid gland,Heart,Topography, multiple sites,Testes, both,Retropharyngeal lymph node,Cerebral cortex,Kidney,Lung,Lung,Aorta,Mandibular lymph node,Liver,Prescapular lymph node,Bone marrow,Lung,Kidney,Prostate,Skin,Spleen,|EMH WITH SOME HEMORRHAGE IN CENTER,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2752|4|5245|Hemangioma, benign,Adenoma, benign,Leydig cell tumor, benign,Adenoma, benign,Paralysis,Degeneration,Hyperplasia, lymphoid,Hematoma,Hyperplasia, lymphoid,Fibrosis,Hyperplasia, lymphoid,Undetermined manner of death,Inflammation, chronic,Atrophy,Hyperplasia,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Hemorrhage,Atrophy,|Prescapular lymph node,Thyroid gland,Testis, left,Perianal gland,Radial nerve,Liver,Prescapular lymph node,Spleen,Peyer's patch,Aorta,Axillary lymph node,Topography, multiple sites,Kidney,Biceps brachii muscle,Adrenal gland,Prostate,Spleen,Cerebral cortex,Testis, right,|,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2756|4|3994|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Leydig cell tumor, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Papilloma, benign,Adenoma, benign,Adenoma, benign,Papilloma, benign,Leydig cell tumor, benign,Retention of fluid  (Hydronephrosis),Deposition, calcium,Degeneration, fatty,Atelectasis,Hyperplasia,Retention of fluid  (Hydronephrosis),Hyperplasia,|Prostate,Iliac lymph node,Testis, left,Testis, right,Ileum,Perianal gland,Perianal gland,Duodenum,Prostate,Kidney,Stomach,Liver,Lung,Bone marrow,Kidney,Adrenal cortex,|NODULAR HYPERPLASIA.   MARKED ATROPHY OF MEDULLA WHICH IS DIFFUSELY INFILTRATED WITH ACUTE INFLAMMATORY EXUDATE.DILATATION OF BOWMANS SPACE FILLED WITH PROTEINACEOUS MATERIAL.FOCAL INTERSTITIAL NEPHRITIS AND CALCIUM CASTS.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2757|4|3299|Carcinoma, malignant,Toxic state,Inflamation, acute exudative (suppurative),Degeneration, fatty,Deposition, calcium,|Pituitary anterior lobe (Pars Glandularis),Kidney,Liver,Lung,|MICROLITHIASIS,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2763|4|4630|Mixed tumor, uncertain whether benign or malignant,Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Adenocarcinoma, malignant,Heart failure, (Congestive),Adenoma, benign,Adenoma, benign,Adenoma, benign,Leiomyoma, benign,Fibroadenoma, benign,Degeneration,Metaplasia, myeloid  (extramedulary hematopoesis),Degeneration,Hyperplasia,Congestion,Inflammation,Hyperplasia,Hyperplasia,Ulcer,Hyperplasia,Hyperplasia,Congestion,Inflammation, chronic,Degeneration,Pigmentation, hemosiderin,Congestion,Degeneration,Cyst,Hyperplasia,Regeneration,Hematoma,Hyperplasia,|Mammary gland #3, right,Mammary gland,Mammary gland #5, left,Iliac lymph node,Mammary gland,Pancreas (Exocrine Pancreas),Lung,Ovary,Heart,Pituitary gland,Salivary gland,Buccal mucosa,Stomach,Uterus,Myocardium,Spleen,Heart,Adrenal gland,Adrenal gland,Diaphragm,Spleen,Atrioventricular valve,Mammary gland #2, right,Ureter,Urinary bladder,Jejunum,Lung,Liver,Tracheobronchial lymph node,Kidney,Kidney,Thyroid gland,Liver,Liver,Spleen,Pleura,|PLEURAL SURFACE OF LUNG THICKENED,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2764|4|3446|Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, malignant,Cyst,Atrophy,Inflammation, chronic,Pigmentation,Degeneration, fatty,Hyperplasia,|Jejunum,Topography, multiple sites,Ovary,Ovary,Atrioventricular valve,Spleen,Liver,Adrenal cortex,| NODULAR HYPERPLASIA,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2765|4|4228|Granulosa cell tumor, malignant,Granulosa cell tumor, malignant,Mixed tumor, malignant (AFIP 80850),Fibroma, benign,Regeneration,Inflammation,Polyp,Regeneration,Hyperplasia,Cyst,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Polyp,Deposition, calcium,Hyperplasia,Cyst,Regeneration,|Ovary,Topography, multiple sites,Mammary gland #2, left,Vagina,Lung,Heart,Ileum,Liver,Jejunum,Uterus,Bone marrow,Spleen,Cervix uteri (exocervix and endocervix),Kidney,Stomach,Pituitary gland,Liver,|REGE/DEGE NODULES.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2766|4|3649|Carcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Fibroadenoma, benign,Leiomyoma, benign,Leiomyoma, benign,Shock,Disseminated intravascular coagulation (DIC) syndrome,Inflammation, chronic,Inflammation, acute,Necrosis,Inflammation, acute,Congestion,Degeneration, fatty,Inflammation, chronic,Hyperplasia,Disseminated intravascular coagulation (DIC) syndrome,Pigmentation,Inflammation, chronic,Disseminated intravascular coagulation (DIC) syndrome,Inflammation, acute,|Thyroid gland, right lobe,Mammary gland #5, right,Mammary gland #5, right,Vagina,Horn of uterus, left,Lung,Cervix uteri (exocervix and endocervix),Vagina,Adrenal gland,Uterus,Spleen,Liver,Skeletal muscle,Bony tissue (bone),Liver,Liver,Horn of uterus, left,Heart,Mucous membrane of urinary bladder,|AC NECROTIZING CYSTITIS.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2767|4|4286|Mixed tumor, uncertain whether benign or malignant,Mixed tumor, uncertain whether benign or malignant,Adenoma, benign,Leiomyoma, benign,Adenoma, benign,Disseminated intravascular coagulation (DIC) syndrome,Inflamation, acute exudative (suppurative),Atrophy,Fibrosis,Hyperplasia,Pigmentation, hemosiderin,Cyst,Hyperplasia,Hyperplasia,Hyperplasia,Disseminated intravascular coagulation (DIC) syndrome,|Mammary gland,Topography, multiple sites,Parathyroid gland,Stomach,Ovary,Lung,Endometrium,Muscle,Kidney,Mammary gland,Liver,Ovary,Bone marrow,Lymph node,Adrenal gland,Heart,|FIBRIN THROMBI&SMALLINFARCTS.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2768|4|4048|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Intraductal papilloma, benign,Fibroma, benign,Fibroma, benign,Leiomyoma, benign,Sepsis,Fibrosis,Inflammation,Degeneration, fatty,Hyperplasia,Cyst,Abscess,Atelectasis,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Cyst,Cyst,Hemorrhage,Polyp,Hyperplasia,Hyperplasia,Abscess,Regeneration,Hyperplasia,|Mammary gland #5, left,Mammary gland,Lung,Mammary gland #5, left,Vagina,Vagina,Stomach,Blood,Kidney,Liver,Liver,Spleen,Ovary,Topography, multiple sites,Lung,Spleen,Uterus,Ovary,Pituitary gland,Brain,Skin,Bone marrow,Adrenal gland,Skin,Liver,Lymph node,|REACTIVE HYPERPLASIA.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2769|4|2131|Hemostatic function, abnormal,Inflamation, acute exudative (suppurative),Atelectasis,Inflammation, acute,Pigmentation,Fibrosis,Deposition of foreign crystalline material,Deposition of foreign crystalline material,Inflammation, acute,Congestion,Deposition of foreign crystalline material,Hyperplasia,|Thoracic cavity,Lung,Lung,Lung,Spleen,Myocardium,Liver,Adrenal gland,Pleura,Liver,Testis,Bone marrow,|MYELOID HYPERPLASIA.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2773|4|4944|Mast cell sarcoma, malignant,Mast cell sarcoma, malignant,Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Adenocarcinoma, malignant,Fibroma, benign,Leiomyoma, benign,Leiomyoma, benign,Papillary cystadenoma, benign,Adenoma, benign,Fibroma, benign,Adenoma, benign,Leiomyoma, benign,Lipoma, benign,Inflammation, chronic,Inflammation,Inflammation,Hyperplasia,Hematoma,Hyperplasia,Hyperplasia,Degeneration,Hyperplasia, lymphoid,Hyperplasia,|Subcutaneous tissue,Liver,Mammary gland #2, left,Mammary gland #5, left,Lung,Vagina,Urinary bladder,Stomach,Ovary,Pituitary gland,Vagina,Eyelid,Vagina,Mammary gland #4, left,Kidney,Endometrium,Uterus,Endometrium,Spleen,Adrenal gland,Parathyroid gland,Liver,Mesenteric lymph node,Uterus,|HYPERPLASTIC POLYPS.,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2775|4|1140|Myeloid leukemia, malignant,Congestion,Inflammation, acute,|Topography, multiple sites,Liver,Lung,|C ABSCESSATION,|
1003-6-4|3.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,05T2000|1| 463|gamma-rays Co-60|3.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|13 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-4-2776|4|3856|Adenoma, benign,Papillary adenoma, benign,Adenoma, benign,Papillary adenoma, benign,Functional disorder,Sepsis,Hyperplasia,Hyperplasia,Degeneration, fatty,Inflammation, acute,Hyperplasia,Inflammation, acute,Disseminated intravascular coagulation (DIC) syndrome,Fibrosis,Disseminated intravascular coagulation (DIC) syndrome,Disseminated intravascular coagulation (DIC) syndrome,Disseminated intravascular coagulation (DIC) syndrome,Abscess,Inflammation, acute,Inflammation, acute,Metaplasia, myeloid  (extramedulary hematopoesis),Atrophy,Hyperplasia,Disseminated intravascular coagulation (DIC) syndrome,Disseminated intravascular coagulation (DIC) syndrome,Inflammation, chronic,|Pituitary gland,Pylorus,Thyroid gland, left lobe,Colon,Endocrine gland,Bony tissue (bone),Stomach,Liver,Prostate,Liver,Abdomen,Liver,Lung,Pituitary gland,Kidney,Adrenal gland,Liver,Pancreas (Exocrine Pancreas),Omentum (Abdominal Fat),Spleen,Skeletal muscle,Prostate,Pancreas (Exocrine Pancreas),Lung,Skeletal muscle,|POLYMYOSITIS.,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-2933|5|4346|Lymphosarcoma, malignant,Lymphosarcoma, malignant,Lymphosarcoma, malignant,Melanoma, (Pigmented nevus), benign,Adenoma, benign,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,|Skin,Topography, multiple sites,Skin,Skin of chin,Anal gland,Liver,Spleen,Adrenal gland,|CORTICAL,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-2939|5|3746|Papillary adenocarcinoma, malignant,Papillary adenocarcinoma, malignant,Leydig cell tumor, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Adenoma, benign,Degeneration, fatty,Edema,Atelectasis,Hyperplasia,Hyperplasia,|Unknown primary neoplasia site,Topography, multiple sites,Testis, left,Testis, left,Perianal gland,Liver,Heart,Lung,Lymph node,Bone marrow,|MYELOID&ERYTHROID HYPERPLASIA.,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-2941|5|4793|Adenocarcinoma, malignant,Sarcoma, malignant,Carcinoma, malignant,Hemangioma, benign,Leydig cell tumor, benign,Degeneration,Hyperplasia,Congestion,Congestion,Congestion,Hyperplasia,Hyperplasia,Congestion,Inflammation,Congestion,|Lung,Mediastinum,Parathyroid gland,Mesenteric lymph node,Testes, both,Liver,Bone marrow,Retropharyngeal lymph node,Colon,Ileum,Prostate,Adrenal gland,Kidney,Diaphragm,Iliac lymph node,|,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-2945|5|3121|Myeloproliferative disease, malignant, acute,Intraductal adenoma, benign,Fibrosis,Congestion,Inflammation, chronic,Hypertrophy,Traumatic abnormality,Hyperplasia,Inflammation, chronic,Congestion,Pigmentation,Hypertrophy,Congestion,Hyperplasia,Aplasia,Congestion,Hyperplasia,Inflammation,|Topography, multiple sites,Skin,Heart,Kidney,Small intestine mucous membrane,Bone marrow,Esophageal mucous membrane,Ovary,Brain,Lung,Bone marrow,Coronary artery,Liver,Lymph node,Bone marrow,Uterus,Adrenal cortex,Lung,| INTERSTITIAL,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-2949|5|4894|Carcinoma, malignant,Hemangioma, benign,Leydig cell tumor, benign,Bacterial endocarditis,Inflammation, acute,Congestion,Disease caused by bacteria,Inflammation, chronic,Hematoma,Degeneration,Hemorrhage,Congestion,Disease caused by bacteria,Hyperplasia,Hyperplasia, lymphoid,Hyperplasia, lymphoid,Congestion,Edema,Congestion,|Lung,Iliac lymph node,Testis, left,Atrioventricular valve,Pancreas (Exocrine Pancreas),Liver,Brain,Kidney,Spleen,Liver,Brain,Kidney,Heart,Adrenal gland,Iliac lymph node,Mandibular lymph node,Mandibular lymph node,Lung,Lung,|,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-2958|5|3899|Ependymoma, malignant,Mixed tumor, uncertain whether benign or malignant,Fibroma, benign,Adenoma, benign,Papilloma, benign,Degeneration,Inflammation,Inflammation,Polyp,Cyst,Fibrosis,Cyst,Hemorrhage,Cyst,Cyst,Hyperplasia,Hyperplasia,|Brain,Mammary gland,Vagina,Ovary,Mammary gland,Liver,Liver,Kidney,Cervix uteri (exocervix and endocervix),Ovary,Lung,Kidney,Spleen,Liver,Kidney,Adrenal gland,Uterus,|LEIOMYOMATUS,LOCALISED.,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-2960|5|3587|Adenocarcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Fibroma, benign,Retention of fluid  (Hydronephrosis),Inflammation, pneumonia, septic,Inflammation,Pigmentation,Inflammation,Inflammation,Disseminated intravascular coagulation (DIC) syndrome,Hyperplasia,Hyperplasia,Hyperplasia,Hyperplasia,Congestion,Hyperplasia,Hyperplasia,|Mammary gland #1, right,Mammary gland #4, left,Mammary gland #4, left,Mammary gland,Topography, multiple sites,Vagina,Thorax,Lung,Mediastinum,Spleen,Kidney,Diaphragm,Lung,Adrenal gland,Mammary gland,Uterus,Bone marrow,Liver,Mammary gland,Lymph node,|HYPERPLASIA & CONGESTION .,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-2963|5|5518|Fibrosarcoma, malignant,Carcinoma, malignant,Leydig cell tumor, benign,Polyp,Leydig cell tumor, benign,Leiomyoma, benign,Obstructive disease, partially,Degeneration,Hyperplasia,Hyperplasia,Pigmentation, hemosiderin,Inflammation,|Jejunum,Thyroid gland,Testis,Stomach,Testis, left,Stomach,Intestine,Liver,Adrenal cortex,Liver,Prescapular lymph node,Kidney,|GLOMERULONEPHRITIS, MODERATE/MARKED,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-2964|5|4940|Meningioma, malignant,Carcinoma, malignant,Carcinoma, malignant,Tubular androblastoma (Sertoli Cell Tumor), benign,Leiomyoma, benign,Consolidation,Congestion,Congestion,Hematoma,Degeneration,Congestion,Congestion,Hyperplasia,Edema,Hyperplasia,Congestion,|Cerebellum,Perianal gland,Colic lymph node,Testis,Urinary bladder,Lung,Liver,Brain,Spleen,Liver,Kidney,Retropharyngeal lymph node,Adrenal gland,Lung,Prostate,Mandibular lymph node,|MARKED CONGESTION/HEMORRHAGE,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-2965|5|5637|Sarcoma, malignant,Leiomyoma, benign,Leydig cell tumor, benign,Paralysis,Pigmentation, hemosiderin,Hyperplasia,Cyst,Atrophy,Inflammation,Hyperplasia,Adenoma, benign,Deposition, calcium,Degeneration,Inflammation,Hyperplasia,Inflammation,Hyperplasia,|Spleen,Stomach,Testis, left,Hindlimb,Iliac lymph node,Liver,Pituitary gland,Testis, left,Prostate,Adrenal cortex,Parathyroid gland,Aorta,Liver,Kidney,Pancreatic lymph node,Mandibular lymph node,Prostate,|MILD,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-3066|5|3594|Degeneration,Infarct,Regeneration,Degeneration, fatty,Deposition, calcium,Cyst,Atrophy,Hyperplasia,Inflammation,Hemorrhage,Fibrosis,Atrophy,Pigmentation, hemosiderin,Inflammation,Inflammation,Fibrosis,Inflammation,Hyperplasia,Ulcer,Pigmentation, hemosiderin,Pigmentation, hemosiderin,|Cerebellum,Brain,Liver,Liver,Kidney,Ovary,Cerebellum,Spleen,Kidney,Lung,Pleura,Corpus uteri,Lymph node,Tongue,Lymph node,Lung,Kidney,Bone marrow,Urinary bladder,Spleen,Lung,|2+ HEMOSIDEROSIS.,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-3068|5|4325|Lymphosarcoma, malignant,Adenoma, benign,Carcinoma, undifferentiated type, malignant,Adenocarcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Carcinoma, malignant,Mastocytoma, uncertain whether benign or malignant,Carcinoma, malignant,Carcinoma, malignant,Inflammation, acute,Inflammation, acute,Abscess,Cyst,Degeneration,Hyperplasia,Hyperplasia,Hyperplasia, lymphoid,|Topography, multiple sites,Uterus,Mammary gland,Mammary gland #4, right,Mammary gland #5, right,Thyroid gland,Skin,Lung,Jejunum,Intestine,Uterus,Mammary gland #5, left,Ovary,Liver,Adrenal gland,Atrioventricular valve,Tonsil,|,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-3069|5|5071|Adenocarcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Mixed tumor, uncertain whether benign or malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Hemangioendothelioma, benign,Adenoma, benign,Fibroma, benign,Valvular heart disease or syndrome,Inflammation,Inflammation,Inflammation, chronic,Edema,Congestion,Degeneration,Cyst,Degeneration,Undetermined manner of death,Autolysis,Degeneration,Inflammation,Hyperplasia,|Mammary gland #2, left,Mammary gland #5, right,Mammary gland #4, left,Mammary gland #3, left,Mammary gland,Mammary gland #4, right,Mandibular lymph node,Thyroid gland,Vagina,Heart,Brain,Uterus,Kidney,Lung,Lung,Gluteus maximus muscle,Parathyroid gland,Biceps brachii muscle,Whole body,Gastrointestinal tract,Liver,Kidney,Adrenal gland,|CORTICAL,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-3070|5|5477|Fibrosarcoma, malignant,Leydig cell tumor, benign,Leiomyoma, benign,Adenoma, benign,Leiomyoma, benign,Bacterial endocarditis,Degeneration,Inflammation,Undetermined manner of death,Ulcer,Hyperplasia,Hyperplasia,Inflammation,Cyst,Metaplasia, myeloid  (extramedulary hematopoesis),|Toe,Testis,Urinary bladder,Thyroid gland,Esophagus,Heart,Liver,Gluteus maximus muscle,Topography, multiple sites,Skin,Prostate,Adrenal cortex,Kidney,Thyroid gland,Spleen,|MODERATE,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-3168|5|4369|Mixed tumor, uncertain whether benign or malignant,Papillary carcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Fibroma, benign,Hemangioendothelioma, benign,Degeneration,Hyperplasia,Fibrosis,Inflammation, chronic,Hyperplasia,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),|Mammary gland,Female breast, right,Mammary gland #4, left,Axillary lymph node,Salivary gland,Mesenteric lymph node,Pancreatic lymph node,Vagina,Spleen,Liver,Skin,Aorta,Kidney,Parathyroid gland,Bone marrow,Spleen,|,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-3169|5|3616|Sarcoma, malignant,Mixed tumor (Pleomorphic adenoma), benign,Sarcoma, w/evidence of metastasis,Adenoma, benign,Adenoma, benign,Fibrosis,Infarct,Congestion,Thrombus,Cyst,Fibrosis,Hemorrhage,Polyp,|Mammary gland,Mammary gland,Lung,Parathyroid gland,Liver,Kidney,Lung,Liver,Lung,Pituitary gland,Skin,Lung,Stomach,|HYPERPLASTIC POLYP.,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-3170|5|3593|Mixed tumor, uncertain whether benign or malignant,Leiomyoma, benign,Adenoma, benign,Hemangioendothelioma, benign,Papilloma, benign,Hydrocephalus,Hyperplasia,Degeneration, fatty,Atrophy,Inflammation,Pigmentation, hemosiderin,Deposition, calcium,Cyst,Emphysema,|Mammary gland,Vagina,Ovary,Skin,Mammary gland,Brain,Uterus,Liver,Brain,Lymph node,Spleen,Kidney,Pituitary gland,Lung,|FOCAL ATELECTASIS,EMPH,INTERS FIBRO,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-3171|5|5294|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Leydig cell tumor, benign,Epithelioma, malignant,Adenoma, benign,Fibroma, benign,Insufficiency,Fibrosis,Hypertrophy,Valvular heart disease or syndrome,Inflammation,Inflammation,Undetermined manner of death,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Congestion,|Prostate,Iliac lymph node,Testis,Skin of face,Thyroid gland,Urinary bladder,Heart,Atrioventricular valve,Myocardium and cardiac conduction system,Heart,Heart,Kidney,Topography, multiple sites,Adrenal cortex,Spleen,Liver,|MILD,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-3173|5|5114|Neoplasm, uncertain whether benign or malignant,Leydig cell tumor, benign,Adenoma, benign,Leydig cell tumor, benign,Hemangioendothelioma, benign,Chronic renal disease,Autolysis,Hyperplasia,Inflammation, acute,Inflammation, chronic,Hyperplasia,Hyperplasia,Fibrosis,Undetermined manner of death,|Duodenum,Testis, right,Kidney,Testis,Skin of hip,Kidney,Topography, multiple sites,Pancreas (Exocrine Pancreas),Prostate,Kidney,Prostate,Adrenal gland,Heart,Whole body,|UNDETERMINED BY HISTOPATH,|
1003-6-5|7.5 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,10T0600|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|8 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-5-3192|5|4139|Extra-adrenal (nonchromaffin) paraganglioma, benign or malig,Chemodectoma, malignant,Extra-adrenal (nonchromaffin) paraganglioma, benign or malig,Extra-adrenal (nonchromaffin) paraganglioma, benign or malig,Extra-adrenal (nonchromaffin) paraganglioma, benign or malig,Extra-adrenal (nonchromaffin) paraganglioma, benign or malig,Extra-adrenal (nonchromaffin) paraganglioma, benign or malig,Extra-adrenal (nonchromaffin) paraganglioma, benign or malig,Tubular androblastoma (Sertoli Cell Tumor), benign,Insufficiency,Leydig cell tumor, benign,Degeneration,Congestion,Hyperplasia,Hyperplasia,|Carotid body,Heart,Kidney,Lung,Thyroid gland,Adrenal gland,Lymph node,Liver,Testis,Heart,Testis,Liver,Topography, multiple sites,Bone marrow,Prostate,|,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2539|6|4667|Adenocarcinoma, malignant,Adenocarcinoma, simple, papillary (AFIP 80822), malignant,Leiomyoma, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Osteoarthropathy, hypertrophic,Hyperplasia,Inflammation,Hyperplasia,Atrophy,Degeneration,Hyperplasia,Pigmentation, hemosiderin,Inflammation,Inflammation,Atelectasis,|Lung,Topography, multiple sites,Colon,Testis,Humerus,Bony tissue (bone),Kidney,Stomach,Testis,Liver,Bone marrow,Spleen,Kidney,Lung,Lung,|EMPHYSEMA&ATELECTASIS.,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2540|6|5030|Lymphoid leukemia, malignant,Lymphoid leukemia, malignant,Lymphoid leukemia, malignant,Lymphoid leukemia, malignant,Leydig cell tumor, benign,Adenoma, benign,Hemangioendothelioma, benign,Atelectasis,Hyperplasia,Cyst,Inflammation, chronic,Degeneration,|Bone marrow,Topography, multiple sites,Kidney,Adrenal gland,Testis,Pancreas (Exocrine Pancreas),Prescapular lymph node,Lung,Parathyroid gland,Prostate,Prostate,Liver,|DUE TO NEOPLASTIC CELL INFILTRATES,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2543|6|4785|Sarcoma, malignant,Mixed tumor, uncertain whether benign or malignant,Mixed tumor, uncertain whether benign or malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Hemangioma, benign,Lipoma, benign,Hyperplasia,Inflammation, chronic,Cyst,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Inflammation,Inflammation, chronic,Hyperplasia,Hyperplasia,Cyst,Cyst,|Colon,Mammary gland,Mammary gland #2, left,Mammary gland,Mammary gland #4, right,Ovary, left,Skin,Vaginal muscularis,Liver,Uterus,Ovary, right,Spleen,Adrenal gland,Atrioventricular valve,Lymph node,Thyroid gland, right lobe,Bone marrow,Uterus,Pituitary pars intermedia (Pars Intermedia),|COLLOID CYSTS.,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2544|6|1269|Glioma, malignant,Glioma, malignant,Atrophy,Congestion,Atrophy,|Lumbosacral spinal cord, white matter,Peripheral nerve,Skeletal muscle,Liver,Testis,|,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2545|6|3665|Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Leydig cell tumor, benign,Papillary adenoma, benign,Papillary adenoma, benign,Papillary adenoma, benign,Leiomyoma, benign,Intraductal adenoma, benign,Deposition, calcium,Hemorrhage,Hyperplasia,Cyst,Degeneration,|Spleen,Omentum (Abdominal Fat),Liver,Kidney,Testis,Ileal mucous membrane,Duodenal mucous membrane,Jejunal mucous membrane,Prostate,Skin,Lung,Lymph node,Parasternal lymph node,Pituitary gland,Myocardium,|MYXOMATOUS IN A.V. VALVES           +,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2546|6|1290|Filarioidea,Fibrosis,Atrophy,Inflammation,Undetermined manner of death,Inflammation,|Heart,Pulmonary artery,Testis,Kidney,Topography, multiple sites,Lung,| GRANULOMATA,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2547|6|5209|Leydig cell tumor, benign,Adenoma, benign,Papilloma, benign,Adenoma, benign,Adenoma, benign,Hydrocephalus,Hyperplasia,Dilatation,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation, acute,Degeneration,Atrophy,Hyperplasia, lymphoid,Hyperplasia,Hyperplasia,Congestion,Retention of fluid  (Hydronephrosis),Atrophy,Atrophy,Hyperplasia,Inflammation, acute,Edema,Hyperplasia,Hyperplasia, lymphoid,Hyperplasia,Inflammation, chronic,Cyst,|Testis,Thyroid gland,Skin,Perianal gland,Skin,Brain,Prostate,Kidney,Pancreas (Exocrine Pancreas),Spleen,Pharynx,Liver,Testis,Mandibular lymph node,Skin,Adrenal gland,Pituitary gland,Brain,Brain,Spinal cord,Bone marrow,Prescapular lymph node,Lung,Esophagus,Iliac lymph node,Parathyroid gland,Kidney,Kidney,|ONE SMALL IN CORTEX,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2572|6|5409|Carcinoma, malignant,Carcinoma, malignant,Leydig cell tumor, benign,Hematoma,Autolysis,Hyperplasia,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Fibrosis,Hyperplasia,Hyperplasia,Hemorrhage,Hematoma,Inflammation, chronic,Fibrosis,|Thyroid gland, right lobe,Lung,Testis,Spleen,Whole body,Adrenal gland,Bony tissue (bone),Spleen,Heart,Parathyroid gland,Prostate,Brain,Spleen,Kidney,Aorta,|INTIMAL THICKENING,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2574|6|3653|Cholangiocarcinoma (Bile duct carcinoma), malignant,Cholangiocarcinoma (Bile duct carcinoma), malignant,Cholangiocarcinoma (Bile duct carcinoma), malignant,Cholangiocarcinoma (Bile duct carcinoma), malignant,Leydig cell tumor, benign,Adenoma, benign,Inflammation, acute,Cyst,Hemorrhage,Fibrosis,Congestion,Inflammation, chronic,Hemorrhage,|Liver,Diaphragm,Lung,Testis,Testis,Thyroid gland, left lobe,Abdomen, peritoneum and retroperitoneum,Pituitary anterior lobe (Pars Glandularis),Brain,Kidney,Lung,Abdomen,Spleen,| HEMATOMA,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2581|6|3679|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Leydig cell tumor, benign,Inflammation, pneumonia, septic,Inflamation, acute exudative (suppurative),Ulcer,Inflammation, acute,Congestion,Fibrosis,Congestion,|Lung,Topography, multiple sites,Testis,Lung,Prostate,Esophageal mucous membrane,Visceral pleura,Lung,Pericardium,Liver,|CPC,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2582|6|2892|Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Leydig cell tumor, benign,Deposition of foreign crystalline material,Inflammation, chronic,Fibrosis,Hyperplasia,Inflammation, chronic,Pigmentation,Deposition, calcium,|Spleen,Liver,Liver,Testis, right,Liver,Parietal peritoneum,Kidney,Lymph node,Lung,Iliac lymph node,Lung,|CALCOSPHERULES.,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2593|6|2032|Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,Inflammation, acute,Inflammation, chronic,Atrophy,Hemorrhage,|Trabecula of spleen,Liver,Cortex of kidney,Lymph node,Prostate,Testis,Spleen,|HEMATOMAS, CONGESTION,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2606|6|4553|Inflammation, acute,Leydig cell tumor, benign,Ulcer,Adenoma, benign,Thrombus,Thrombus,Infarct,Infarct,Thrombus,Polyp,Hyperplasia,Thrombus,Inflammation,Infarct,Hyperplasia,Hyperplasia,Inflammation,Infarct,Fibrosis,Hyperplasia,Pigmentation,Thrombus,Metaplasia, myeloid  (extramedulary hematopoesis),Abscess,Hyperplasia,Inflammation,Infarct,Hyperplasia,Pigmentation,Inflammation,|Abdomen, peritoneum and retroperitoneum,Testis,Jejunum,Pancreas (Exocrine Pancreas),Adrenal gland,Lung,Testis,Adrenal gland,Kidney,Stomach,Prostate,Heart,Liver,Lung,Prostate,Spleen,Spleen,Heart,Kidney,Parathyroid gland,Lymph node,Brain,Spleen,Jejunum,Lymph node,Diaphragm,Pituitary gland,Bone marrow,Spleen,Peritoneum,|PERITONITIS,SUBACUTE.,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2616|6|2866|Chronic lymphoproliferative disease, uncertain whether benig,Inflammation,Necrosis,Fibrosis,Deposition, amyloid,Degeneration, fatty,Atrophy,|Topography, multiple sites,Salivary gland,Colonic mucous membrane,Lung,Spleen,Liver,Testis,|,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2617|6|4093|Bronchiolo-alveolar adenocarcinoma, malignant,Hemangiosarcoma (Angiosarcoma), malignant,Hemangiosarcoma (Angiosarcoma), w/evidence of metastasis,Leydig cell tumor, benign,Shock,Hemorrhage,Infarct,Metaplasia, myeloid  (extramedulary hematopoesis),Deposition, calcium,Hyperplasia,Fibrosis,|Lung,Liver,Spleen,Testis,Spleen,Kidney,Liver,Small intestine serosa,Bony tissue (bone),Endocardium,|FIBROSIS&MYOC ATROPHY,APE,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2620|6|4439|Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Atrophy,Abscess,Hyperplasia,Hyperplasia,Nephrosis,Fibrosis,Inflammation,Inflammation,|Spleen,Liver,Adrenal gland,Lung,Testis,Skin,Lymph node,Bone marrow,Kidney,Testis,Peritoneum,Colon,|SEROSITIS&PERITONITIS.,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2621|6|5194|Carcinoma, malignant,Seminoma, malignant,Leydig cell tumor, benign,Adenoma, benign,Spondylosis,Hyperplasia,Cyst,Fibrosis,Hyperplasia, lymphoid,Inflammation, acute,Inflammation, acute,Degeneration,Atherosclerosis,Hemorrhage,Hyperplasia,Congestion,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Hemorrhage,Hyperplasia, lymphoid,Pigmentation, hemosiderin,Hyperplasia, lymphoid,Hyperplasia,Congestion,Cyst,Hyperplasia,Inflammation, acute,Atherosclerosis,Inflammation, chronic,|Endocrine pancreas (Islets of Langerhans),Testis, left,Testis, right,Thyroid gland,Vertebrae, thoracic,Liver,Liver,Heart,Prescapular lymph node,Mandibular lymph node,Urinary bladder,Liver,Aorta,Muscle of back,Bone marrow,Retropharyngeal lymph node,Adrenal gland,Spleen,Brain,Iliac lymph node,Tracheobronchial lymph node,Ileum,Parathyroid gland,Iliac lymph node,Thyroid gland,Prostate,Iliac lymph node,Coronary artery,Kidney,|CHRONIC INFL/FIBROSIS-OLD INFARCTS,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2625|6|4091|Adenoma, benign,Carcinoma, malignant,Abscess,Toxic state,Fibroma, benign,Hyperplasia,Cyst,Necrosis,Polyp,Hyperplasia,Nephrosis,Inflammation,Inflammation,Hyperplasia,Inflamation, acute exudative (suppurative),Cyst,Undetermined manner of death,Disseminated intravascular coagulation (DIC) syndrome,Inflammation,Abscess,Hyperplasia,Abscess,|Adrenal gland,Mammary gland,Mammary gland,Vagina,Lymph node,Pituitary gland,Heart,Skin,Mammary gland,Kidney,Lymph node,Eye,Parathyroid gland,Uterus,Ovary,Topography, multiple sites,Topography, multiple sites,Thyroid gland,Mammary gland,Bony tissue (bone),Mammary gland,|ABSCESS WITH TOXEMI,L 2.,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2647|6|3029|Aspiration, food material,Leydig cell tumor, benign,Hemorrhage,Hyperplasia,Congestion,|Testis,Lung,Prostate,Liver,|ACUTE CONGESTION,SEVERE.,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2650|6|4492|Mixed tumor, uncertain whether benign or malignant,Carcinoma, malignant,Fibroma, benign,Adenoma, benign,Adenoma, benign,Adenoma, benign,Adenoma, benign,Hemangioma, benign,Shock,Calcium, decreased level,Fibrosis,Atrophy,Osteoporosis,Inflamation, acute exudative (suppurative),Metaplasia, myeloid  (extramedulary hematopoesis),Atrophy,Hyperplasia,Edema,Fibrosis,Degeneration,Hemorrhage,|Mammary gland #4, right,Adrenal gland,Vagina,Ovary,Stomach,Mammary gland,Colon,Spleen,Blood,Heart,Adrenal gland,Bony tissue (bone),Uterus,Spleen,Brain,Bone marrow,Lung,Kidney,Liver,Pancreas (Exocrine Pancreas),|MULTIPLE HEMORRHAGES.,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2694|6|3355|Sepsis,Inflammation, acute,Adenoma, benign,Inflammation, chronic,Inflammation, acute,Congestion,Infarct,Congestion,Congestion,|Blood,Prostate,Parathyroid gland,Mucous membrane of urinary bladder,Prostate,Kidney,Lung,Liver,Spleen,|SEVERE CONGESTION.,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2702|6|5050|Mixed tumor, malignant (AFIP 80850),Fibroma, benign,Adenoma, benign,Cystadenoma, benign,Pyometra,Degeneration,Hemorrhage,Inflammation, chronic,Hyperplasia, lymphoid,Hyperplasia,Inflammation, acute,Hyperplasia,Hyperplasia, lymphoid,Sepsis,Carcinoma, malignant,Epulis,Hyperplasia,Congestion,Hyperplasia, lymphoid,Hyperplasia,Hyperplasia, lymphoid,Hyperplasia, lymphoid,|Mammary gland,Vagina,Thyroid gland,Ovary, right,Uterus,Liver,Spleen,Kidney,Axillary lymph node,Bone marrow,Uterus,Adrenal gland,Mandibular lymph node,Topography, multiple sites,Liver,Gum,Pituitary gland,Lung,Mesenteric lymph node,Pancreas (Exocrine Pancreas),Iliac lymph node,Prescapular lymph node,|,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2715|6|3830|Leydig cell tumor, benign,Adenoma, benign,Degeneration,Hyperplasia,Hyperplasia,Atrophy,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,|Testis,Perianal gland,Cerebellum,Prostate,Liver,Cerebellum,Spleen,Skin,|SEBACEOUS HYPERPL,NECK.,|
1003-6-6|7.5 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,10T1400|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|20 (24 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-6-2720|6|4186|Adenocarcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Carcinoma, undifferentiated type, malignant,Adenocarcinoma, malignant,Fibroma, benign,Leiomyoma, benign,Hemangioendothelioma, benign,Inflammation, hemorrhagic,Hemorrhage,Pigmentation, hemosiderin,Necrosis,Metaplasia, myeloid  (extramedulary hematopoesis),Pigmentation, hemosiderin,Inflammation,Hemorrhage,Disseminated intravascular coagulation (DIC) syndrome,Deposition, calcium,Retention of fluid  (Hydronephrosis),Disseminated intravascular coagulation (DIC) syndrome,Disseminated intravascular coagulation (DIC) syndrome,Hyperplasia,Regeneration,Hemorrhage,Atrophy,Disseminated intravascular coagulation (DIC) syndrome,|Mammary gland,Mammary gland,Mammary gland,Topography, multiple sites,Vagina,Vagina,Lymph node,Intestine,Kidney,Spleen,Heart,Spleen,Liver,Liver,Pancreas (Exocrine Pancreas),Kidney,Kidney,Kidney,Kidney,Lymph node,Bone marrow,Liver,Jejunum,Muscle,Kidney,|FIBRIN THROMBI.,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2072|7|5281|Carcinoma, malignant,Adenocarcinoma, malignant,Tubular androblastoma (Sertoli Cell Tumor), benign,Leydig cell tumor, benign,Leiomyoma, benign,Leiomyoma, benign,Papillary adenoma, benign,Adenoma, benign,Inflammation, chronic, glomerulonephritis,Polycystic change, multiple,Hemorrhage,Hyperplasia,Inflammation, acute,Hemorrhage,Metaplasia, myeloid  (extramedulary hematopoesis),Fibrosis,Hyperplasia,Inflammation, chronic,Hyperplasia,Hyperplasia,Hemorrhage,Atrophy,Hyperplasia,Atrophy,Hypoplasia,Hyperplasia,|Thyroid gland, right lobe,Lung,Testis, right,Testis, left,Gallbladder,Gastric cardia,Pylorus,Perianal gland,Kidney,Kidney,Spinal cord,Skin,Lung,Hematopoietic and reticuloendothelial system,Spleen,Pancreas (Exocrine Pancreas),Pylorus,Kidney,Adrenal gland,Liver,Pancreas (Exocrine Pancreas),Skeletal bone,Parathyroid gland,Skeletal muscle,Skeletal bone,Prostate,|CYSTIC HYPERP&CH INFLAMMA,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2079|7|2036|Seizure syndrome,Atrophy,Aplasia,|Brain,Testis,Bone marrow,|,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2086|7|3499|Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Hyperplasia,Edema,Fibrosis,Fibrosis,Degeneration, fatty,|Thyroid gland, left lobe,Tracheobronchial lymph node,Lung,Liver,Thorax,Spleen,Thyroid gland, right lobe,Liver,|FATTY NODULES,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2088|7|1973|Leydig cell tumor, benign,Inflammation, pneumonia, septic,Seizure syndrome,Inflammation, pleuritis,Hyperplasia,Hemorrhage,Inflammation, acute,Congestion,Atrophy,Inflammation, chronic,Inflammation, acute,Inflammation, chronic,Inflammation, acute,Inflammation, chronic,Cyst,|Testis,Lung,Brain,Pleural cavity,Renal pelvis,Topography, multiple sites,Thorax,Liver,Testis,Kidney,Lung,Colon,Mesenteric lymph node,Small intestine,Thyroid gland,|EPIDERMAL INCLUSION,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2100|7|3051|Mixed tumor, uncertain whether benign or malignant,Carcinoma, malignant,Adenocarcinoma, malignant,Intraductal papilloma, benign,Carcinoma, malignant,Leiomyoma, benign,Hyperplasia,Hyperplasia,Inflammation,Atrophy,Inflammation, chronic,Edema,Inflammation,Hyperplasia,Cyst,Cyst,Inflammation, chronic,|Mammary gland #4, right,Mammary gland #1, left,Mammary gland #2, right,Mammary gland #5, right,Topography, multiple sites,Vaginal muscularis,Mammary gland #2, left,Mammary gland #1, right,Parasternal lymph node,Liver,Endometrium,Lung,Lung,Mammary gland #5, right,Mammary gland #5, left,Subcutaneous tissue of chest,Kidney,|,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2293|7|4052|Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Tubular androblastoma (Sertoli Cell Tumor), benign,Adenoma, benign,Adenoma, benign,Degeneration, fatty,|Spleen,Omentum (Abdominal Fat),Diaphragm,Liver,Testis,Perianal gland,Parathyroid gland,Skeletal muscle,|ELBOW  & THORACIC LIMB,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2295|7|3640|Carcinoma, undifferentiated type, malignant,Carcinoma, undifferentiated type, malignant,Adenocarcinoma, malignant,Carcinoma, undifferentiated type, malignant,Intraductal papilloma, benign,Intraductal papilloma, benign,Intraductal papilloma, benign,Papillary adenoma, benign,Hyperplasia,Hyperplasia,|Mammary gland #4, left,Mammary gland,Mammary gland #5, left,Topography, multiple sites,Mammary chain, left,Mammary gland #3, left,Mammary gland #2, left,Gastric mucous membrane,Mammary chain, left,Liver,| REGENERATAVE NODULES,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2300|7|4317|Adenocarcinoma, malignant,Leydig cell tumor, benign,Adenoma, benign,Adenoma, benign,Adenoma, benign,Adenoma, benign,Adenoma, benign,Inflammation,Atrophy,Infarct,Inflammation, chronic,Inflammation, acute,Inflammation, acute,Inflammation,Inflammation,Hyperplasia,Fibrosis,Hemorrhage,Hyperplasia,Hyperplasia,Inflammation,Inflammation,Pigmentation,|Skin appendage (Adnexal structure),Testis,Pancreatic duct,Perianal gland,Perianal gland,Pituitary anterior lobe (Pars Glandularis),Parathyroid gland,Skeletal muscle,Testis,Kidney,Lung,Mucous membrane of urinary bladder,Colonic mucous membrane,Diaphragm,Kidney,Adrenal gland,Mesenteric lymph node,Spleen,Liver,Brain,Prostate,Lymph node of thorax,Spleen,| SIDEROFIBROSIS,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2332|7|4523|Sarcoma, malignant,Sarcoma, malignant,Adenocarcinoma, malignant,Leydig cell tumor, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Leiomyoma, benign,Inflammation, acute,Atrophy,Inflammation,Inflammation, acute,|Spleen,Liver,Perianal gland,Testis, right,Testis, left,Small intestine muscularis propria,Abdomen, peritoneum and retroperitoneum,Skeletal muscle,Myocardium,Cecum,|POSTSURG PERFORATION+INFL,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2348|7|3334|Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Intraductal papilloma, benign,|Mammary gland #4, left,Topography, multiple sites,Mammary gland #4, right,|,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2377|7|2327|Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,Inflammation, acute,Hypoplasia,Hyperplasia,Hyperplasia,|Trabecula of spleen,Liver,Omentum (Abdominal Fat),Abdomen,Lung,Spleen,Adrenal gland,Mammary gland #3, left,|,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2380|7|5397|Sarcoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Trichoepithelioma, benign,Adenoma, benign,Leiomyoma, benign,Leydig cell tumor, benign,Trichoepithelioma, benign,Squamous cell papilloma, benign,Adenoma, benign,Adenoma, benign,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Hyperplasia,Inflammation, chronic,Hyperplasia,|Mouth,Prostate,Liver,Axillary lymph node,Iliac lymph node,Subcutaneous tissue,Perianal gland,Colon,Testes, both,Skin,Skin,Thyroid gland,Parathyroid gland,Spleen,Atrioventricular valve,Liver,Kidney,Adrenal gland,|CORTICAL HYPERPLASIA,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2383|7|2831|Mixed tumor, uncertain whether benign or malignant,Intraductal carcinoma, non-infiltrating,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Hyperplasia,|Mammary gland #2, left,Mammary chain, left,Mammary chain, right,Lung,Visceral peritoneum,Bony tissue (bone),Mammary gland #3, left,|MASSES,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2391|7|2262|Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,Inflammation, chronic,Traumatic abnormality,Inflammation, chronic,Hyperplasia,Hyperplasia,Degeneration,|Trabecula of spleen,Abdomen,Liver,Lung,Liver,Mucosa of gallbladder,Mammary gland #4, left,Adrenal gland,Kidney,|NEPHROSIS, FOCAL,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2392|7|3206|Adenocarcinoma, malignant,Hemangioendothelioma, benign,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Embolus,Traumatic abnormality,Hyperplasia,|Mammary gland #5, left,Abdomen,Iliac lymph node,Prescapular lymph node,Mammary gland #4, left,Mammary gland #4, right,Mammary gland #3, left,Mammary gland #2, left,Mammary gland #1, left,Lung,Tracheobronchial lymph node,Aorta,Aorta,Liver,| ALTERED CELL NODULE,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2403|7|3214|Mixed tumor, uncertain whether benign or malignant,Papillary carcinoma, malignant,Papillary carcinoma, malignant,Papillary carcinoma, malignant,Squamous cell carcinoma, malignant (epidermoid carcinoma),Adenoma, benign,Adenoma, benign,Mixed tumor, uncertain whether benign or malignant,Hemangioendothelioma, benign,Uremia syndrome,Hemangioendothelioma, benign,Leiomyoma, benign,Inflammation, chronic,Inflammation,Inflammation,Hyperplasia,Hyperplasia,Inflammation, acute,Ulcer,Inflammation, chronic,Congestion,Hyperplasia,Inflammation, acute,Inflammation, chronic,|Mammary gland #2, left,Mammary gland #4, left,Mammary gland #5, left,Lung,Mammary gland #3, left,Mammary gland #5, left,Mammary gland #4, left,Mammary gland #2, right,Mammary gland #2, right,Kidney,Skin of knee,Vagina,Colon,Kidney,Lung,Mammary gland #4, right,Mammary gland #3, right,Visceral peritoneum,Small intestine,Mucous membrane of urinary bladder,Liver,Mucous membrane of urinary bladder,Lung,Small intestine,| PLASMA CS & LYMPHOCYTES,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2404|7|969|Myelofibrosis,Anemia,Hypoplasia,Fibrosis,Hypoplasia,Hypoplasia,|Blood,Bone marrow,Bone marrow,Lymph node,Spleen,|LYMPHOID,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2405|7|2471|Reticulosarcoma (Histocytic Lymphosarcoma), malignant,Compound leukemia, malignant,Hyperplasia,Inflamation, acute exudative (suppurative),Inflammation, acute,Infarct,Atrophy,|Popliteal lymph node,Topography, multiple sites,Pituitary anterior lobe (Pars Glandularis),Prostate,Vein,Cortex of kidney,Testis,|,|
1003-6-7|7.5 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,10T2000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|24 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-7-2406|7|4061|Papillary adenoma, benign,Adenoma, benign,Leiomyoma, benign,Adenoma, benign,Leiomyoma, benign,Inflammation, chronic,Toxic state,Fibrosis,Abscess,Congestion,Hemorrhage,Cyst,Inflammation, chronic,Atrophy,Hyperplasia,Degeneration, fatty,|Stomach,Perianal gland,Colonic muscularis propria,Adrenal gland, right,Esophageal muscularis propria,Forelimb (Upper extremity),Endocardium,Biceps femoris muscle,Liver,Spleen,Thyroid gland, right lobe,Kidney,Testis,Prostate,Skeletal muscle,|FATTY INFILTRATION.,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1598|8|3034|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Melanoma, (Pigmented nevus), benign,Lipoma, benign,Leiomyoma, benign,Trichoepithelioma, benign,Sebaceous adenoma, benign,Transitional cell papilloma, benign,Adenoma, benign,Lipoma, benign,Hemangioendothelioma, benign,Inflammation,Inflammation, chronic,Cyst,Inflammation, chronic,Fibrosis,|Mammary gland,Topography, multiple sites,Sebaceous gland,Mammary gland #3, left,Vaginal muscularis,Sebaceous gland,Sebaceous gland,Mucous membrane of urinary bladder,Mammary gland,Subcutaneous tissue of chest,Thyroid gland,Kidney,Uterus,Epidermis,Gallbladder,Visceral peritoneum,|ADHESIONS SM & LG INTEST,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1676|8|3710|Osteosarcoma, malignant,Osteosarcoma, malignant,Mixed tumor, uncertain whether benign or malignant,Mixed tumor, uncertain whether benign or malignant,Melanoma, (Pigmented nevus), benign,Lipoma, benign,Chondroma, benign,Necrosis,Inflammation,Inflamation, acute exudative (suppurative),Atrophy,Deposition, calcium,Hyperplasia,Hyperplasia,Degeneration, fatty,Inflamation, acute exudative (suppurative),Inflammation, chronic,|Topography, multiple sites,Mammary gland,Mammary gland,Mammary gland #2, right,Sebaceous gland,Subcutaneous tissue of chest,Subcutaneous tissue of chest,Liver,Pulmonary alveoli,Lung,Ovary,Topography, multiple sites,Liver,Parathyroid gland,Liver,Uterus,Salivary gland,|LYMPHO CS PERIDUCTAL,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1677|8|2425|Adenoma, benign,Hyperparathyroidism, primary,Inflammation, pneumonia, septic,Inflamation, acute exudative (suppurative),Deposition, calcium,Hypoplasia,|Parathyroid gland,Lung,Lung,Topography, multiple sites,Bone marrow,|IMPRINT:FATTY,SPARSE CS.,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1678|8|1136|Myeloid leukemia, malignant,Hemorrhage,Atrophy,Fibrosis,Atrophy,Hyperplasia,|Topography, multiple sites,Topography, multiple sites,Testis,Bone marrow,Liver,Spleen,|UNDIFF. & IMMAT. BLAST CS,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1684|8|2985|Mixed tumor, uncertain whether benign or malignant,Injury, recent,Shock,Congestion,Inflamation, acute exudative (suppurative),Deposition, calcium,Atelectasis,Undetermined manner of death,|Mammary gland #4, right,Lung,Endometrium,Pulmonary alveoli,Lung,Topography, multiple sites,|NO COD DETERMINED BY HISTOPATH      X   EXAMINATION OF TISSUES SUBMITTED.,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1685|8|2944|Hemangiosarcoma (Angiosarcoma), malignant,Squamous cell carcinoma, malignant (epidermoid carcinoma),Squamous cell carcinoma, malignant (epidermoid carcinoma),Squamous cell carcinoma, malignant (epidermoid carcinoma),Squamous cell carcinoma, malignant (epidermoid carcinoma),Squamous cell carcinoma, malignant (epidermoid carcinoma),Carcinoma, diffuse type, malignant, metastatic site,Adenoma, benign,Leydig cell tumor, benign,Hyperplasia,Atelectasis,Fibrosis,Fibrosis,Fibrosis,Atrophy,Hyperplasia,Inflammation,|Spleen,Sebaceous gland,Lymph node of neck (Cervical lymph node),Oral mucous membrane,Tongue,Mandible,Skin of face,Perianal gland,Testis, right,Liver,Lung,Kidney,Myocardium,Heart,Testis,Prostate,Kidney,|GLOMERULONEPHRITIS,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1872|8|3430|Adenocarcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Carcinoma, malignant,Adenocarcinoma, malignant,Leiomyoma, benign,Lipoma, benign,Inflamation, acute exudative (suppurative),Inflammation,Inflamation, acute exudative (suppurative),|Mammary gland #3, right,Mammary chain, right,Liver,Lung,Vaginal muscularis,Subcutaneous tissue of chest,Lung,Mammary gland #1, right,Lung,|SUPP. BRONCHOPNEUMONIA,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1876|8|4539|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Leydig cell tumor, benign,Adenoma, benign,Adenoma, benign,Fibroma, benign,Hyperplasia,Degeneration, fatty,Fibrosis,Fibrosis,|Ileal mucous membrane,Submandibular lymph node,Lung,Skin of upper extremity,Testis,Perianal gland,Perianal gland,Gum,Prostate,Liver,Lung,Kidney,|ISCHEM SCAR+INT NEPHRITIS,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1886|8|4148|Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Adenoma, benign,Sebaceous adenoma, benign,Inflammation, chronic,Edema,Metaplasia, myeloid  (extramedulary hematopoesis),Metaplasia, myeloid  (extramedulary hematopoesis),Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Fibrosis,Deposition of foreign crystalline material,Deposition of foreign crystalline material,Inflammation, chronic,Edema,Fibrosis,Inflammation, chronic,Hyperplasia,Degeneration, fatty,Ectopia,Hyperplasia,|Perianal gland,Perianal gland,Lung,Perianal gland,Sebaceous gland,Lung,Lung,Spleen,Liver,Adrenal gland, right,Adrenal gland, right,Kidney,Brain,Liver,Lung,Myocardium,Thyroid gland,Skeletal muscle,Iliac lymph node,Liver,Heart,Bone marrow,|ERYTHROID/MYELOID HYPERPL,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1890|8|3366|Neurofibrosarcoma, malignant,Neurofibrosarcoma, malignant,Seminoma, malignant,Adenoma, benign,Fibrosis,|Spleen,Liver,Testis, left,Perianal gland,Epididymis,|FIBROTIC,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1911|8|2858|Mixed tumor, uncertain whether benign or malignant,Intraductal carcinoma, non-infiltrating,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Cyst,Hyperplasia,Degeneration, fatty,Inflammation, chronic,Osteoblastic osteosarcoma, malignant,Osteoblastic osteosarcoma, malignant,Neoplastic disease, malignant,Neoplastic disease, malignant,Hyperplasia, nodular,Hyperplasia, nodular,Hyperplasia, cystic,Hyperplasia, cystic,Leydig cell tumor, uncertain whether benign or malignant,Neoplastic disease, benign,Neoplastic disease, benign,Leydig cell tumor, uncertain whether benign or malignant,Hyperplasia, focal,Hyperplasia, focal,Radiation disease,Radiation disease,New bone formation,Osteoporosis,New bone formation,Osteoporosis,|Mammary gland #3, right,Mammary gland #5, right,Thyroid gland, right lobe,Lung,Lymph node of neck (Cervical lymph node),Thorax,Iliac lymph node,Skin,Liver,Liver,Lung,Tibia,Tibia,Spleen,Spleen,Prostate,Prostate,Interstitial tissue of testis,Interstitial tissue of testis,Adrenal cortex,Adrenal cortex,Humerus,Humerus,Humerus,Humerus,Humerus,Humerus,|Uncertain attribution to ANL! OSTEOPOROSIS, FOCAL/BONE, HUMERUS, MIDSHAFT (pathol.incidental disease05),|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1913|8|1385|Myeloid leukemia, malignant,Ulcer,Atrophy,Carcinoma, malignant,Neoplastic disease, malignant,Carcinoma, malignant,Neoplastic disease, malignant,Adenocarcinoma, w/evidence of metastasis,Neoplastic disease, malignant w/evidence of metastasis,Neoplastic disease, malignant w/evidence of metastasis,Adenocarcinoma, w/evidence of metastasis,Plaque,Eye disease or syndrome,Eye disease or syndrome,Plaque,Deposition, calcium, focal,Deposition, calcium, focal,Hyperplasia, cystic,Hyperplasia, cystic,Obstruction,Obstruction,Osteoporosis,Osteoporosis,Epulis,Epulis,Epulis,Epulis,Neoplastic disease, benign,Papilloma, benign,Neoplastic disease, benign,Papilloma, benign,Hyperplasia, nodular,Hyperplasia, nodular,Cytoplasmic vacuolization,Cytoplasmic vacuolization,Atrophy,Atrophy,Cystadenoma, benign,Neoplastic disease, benign,Neoplastic disease, benign,Cystadenoma, benign,|Topography, multiple sites,Ileal mucous membrane,Testis,Pituitary anterior lobe (Pars Glandularis),Pituitary anterior lobe (Pars Glandularis),Prostate,Prostate,Iris,Iris,Lung,Lung,Mucosa of gallbladder,Mucosa of gallbladder,Common bile duct,Common bile duct,Femur,Femur,Gum,Gum,Gum,Gum,Gum,Gum,Hepatic parenchymal cell,Hepatic parenchymal cell,Hepatic parenchymal cell,Hepatic parenchymal cell,Testis,Testis,Thyroid gland,Thyroid gland,|Uncertain attribution to ANL! CYSTADENOMA/THYROID/NEOPLASIA/ (incidental disease12),|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1917|8|2891|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Inflammation, acute,Inflammation, acute,Pigmentation,Inflammation, acute,Congestion,Cyst,Inflamation, acute exudative (suppurative),Pigmentation,Hyperplasia,Hyperplasia,Necrosis,|Mammary gland #5, right,Lung,Abdomen, peritoneum and retroperitoneum,Pancreas (Exocrine Pancreas),Pulmonary alveoli,Kidney,Liver,Mammary gland #5, left,Horn of uterus, left,Spleen,Mammary gland #5, right,Mammary gland #5, left,Abdomen,|FAT NECROSIS C CALCIFICAT,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1921|8|2786|Deposition, amyloid,Deposition, amyloid,Deposition, amyloid,Amyloidosis,Deposition, amyloid,Amyloidosis,Thrombus,Thrombus,Infarct,Infarct,Congestion, acute,Congestion, acute,Lysis,Disease or syndrome of skeletal system,Disease or syndrome of skeletal system,Lysis,Hyperplasia, focal,Hyperplasia, focal,Hemosiderosis, (siderosis),Hemosiderosis, (siderosis),Fibrosis, focal,Fibrosis, focal,Inflammation, chronic,Inflammation, chronic,Mucinous adenocarcinoma, malignant,Mucinous adenocarcinoma, malignant,Mucinous adenocarcinoma, malignant,Inflammation,Embolus,Atrophy,Inflammation, chronic,Atelectasis,Edema,Hyperplasia,|Kidney,Kidney,Glomerulus,Glomerulus,Pulmonary artery,Pulmonary artery,Lung,Lung,Hepatic sinusoid,Hepatic sinusoid,Tibia, left,Tibia, left,Kupffer cell,Kupffer cell,Kupffer cell,Kupffer cell,Pancreas (Exocrine Pancreas),Pancreas (Exocrine Pancreas),Pancreas (Exocrine Pancreas),Pancreas (Exocrine Pancreas),Duodenal mucous membrane,Liver,Omentum (Abdominal Fat),Kidney,Artery,Testis,Lung,Lung,Mesenteric lymph node,Bone marrow,|GRANULO-& MEGAKARYO-CYTIC,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-1933|8|1216|Inflammation, necrotizing,Inflammation, necrotizing,Atrophy,Atrophy,Degeneration, hydropic,Degeneration, hydropic,Hemosiderosis, (siderosis),Hemosiderosis, (siderosis),Cataract,Eye disease or syndrome,Eye disease or syndrome,Cataract,Thymoma, benign,Neoplastic disease, benign,Thymoma, benign,Neoplastic disease, benign,Cyst, epithelial inclusion,Cyst, epithelial inclusion,Myeloid leukemia, malignant,|Small intestine,Small intestine,Pancreas (Exocrine Pancreas),Pancreas (Exocrine Pancreas),Hepatic parenchymal cell,Hepatic parenchymal cell,Kupffer cell,Kupffer cell,Crystalline lens,Crystalline lens,Thymus,Thymus,Skin of neck,Skin of neck,Topography, multiple sites,|/ ADENOMA, PITUITARYCHRONIC NEPHRITIS /,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-2067|8|3113|Inflammation, pneumonia, septic,Inflammation, chronic exudative,Paralysis,Hyperplasia,Inflamation, acute exudative (suppurative),Inflamation, acute exudative (suppurative),Hemorrhage,Inflammation,Inflammation, chronic,Atrophy,Congestion,Edema,Atrophy,Infarct,Degeneration,Degeneration, fatty,Deposition, calcium,Inflamation, acute exudative (suppurative),Inflammation,Inflamation, acute exudative (suppurative),Atrophy,Inflammation, chronic,Inflammation, chronic,Hyperplasia,Hyperplasia,Hyperplasia,Inflammation, chronic,Hyperplasia,Degeneration,Inflamation, acute exudative (suppurative),|Lung,Hindlimbs, (Lower extremity) both,Mucous membrane of urinary bladder,Lung,Subcutaneous tissue of lower extremity,Spleen,Colonic mucous membrane,Prostate,Lymphatic follicle of spleen (Spleenic white pulp),Liver,Subcutaneous tissue of foot,Skeletal muscle,Cortex of kidney,Heart,Skeletal muscle,Muscle of hip and thigh,Testis,Mucosa of gallbladder,Skeletal muscle,Testis,Kidney,Small intestine,Renal pelvis,Adrenal gland,Pituitary anterior lobe (Pars Glandularis),Testis,Liver,Skeletal muscle,Popliteal lymph node,|LYMPHADENITIS, CORTEX,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-2138|8|2952|Hemangiosarcoma (Angiosarcoma), malignant,Adenocarcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Adenocarcinoma, malignant,Papilloma, benign,Shock,Congestion,Degeneration,Inflammation,Edema,Hyperplasia,Inflammation, chronic,Hyperplasia,|Spleen,Mammary gland #3, right,Mammary gland #2, left,Lung,Vaginal mucous membrane,Liver,Coronary artery,Kidney,Lung,Pituitary anterior lobe (Pars Glandularis),Mucosa of gallbladder,Adrenal gland,|CORT. NODULAR,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-2142|8|1549|Lymphoid leukemia, malignant,Inflammation, chronic, glomerulonephritis,Hyperplasia,Edema,|Topography, multiple sites,Kidney,Adrenal gland,Lung,|,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-2145|8|3456|Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Mixed tumor, uncertain whether benign or malignant,Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Basal cell carcinoma, malignant,Adenoma, benign,Compression injury,Hyperplasia,Inflammation, chronic,Inflammation, chronic,Fibrosis,Inflammation, chronic,Traumatic abnormality,Inflamation, acute exudative (suppurative),Atrophy,Hyperplasia,Inflammation, chronic,|Unknown primary neoplasia site,Liver,Pylorus,Mesenteric lymph node,Lung,Spleen,Adrenal gland,Mammary gland #1, left,Mammary gland #4, right,Mammary gland #3, right,Mammary gland #2, right,Sebaceous gland,Parathyroid gland,Spinal cord,Liver,Thyroid gland, left lobe,Myocardium,Bone marrow,Kidney,Cervical vertebra,Uterus,Skeletal muscle,Gum,Coronary artery,| RHEUMATOID NOD. ADJ CORO           N,|
1003-6-8|7.5 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,10T4000|1| 463|gamma-rays Co-60|7.5|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-8-2156|8|2782|Lymphosarcoma, malignant, poorly differientated,Adenoma, benign,Hyperplasia,Traumatic abnormality,Inflammation,Necrosis,Hyperplasia,|Topography, multiple sites,Mammary chain, left,Parathyroid gland,Lung,Lung,Adrenal gland,Endometrium,| ENDOMET.,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-1728|9|610|n/a|n/a|n/a|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-2935|9|4772|Adenocarcinoma, malignant,Adenoma, benign,Inflammation, acute,Inflamation, acute exudative (suppurative),Inflammation, acute,Inflammation, acute,Congestion,Congestion,Congestion,Congestion,Hyperplasia,Hyperplasia, lymphoid,Inflammation,Inflammation, acute,Congestion,Inflammation, chronic,Congestion,Inflammation,Congestion,Pigmentation, hemosiderin,Regeneration,Degeneration,Tubular androblastoma (Sertoli Cell Tumor), benign,Hyperplasia, lymphoid,Hyperplasia,Congestion,Hyperplasia,Inflammation, acute,|Lung,Thyroid gland,Abdomen, peritoneum and retroperitoneum,Prostate,Diaphragm,Kidney,Kidney,Adrenal gland,Liver,Pancreas (Exocrine Pancreas),Adrenal gland,Retropharyngeal lymph node,Iliac lymph node,Spleen,Urinary bladder,Kidney,Lung,Liver,Brain,Liver,Liver,Liver,Testis,Iliac lymph node,Bone marrow,Spleen,Parathyroid gland,Prostate,|COMPLETELY FILLED W/AC.INFL CELLS,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-2940|9|4751|Leiomyosarcoma, malignant,Heart failure, (Congestive),Leydig cell tumor, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Leydig cell tumor, benign,Hematoma, acute,Hemangioma, benign,Anemia,Hyperplasia,Deposition, amyloid,Disseminated intravascular coagulation (DIC) syndrome,Cardiac tamponade,Inflammation,Hyperplasia,Atrophy,Congestion,Inflammation,Disseminated intravascular coagulation (DIC) syndrome,Autolysis,Inflammation,Hyperplasia, lymphoid,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Cyst,Degeneration,Inflammation,Inflammation,Cyst,Cyst,Fibrosis,|Duodenum,Heart,Testis, left,Testis, right,Testis, right,Heart,Subcutaneous tissue,Blood,Pancreas (Exocrine Pancreas),Kidney,Lung,Heart,Prescapular lymph node,Atrioventricular valve,Parotid gland, right,Liver,Axillary lymph node,Lung,Gallbladder,Prostate,Mandibular lymph node,Bone marrow,Spleen,Adrenal gland,Pituitary gland,Liver,Diaphragm,Visceral pericardium (Epicardium),Parathyroid gland,Thyroid gland,Liver,|CAPSULAR THICKENING EXTENDS INTO   PARENCHYMA IN SEVERAL AREAS-FIBRIN COVERING CAPSULE ALSO,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-2947|9|3706|Mixed tumor, uncertain whether benign or malignant,Mixed tumor, uncertain whether benign or malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Adenoma, benign,Adenoma, benign,Inflammation, pneumonia, septic,Inflammation, chronic,Degeneration, fatty,Degeneration, fatty,Hyperplasia,Cyst,Hyperplasia,Inflammation,Metaplasia, myeloid  (extramedulary hematopoesis),Deposition, calcium,Degeneration,Pigmentation,Inflammation,|Mammary gland #1, left,Mammary gland,Mammary gland,Mammary gland,Mammary gland,Adrenal gland,Pituitary gland,Lung,Uterus,Heart,Liver,Bone marrow,Ovary,Lymph node,Kidney,Spleen,Kidney,Liver,Liver,Lung,|AC LOBAR PNEUMONIA,MASSIVE.,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-2948|9|4594|Carcinoma, malignant,Carcinoma, malignant,Adenoma, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Leydig cell tumor, benign,Fibrosis,Atrophy,Edema,Consolidation,Inflammation,Inflammation, chronic,Inflammation,Degeneration,Fibrosis,Fibrosis,Hypoplasia,|Adrenal gland,Lung,Thyroid gland,Testis,Testis,Prostate,Skin,Lung,Lung,Renal pelvis,Kidney,Iliac lymph node,Liver,Atrioventricular valve,Heart,Spleen,|LYMPHOID DEPLETION-NO WHITE PULP,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-2955|9|3642|Sarcoma, malignant,Carcinoma, malignant,Sarcoma, malignant,Adenoma, benign,Leydig cell tumor, benign,Cyst,Ulcer,Inflammation,Fibrosis,Pigmentation,Hyperplasia,Inflammation, chronic,|Spleen,Thyroid gland, left lobe,Topography, multiple sites,Thyroid gland, left lobe,Testis,Pituitary gland,Skin,Bony tissue (bone),Lung,Lymph node,Prostate,Skeletal muscle,|POLYMYOSITIS WITH ATROPHY,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-2959|9|3901|Sarcoma, malignant,Sarcoma, malignant,Mixed tumor, uncertain whether benign or malignant,Mixed tumor, malignant (AFIP 80850),Mixed tumor, uncertain whether benign or malignant,Papillary carcinoma, malignant,Papilloma, benign,Fibroma, benign,Hemangioendothelioma, benign,Papilloma, benign,Leiomyoma, benign,Papilloma, benign,Cardiomyopathy,Hyperplasia,Hyperplasia,Hyperplasia,Inflamation, acute exudative (suppurative),Hyperplasia,Abscess,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation,Atelectasis,Cyst,Hyperplasia,Hyperplasia,|Liver,Topography, multiple sites,Mammary gland,Mammary gland #3, left,Mammary gland,Mammary gland #4, left,Duodenum,Vagina,Vagina,Stomach,Vagina,Mammary gland,Heart,Mammary gland,Mammary gland,Bone marrow,Uterus,Adrenal gland,Mammary gland #4, right,Spleen,Lung,Lung,Thyroid gland,Lymph node,Spleen,|LYMPHOID HYPL?LYMPHOMA.   NUMEROUS PLASMA CELLS SEEN.,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-2962|9|4128|Leydig cell tumor, benign,Leydig cell tumor, benign,Adenoma, benign,Adenoma, benign,Thrombus,Valvular heart disease or syndrome,Pigmentation, hemosiderin,Inflammation, chronic,Atrophy,Atherosclerosis,Thrombus,Thrombus,Congestion,Inflammation, chronic,Hyperplasia,Congestion,Thrombus,Inflammation, chronic,Hyperplasia,Pigmentation, hemosiderin,Atherosclerosis,Inflammation, chronic,Hyperplasia,Fibrosis,|Testis, left,Testis, right,Pancreas (Exocrine Pancreas),Thyroid gland,Aorta,Heart,Retropharyngeal lymph node,Prostate,Gluteus maximus muscle,Artery,Artery,Aorta,Liver,Kidney,Prostate,Urinary bladder,Lung,Iliac lymph node,Adrenal gland,Liver,Aorta,Stomach,Thyroid gland,Atrioventricular valve,|NODULAR FIBROSIS RT &LEFT AV VALVES,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3088|9|4673|Melanoma, malignant,Melanoma, malignant,Melanoma, malignant,Melanoma, malignant,Melanoma, malignant,Melanoma, malignant,Melanoma, malignant,Melanoma, malignant,Melanoma, malignant,Melanoma, malignant,Melanoma, malignant,Carcinoma, malignant,Adenocarcinoma, malignant,Tubular androblastoma (Sertoli Cell Tumor), benign,Fibroma, benign,Melanoma, malignant,Hyperplasia,Hyperplasia, lymphoid,Hyperplasia, lymphoid,Degeneration,Inflammation, chronic,Hyperplasia,Polyp,Hyperplasia,Hyperplasia, lymphoid,Edema,Hyperplasia,Hyperplasia,|Gum,Lung,Lip,Heart,Liver,Muscle,Kidney,Prescapular lymph node,Pleura,Tracheobronchial lymph node,Mandibular lymph node,Perianal gland,Lung,Testis,Stomach,Retropharyngeal lymph node,Parathyroid gland,Iliac lymph node,Tonsil,Liver,Kidney,Prostate,Stomach,Diaphragm,Axillary lymph node,Lung,Bone marrow,Adrenal gland,|CORTICAL,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3093|9|4820|Leydig cell tumor, benign,Adenoma, benign,Inflammation, acute,Inflammation, acute,Congestion,Edema,Hemorrhage,Pigmentation, hemosiderin,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Hemorrhage,Hyperplasia,Hyperplasia,Cyst,|Testis,Salivary gland,Intestine,Abdomen, peritoneum and retroperitoneum,Topography, multiple sites,Lung,Small intestine,Topography, multiple sites,Spleen,Bone marrow,Spleen,Prostate,Adrenal gland,Ileum,|CYST CONTAINING AMORPHOUS MATERIAL,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3095|9|4724|Carcinoma, malignant,Mast cell sarcoma, malignant,Mast cell sarcoma, malignant,Leydig cell tumor, benign,Pigmentation, hemosiderin,Inflammation, chronic,Congestion,Hyperplasia,Congestion,Degeneration,Hyperplasia, lymphoid,Hyperplasia,Fibrosis,Congestion,Polyp,Hyperplasia,|Stomach,Jejunum,Mesenteric lymph node,Testis,Prescapular lymph node,Kidney,Lung,Adrenal gland,Liver,Liver,Retropharyngeal lymph node,Prostate,Aorta,Spleen,Stomach,Atrioventricular valve,|FIBROUS NODULAR HYPERPLASIA,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3097|9|5546|Carcinoma, malignant,Transitional cell carcinoma, malignant,Leiomyoma, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Leydig cell tumor, benign,Deposition, calcium,Cyst,Pigmentation, hemosiderin,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Inflammation,Pigmentation,Hyperplasia,Degeneration,Undetermined manner of death,Inflammation,|Perianal gland,Topography, multiple sites,Stomach,Testis,Testis,Lung,Prostate,Iliac lymph node,Spleen,Retropharyngeal lymph node,Kidney,Iliac lymph node,Adrenal cortex,Liver,Topography, multiple sites,Prostate,|MODERATE,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3111|9|4291|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Leydig cell tumor, benign,Retention of fluid  (Hydronephrosis),Metaplasia, myeloid  (extramedulary hematopoesis),Degeneration,Inflammation,Hyperplasia,Hyperplasia,Hyperplasia,Congestion,|Lung,Aorta,Lymph node,Testis,Thorax,Spleen,Liver,Diaphragm,Prostate,Atrioventricular valve,Bone marrow,Liver,|MARKED-HEMOR IN 1 SECT W/NECROSIS,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3120|9|3307|Osteosarcoma, malignant,Osteosarcoma, malignant,Carcinoma, malignant,Abscess,Hemangioma, benign,Sepsis,Adhesion,Inflammation,Deposition, calcium,Inflammation,Disseminated intravascular coagulation (DIC) syndrome,Hyperplasia,Inflammation,Inflammation,Hyperplasia,Inflammation,Cyst,Hyperplasia,Necrosis,Infarct,|Skeletal bone,Lung,Mammary gland,Mammary gland,Vulva,Blood,Pericardium,Meninges,Lung,Heart,Topography, multiple sites,Lymph node,Muscle,Coronary artery,Bone marrow,Thyroid gland,Ovary,Bony tissue (bone),Omentum (Abdominal Fat),Spleen,|INRARCT+HEMOSID+EMH+LYMP HYPERPLASI,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3122|9|5090|Adenocarcinoma, w/evidence of metastasis,Mixed tumor, uncertain whether benign or malignant,Mixed tumor (Pleomorphic adenoma), benign,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Leiomyoma, benign,Adenoma, benign,Inflammation,Pigmentation, hemosiderin,Inflammation, chronic,Hyperplasia,Degeneration,Atrophy,Atrophy,Hyperplasia,Congestion,Hyperplasia,Cyst,Dysplasia,Inflammation,Cyst,Inflammation,|Mammary gland,Mammary gland,Mammary gland,Lymph node of thorax,Lung,Vagina,Thyroid gland,Ear,Liver,Kidney,Adrenal gland,Liver,Diaphragm,Gluteus maximus muscle,Pancreas (Exocrine Pancreas),Liver,Uterus,Ovary,Mammary gland,Omentum (Abdominal Fat),Kidney,Skin of leg,|KNEE/ULCERATION W/ACUTE INFL,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3128|9|5514|Uremia syndrome,Tubular androblastoma (Sertoli Cell Tumor), benign,Adenoma, benign,Inflammation,Pigmentation, hemosiderin,Fibrosis,Metaplasia, myeloid  (extramedulary hematopoesis),Pigmentation, hemosiderin,Pigmentation, hemosiderin,Hyperplasia,|Kidney,Testis,Thyroid gland,Prostate,Iliac lymph node,Kidney,Spleen,Prescapular lymph node,Retropharyngeal lymph node,Adrenal cortex,|MODERATE,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3196|9|4859|Fibrosarcoma, malignant,Fibrosarcoma, malignant,Fibrosarcoma, malignant,Adenocarcinoma, malignant,Fibroma, benign,Leiomyoma, benign,Adenoma, benign,Leiomyoma, benign,Cyst,Inflammation, chronic,Congestion,Inflammation,Hyperplasia,Cyst,Hyperplasia,Hyperplasia,Autolysis,|Spleen,Liver,Colon,Lung,Vagina,Vagina,Thyroid gland,Vagina,Pituitary gland,Kidney,Topography, multiple sites,Colon,Uterus,Ovary,Female breast, right,Adrenal gland,Gastrointestinal tract,|;  ,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3203|9|3828|Mixed tumor, uncertain whether benign or malignant,Carcinoma, malignant,Adenoma, benign,Leiomyoma, benign,Fibroadenoma, benign,Perforation,Inflammation, acute,Metaplasia, myeloid  (extramedulary hematopoesis),Sepsis,Hyperplasia,Inflammation,Deposition, calcium,Hyperplasia,Inflammation,Inflammation,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation,Inflammation,Degeneration,|Mammary gland,Mammary gland,Adrenal gland,Vagina,Mammary gland,Abdomen, peritoneum and retroperitoneum,Abdomen, peritoneum and retroperitoneum,Spleen,Topography, multiple sites,Adrenal gland,Lymph node,Lung,Bone marrow,Jejunum,Peritoneum,Spleen,Lymph node,Thyroid gland,Kidney,|BILE NEPHROSIS.;  ,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3204|9|4275|Adenocarcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Adenoma, benign,Leiomyoma, benign,Leiomyoma, benign,Toxic state,Hyperplasia,Degeneration,Hyperplasia,Hyperplasia, lymphoid,Hyperplasia,|Mammary gland #3, left,Mammary gland,Iliac lymph node,Lung,Prescapular lymph node,Kidney,Axillary lymph node,Mammary gland,Vagina,Vagina,Adrenal gland,Liver,Uterus,Lymph node,Pancreas (Exocrine Pancreas),|NODULAR ACINAR HYPERPLASIA;  ,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3210|9|4156|Hemangiosarcoma (Angiosarcoma), malignant,Hemangiosarcoma (Angiosarcoma), malignant,Adenoma, benign,Adenoma, benign,Lipoma, benign,Rupture,Hemorrhage,Inflammation, chronic,Hyperplasia,Autolysis,|Spleen,Pituitary gland,Adrenal gland,Thyroid gland,Subcutaneous tissue,Spleen,Spleen,Kidney,Atrioventricular valve,Topography, multiple sites,|MANY TISSUES NOT READABLE;  ,|
1003-6-9|12.8 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,17T0600|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|20 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-9-3216|9|3521|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenoma, benign,Lesion,Cyst,Cyst,Inflammation, chronic,Regeneration,Hyperplasia,Hyperplasia,Hyperplasia,Normal tissue morphology,Inflammation,Metaplasia, myeloid  (extramedulary hematopoesis),|Mammary gland #4, left,Lung,Topography, multiple sites,Adrenal gland,Brain,Kidney,Liver,Uterus,Liver,Spleen,Lymph node,Bone marrow,Ovary,Kidney,Spleen,|SMALL NODULE OF EXMH&HEMOSIDEROSIS.;  ,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2703|10|3951|Chondrosarcoma, malignant,Mixed tumor, uncertain whether benign or malignant,Mixed tumor, malignant (AFIP 80850),Lipoma, benign,Fibroma, benign,Leiomyoma, benign,Pyometra,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation, chronic,Inflammation, acute,Hyperplasia,Inflammation, chronic,Metaplasia, myeloid  (extramedulary hematopoesis),|Bony tissue (bone),Mammary gland #3, right,Mammary gland #4, right,Small intestine mucous membrane,Vagina,Uterus,Uterus,Liver,Kidney,Uterus,Bony tissue (bone),Skeletal muscle,Spleen,|,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2706|10|3987|Lymphoma, lymphocytic, malignant, poorly differentiated,Lymphoma, lymphocytic, malignant, poorly differentiated,Leydig cell tumor, benign,Cyst,Degeneration, fatty,Hypoplasia,Fibrosis,Deposition, calcium,Hemorrhage,Hemorrhage,Hyperplasia,Hyperplasia,|Lymph node,Hematopoietic and reticuloendothelial system,Testis,Lung,Liver,Skeletal bone,Lung,Lung,Brain,Lung,Kidney,Liver,|REGENERATING NODULES.,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2722|10|4897|Lymphosarcoma, malignant,Lymphosarcoma, malignant,Lymphosarcoma, malignant,Seminoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Leydig cell tumor, benign,Adenoma, benign,Adenoma, benign,Adenoma, benign,Inflamation, acute exudative (suppurative),Inflammation, acute,Congestion,Pigmentation, hemosiderin,Pigmentation, hemosiderin,Congestion,Hyperplasia, lymphoid,Hemorrhage,Inflammation, acute,Hyperplasia,Autolysis,Autolysis,Autolysis,Inflammation, chronic,Degeneration,Congestion,Metaplasia, myeloid  (extramedulary hematopoesis),Autolysis,Autolysis,Regeneration,Cyst,Cyst,Autolysis,Hyperplasia,Autolysis,|Bone marrow,Liver,Cranial pia mater,Testis,Perianal gland,Colic lymph node,Lung,Iliac lymph node,Testis,Perianal gland,Perianal gland,Anal gland,Lung,Lung,Iliac lymph node,Iliac lymph node,Mesenteric lymph node,Ileum,Mandibular lymph node,Colon,Prostate,Adrenal gland,Salivary gland,Gluteus maximus muscle,Duodenum,Kidney,Liver,Mesenteric lymph node,Spleen,Pancreas (Exocrine Pancreas),Biceps brachii muscle,Liver,Parathyroid gland,Thyroid gland,Jejunum,Parathyroid gland,Topography, multiple sites,|POST MORTEM DEGENERATION,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2729|10|3996|Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Fibroma, benign,Leiomyoma, benign,Atrophy,Hemorrhage,Hyperplasia,Hemorrhage,|Mammary gland,Hematopoietic and reticuloendothelial system,Skin,Urinary bladder,Skeletal muscle,Adrenal gland,Skeletal bone,Heart,|,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2731|10|3690|Adenoma, benign,Degeneration,Degeneration, fatty,Cyst,Fibrosis,Hyperplasia,Hyperplasia,Atrophy,Pigmentation,Retention of fluid  (Hydronephrosis),Hyperplasia,Hyperplasia,|Perianal gland,Cerebellum,Liver,Pituitary gland,Lung,Bone marrow,Testis,Brain,Spleen,Brain,Lymph node,Prostate,|CYSTIC HYPERPLASIA.,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2751|10|3913|Intussusception,Adenoma, benign,Leydig cell tumor, benign,Toxic state,Atrophy,Necrosis,Hyperplasia,Hyperplasia,Nephrosis,Fibrosis,Hyperplasia,Embolus,Hyperplasia,Congestion,Disseminated intravascular coagulation (DIC) syndrome,Inflammation,|Intestine,Liver,Testis,Testis,Small intestine,Lymph node,Urinary bladder,Kidney,Lung,Bone marrow,Lung,Adrenal gland,Liver,Topography, multiple sites,Prostate,|LYMPHOCYTIC PROSTATITIS.,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2774|10|4737|Adenocarcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Adenocarcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Chemodectoma, malignant,Granulosa cell tumor, uncertain whether benign or malignant,Intraductal papilloma, benign,Papilloma, benign,Adenoma, benign,Leiomyoma, benign,Fibroma, benign,Extra-adrenal (nonchromaffin) paraganglioma, benign or malig,Leiomyoma, benign,Cardiopulmonary disease or syndrome,Leiomyoma, benign,Degeneration,Hyperplasia,Consolidation,Hyperplasia,Hyperplasia, lymphoid,Degeneration,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia, lymphoid,Congestion,Hyperplasia, lymphoid,Inflammation, chronic,Hyperplasia,Hyperplasia,Degeneration,Hyperplasia,Cyst,Hyperplasia,Degeneration,Hyperplasia, lymphoid,|Mammary gland,Mammary gland #5, left,Mammary gland #4, right,Mammary gland #5, right,Lung,Female breast, left,Mammary gland #4, left,Heart,Ovary,Mammary gland #4, right,Vaginal mucous membrane,Adrenal gland,Vagina,Vagina,Heart,Vagina,Heart,Urinary bladder,Liver,Pericardium,Lung,Visceral pericardium (Epicardium),Tracheobronchial lymph node,Pancreas (Exocrine Pancreas),Spleen,Tonsil,Kidney,Prescapular lymph node,Uterus,Adrenal gland,Bone marrow,Liver,Diaphragm,Pituitary gland,Uterus,Kidney,Mandibular lymph node,|,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2798|10|5656|Mixed tumor, uncertain whether benign or malignant,Adenocarcinoma, malignant,Adenoma, benign,Fibroma, benign,Leiomyoma, benign,Adenoma, benign,Adenoma, benign,Hydrocephalus,Functional disorder,Hyperplasia,Pigmentation, hemosiderin,Pigmentation, hemosiderin,Cyst,Hyperplasia,Dilatation,Inflammation, acute,Inflammation,Hemorrhage,Inflammation,Necrosis,Undetermined manner of death,Hemorrhage,Inflammation,Hematoma,Hemorrhage,|Mammary gland #3, right,Mammary gland #3, right,Pituitary gland,Ovary, right,Urinary bladder,Adrenal gland,Thyroid gland,Lateral ventricle,Endocrine gland,Adrenal gland,Lung,Brain,Thyroid gland,Bone marrow,Brain,Prescapular lymph node,Kidney,Mesenteric lymph node,Lung,Liver,Whole body,Mandibular lymph node,Uterus,Spleen,Retropharyngeal lymph node,|MILD,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2802|10|2950|Mucinous adenocarcinoma, malignant,Mucinous adenocarcinoma, malignant,|Jejunal mucous membrane,Visceral peritoneum,| SEROSA & ADNEXAL FAT,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2805|10|2486|Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Sarcoma, malignant,Mixed tumor, uncertain whether benign or malignant,Intraductal papilloma, benign,Papillary adenoma, benign,Degeneration, fatty,Congestion,Degeneration, fatty,|Spleen,Liver,Abdomen,Mesenteric lymph node,Pancreas (Exocrine Pancreas),Diaphragm,Lung,Mammary gland #3, right,Mammary gland #5, left,Pylorus,Liver,Liver,Myocardium,|,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2810|10|4032|Mixed tumor, uncertain whether benign or malignant,Pheochromocytoma, benign,Hemangioma, benign,Fibroma, benign,Fibroma, benign,Sinus arrhythmia,Death, anesthetic,Undetermined manner of death,Metaplasia, myeloid  (extramedulary hematopoesis),Cyst,Hyperplasia,Hyperplasia,Hyperplasia,Fibrosis,Hyperplasia,|Mammary gland,Adrenal gland,Liver,Vagina,Ovary,Heart,Topography, multiple sites,Topography, multiple sites,Spleen,Pituitary gland,Lymph node,Corpus uteri,Bone marrow,Heart,Spleen,|LYMPHOID HYPERPLASIA.,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2814|10|3575|Infarct,Cardiomyopathy,Leydig cell tumor, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Congestion,Infarct,Infarct,Hyperplasia,Infarct,Embolus,Hemorrhage,Hyperplasia,Hyperplasia,|Myocardium,Heart,Testis,Testis,Liver,Kidney,Brain,Prostate,Myocardium,Lung,Spleen,Pituitary anterior lobe (Pars Glandularis),Bone marrow,|MYELOID HYPER&LEFT SHIFT.,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2815|10|4257|Lymphosarcoma, malignant,Lymphoma, malignant,Carcinoma, malignant,Hemorrhage,Basal cell carcinoma, malignant,Carcinoma, malignant,Melanoma, (Pigmented nevus), benign,Leydig cell tumor, benign,Rupture,Fibrosis,Cyst,Inflammation,Hemorrhage,Disseminated intravascular coagulation (DIC) syndrome,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation,Inflammation,Edema,Hyperplasia,|Lymph node,Skin,Thyroid gland,Brain,Skin,Lung,Gum,Testis,Spleen,Kidney,Kidney,Gum,Brain,Lung,Spleen,Thyroid gland,Liver,Heart,Prostate,|CYSTIC HYPERPLASIA.,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2858|10|2557|Inflammation, acute,Inflammation, acute,Pigmentation,Hemorrhage,Atrophy,Disseminated intravascular coagulation (DIC) syndrome,Deposition of foreign crystalline material,Deposition of foreign crystalline material,Hemorrhage,Infarct,Hemorrhage,|Prostate,Prostate,Lymph node,Liver,Testis,Myocardium,Adrenal gland,Liver,Spleen,Lung,Urinary bladder,|MASSIVE HEMORRHAGES.,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2859|10|5560|Fibrosarcoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Adenoma, benign,Adenoma, benign,Leydig cell tumor, benign,Leiomyoma, benign,Hemangioendothelioma, benign,Hemangioendothelioma, benign,Hemangioendothelioma, benign,Hemangioendothelioma, benign,Edema,Chronic renal disease,Abscess,Hemorrhage,Cyst,Abscess,Hyperplasia,Degeneration,Hyperplasia,Inflammation,Fibrosis,Abscess,Hyperplasia,Cyst,Necrosis,Abscess,Metaplasia, myeloid  (extramedulary hematopoesis),Fibrosis,Hyperplasia,Hemorrhage,Autolysis,|Liver,Perianal gland,Lung,Endocrine pancreas (Islets of Langerhans),Pituitary gland,Testis, left,Stomach,Subcutaneous tissue of chest,Retropharyngeal lymph node,Kidney,Skin of perianal area,Lung,Kidney,Lung,Adrenal gland,Thyroid gland,Skin,Pancreas (Exocrine Pancreas),Liver,Tonsil,Urinary bladder,Kidney,Small intestine serosa,Parathyroid gland,Pituitary gland,Lung,Testis, right,Spleen,Testis, left,Adrenal gland,Iliac lymph node,Liver,|,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2862|10|3616|Fibroma, benign,Intraductal papilloma, benign,Fibroma, benign,Toxic state,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Hyperplasia,Inflammation, chronic,Pigmentation,Abscess,Infarct,Inflammation, chronic,Hyperplasia,Inflammation, acute,|Vagina,Mammary gland #2, right,Vagina,Adrenal gland,Bony tissue (bone),Mammary gland #2, left,Kidney,Liver,Spleen,Lung,Liver,Uterus,Vagina,|AC NECROTISING VAGINITIS,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2866|10|2101|Seizure syndrome,Congestion,Congestion,Congestion,|Brain,Lung,Liver,Kidney,|CONGESTION .,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2868|10|5241|Carcinoma, malignant,Carcinoma, malignant,Aortic body tumor, uncertain whether benign or malignant,Leydig cell tumor, benign,Extra-adrenal (nonchromaffin) paraganglioma, benign or malig,Hemangioma, benign,Hemangioma, benign,Edema,Pigmentation, hemosiderin,Hyperplasia,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Inflammation, chronic,Fibrosis,Congestion,Cyst,Cyst,|Perianal gland,Lung,Aorta,Testis, left,Heart,Skin,Tracheobronchial lymph node,Lung,Iliac lymph node,Liver,Diaphragm,Spleen,Adrenal gland,Kidney,Prostate,Liver,Kidney,Liver,|,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2872|10|2511|Lymphosarcoma, malignant, poorly differientated,Lymphosarcoma, malignant,Reticulosarcoma (Histocytic Lymphosarcoma), malignant,Reticulosarcoma (Histocytic Lymphosarcoma), malignant,Fibrosis,|Lymph node,Lung,Ileal mucous membrane,Liver,Myocardium,|ISCHEMIC SCARS,MULTIFOCAL,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2876|10|4466|Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Inflammation, acute,Hyperplasia,Inflammation, chronic,Hematoma,Cyst,Hyperplasia,Degeneration,Hyperplasia,Congestion,Hyperplasia,Cyst,|Mammary gland,Lung,Prescapular lymph node,Iliac lymph node,Axillary lymph node,Kidney,Bone marrow,Kidney,Spleen,Ovary,Uterus,Liver,Pancreas (Exocrine Pancreas),Mesenteric lymph node,Adrenal gland,Pituitary gland,|,|
1003-6-10|12.8 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,17T1400|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|24 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-10-2878|10|4896|Cholangiocarcinoma (Bile duct carcinoma), malignant,Carcinoma, malignant,Carcinoma, malignant,Leydig cell tumor, benign,Leydig cell tumor, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Abscess,Toxic state,Pigmentation, hemosiderin,Congestion,Hyperplasia, lymphoid,Hyperplasia,Degeneration,Hyperplasia, lymphoid,Inflammation, acute,Congestion,Pigmentation, hemosiderin,Congestion,Abscess,Edema,Inflammation, chronic,Atherosclerosis,Pigmentation, hemosiderin,Pigmentation, hemosiderin,Congestion,Hyperplasia, lymphoid,Hyperplasia,Congestion,Congestion,|Liver and gallbladder,Thyroid gland, right lobe,Liver,Testis, left,Testis,Testis, left,Liver,Axillary lymph node,Jejunum,Duodenum,Adrenal gland,Thyroid gland, left lobe,Retropharyngeal lymph node,Prostate,Retropharyngeal lymph node,Prescapular lymph node,Spleen,Spleen,Lung,Kidney,Aorta,Retropharyngeal lymph node,Iliac lymph node,Mandibular lymph node,Mandibular lymph node,Atrioventricular valve,Mesenteric lymph node,Lung,|MARKED IN ONE SECTION,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2323|11|3897|Adenocarcinoma, malignant,Squamous cell carcinoma, malignant (epidermoid carcinoma),Carcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Adenocarcinoma, malignant,Squamous cell carcinoma, malignant (epidermoid carcinoma),Intraductal adenoma, benign,Intraductal adenoma, benign,Hyperplasia,Hyperplasia,Cyst,Inflammation, chronic,Inflamation, acute exudative (suppurative),|Mammary gland #1, right,Mammary gland #2, right,Mammary gland #4, right,Mammary gland #4, left,Skin of axilla,Lung,Sebaceous gland,Skin of head,Skin,Uterus,Subcutaneous tissue of head,Kidney,Uterus,|,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2330|11|3832|Papillary carcinoma, malignant,Adenocarcinoma, malignant,Adenoma, benign,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Intraductal papilloma, benign,Intraductal papilloma, benign,Leiomyoma, benign,Sebaceous adenoma, benign,Leiomyoma, benign,Bile duct adenoma, benign,Adenoma, benign,Osteoarthritis,Hyperplasia,Fibrosis,Fibrosis,Hyperplasia,Hypertrophy,Deposition, calcium,Cyst,Hyperplasia,Hyperplasia,Hyperplasia,Fibrosis,|Mammary gland #5, left,Mammary gland #4, left,Mammary gland #3, left,Mammary gland #2, left,Mammary gland #3, left,Mammary gland #2, right,Lung,Mammary gland #4, left,Mammary gland #5, left,Vaginal muscularis,Skin,Vaginal muscularis,Liver,Mammary gland #4, left,Skeletal bone,Axillary lymph node,Periosteum,Thorax,Mammary gland #5, left,Periosteum,Lung,Ovary,Bone marrow,Liver,Mammary gland #4, left,Femur,|MARIE S DISEASE,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2331|11|1790|Compound leukemia, malignant,Monocytic leukemia, malignant,|Topography, multiple sites,Blood,| / Bone marrow, NOS, Compound leukemia (T-0X...) (T-06...)MYELOMONOCYTIC LEUKEMIA,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2333|11|3092|Hemangiosarcoma (Angiosarcoma), malignant,Hemangiosarcoma (Angiosarcoma), malignant,Hemangiosarcoma (Angiosarcoma), malignant,Hemorrhage,Deposition, calcium,Deposition of foreign crystalline material,Pigmentation,Atrophy,Fibrosis,Fibrosis,Pigmentation,Degeneration, fatty,Pigmentation,|Subcutaneous tissue of chest,Skin,Lung,Skin,Kidney,Liver,Prescapular lymph node,Testis,Lung,Spleen,Spleen,Liver,Liver,|HEMOSIDEROSIS,MILD&FOCAL.,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2337|11|3914|Inflammation, acute,Leydig cell tumor, benign,Leydig cell tumor, benign,Abscess,Deposition, calcium,Hemorrhage,Abscess,Atrophy,|Abdomen, peritoneum and retroperitoneum,Testis, left,Testis,Spleen,Pulmonary alveoli,Spleen,Spleen,Testis, left,|,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2349|11|4723|Reticulosarcoma (Histocytic Lymphosarcoma), malignant,Papillary carcinoma, malignant,Tubular androblastoma (Sertoli Cell Tumor), benign,Leydig cell tumor, benign,Adenoma, benign,Hyperplasia,Cyst,Infarct,|Topography, multiple sites,Lung,Testis, right,Testis, right,Stomach,Liver,Thyroid gland, right lobe,Kidney,|ISCHEMIC SCARS?INFARCTS,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2494|11|643|Aplasia,Inflammation, chronic,Hemorrhage,Hypoplasia,Congestion,Hypoplasia,Hemorrhage,Degeneration,Fibrosis,|Bone marrow,Kidney,Colonic mucous membrane,Lymph node,Liver,Spleen,Myocardium,Kidney,Lung,|,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2558|11|4502|Cholangiocarcinoma (Bile duct carcinoma), malignant,Adenocarcinoma, malignant,Leydig cell tumor, benign,Anemia,Necrosis,Hemorrhage,Fibrosis,Embolus,Regeneration,Deposition, calcium,Metaplasia, myeloid  (extramedulary hematopoesis),Metaplasia, myeloid  (extramedulary hematopoesis),Infarct,Embolus,Embolus,Fibrosis,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Metaplasia, myeloid  (extramedulary hematopoesis),Infarct,Hyperplasia,Undetermined manner of death,Deposition of foreign crystalline material,Infarct,|Intestine,Thyroid gland,Testis,Blood,Kidney,Spleen,Heart,Heart,Liver,Adrenal gland,Lung,Liver,Heart,Lung,Liver,Lung,Bone marrow,Omentum (Abdominal Fat),Jejunum,Brain,Prostate,Topography, multiple sites,Liver,Kidney,|RECENT/OLD INFARCTS,CORTEX&MEDULLA.,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2889|11|3327|Carcinoma, malignant,Perforation,Inflammation, chronic,Inflammation, acute,Leydig cell tumor, benign,Inflammation, chronic,Atrophy,Hyperplasia,Hyperplasia,Pigmentation,|Thyroid gland, right lobe,Intestine,Ileum,Abdomen, peritoneum and retroperitoneum,Testis,Ileum,Skeletal muscle,Bone marrow,Prostate,Spleen,|ABNORMAL CELLS IN BL VESS           +,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2893|11|3929|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Fibroma, benign,Fibroma, benign,Papilloma, benign,Adenoma, benign,Obstruction,Inflammation, pneumonia, septic,Inflammation, acute,Hyperplasia,Inflammation,Metaplasia, myeloid  (extramedulary hematopoesis),Hemorrhage,Cyst,Regeneration,Necrosis,Fibrosis,|Mammary gland,Topography, multiple sites,Mammary gland,Vagina,Mammary gland,Stomach,Intestine,Lung,Uterus,Bony tissue (bone),Lung,Spleen,Muscle,Thyroid gland,Liver,Heart,Pancreas (Exocrine Pancreas),|CHRONIC FIBROSING PANCREATITIS.,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2895|11|3557|Mixed tumor, uncertain whether benign or malignant,Hematoma,Hyperplasia,Hyperplasia,Deposition, calcium,Infarct,Metaplasia, myeloid  (extramedulary hematopoesis),Cyst,|Mammary gland #4, left,Spleen,Liver,Adrenal gland,Kidney,Adrenal gland,Spleen,Ovary,|FOLLICULAR CYSTS.,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-2899|11|5428|Carcinoma, malignant,Adenoma, benign,Leiomyoma, benign,Adenoma, benign,Leydig cell tumor, benign,Chronic renal disease,Hyperplasia,Pigmentation, hemosiderin,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation,Fibrosis,Hyperplasia,Hemorrhage,Degeneration,Hemorrhage,Inflammation,|Perianal gland,Adrenal gland,Stomach,Thyroid gland,Testis,Kidney,Adrenal gland,Prescapular lymph node,Spleen,Prostate,Kidney,Aorta,Urinary bladder,Brain,Tracheobronchial lymph node,Urinary bladder,|SUBMUCOSAL ACUTE INFL CELLS ACCUM.,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-3148|11|3265|Mixed tumor, malignant (AFIP 80850),Adenocarcinoma, malignant,Adenocarcinoma, malignant,Cholangiocarcinoma (Bile duct carcinoma), malignant,Papilloma, benign,Fibroma, benign,Bile duct adenoma, benign,Intussusception,Metaplasia,Degeneration, fatty,Atrophy,Necrosis,Inflamation, acute exudative (suppurative),Fibrosis,Hyperplasia,Hyperplasia,|Female breast, left,Female breast, left,Lymph node of thorax,Quadrate lobe of liver,Female breast, left,Vaginal muscularis,Liver,Jejunum,Lung,Liver,Skeletal muscle,Jejunal mucous membrane,Uterus,Lung,Bone marrow,Uterus,|CYSTIC ENDOMETRIAL,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-3220|11|3910|Mixed tumor, uncertain whether benign or malignant,Adenocarcinoma, malignant,Hemangioma, benign,Adenoma, benign,Hyperadrenocorticism (Cushings's Disease),Inflammation, acute,Congestion,Inflammation, chronic,Inflammation,Congestion,Edema,Congestion,Hyperplasia,Atrophy,Hyperplasia,Hemorrhage,Atrophy,Congestion,Regeneration,Cyst,Degeneration,Congestion,Hyperplasia,Congestion,Hyperplasia,Congestion,Hypoplasia,Degeneration,Congestion,Congestion,Edema,Congestion,Inflammation,Congestion,Hyperplasia,|Mammary gland #2, left,Mammary gland #5, left,Subcutaneous tissue,Pituitary gland,Adrenal gland,Uterus,Stomach,Kidney,Duodenum,Spleen,Lung,Adrenal gland,Adrenal gland,Gluteus maximus muscle,Parathyroid gland,Lung,Skin,Brain,Liver,Thyroid gland,Liver,Liver,Urinary bladder,Urinary bladder,Bone marrow,Ovary,Spleen,Bony tissue (bone),Colon,Mesenteric lymph node,Atrioventricular valve,Kidney,Urinary bladder,Prescapular lymph node,Pancreas (Exocrine Pancreas),|NODULAR HYPERPLASIA;  ,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-3221|11|4589|Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Cystadenoma, benign,Fibroma, benign,Adenoma, benign,Fibroma, benign,Inflammation,Edema,Inflammation, chronic,Hyperplasia,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Cyst,Degeneration,|Mammary gland,Prescapular lymph node,Thyroid gland,Lung,Ovary,Uterus,Adrenal gland,Vagina,Uterus,Axillary lymph node,Kidney,Bone marrow,Meninges,Spleen,Iliac lymph node,Pituitary gland,Liver,|LRG AREAS(GLYCOGEN)+BILE DUCT HYPL;   AND SOME FIBROSIS,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-3222|11|3383|Adenocarcinoma, w/evidence of metastasis,Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Adenocarcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Adenocarcinoma, malignant,Inflammation, acute,Hyperplasia,Regeneration,Fibroma, benign,Fibroma, benign,Cyst,Hyperplasia,Hyperplasia,|Mammary gland,Mammary gland,Mammary gland,Mammary gland,Mammary gland,Topography, multiple sites,Uterus,Adrenal gland,Liver,Vagina,Ovary, left,Ovary,Uterus,Skin,|SEBACEOUS HYPERPLASIA,SKIN HIP.;  ,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-3348|11|4959|Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Leiomyoma, benign,Fibroma, benign,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation,Hyperplasia,Hyperplasia,Cyst,Cyst,Degeneration,Hemorrhage,Inflammation, acute,|Mammary gland,Iliac lymph node,Lung,Colon,Vagina,Uterus,Spleen,Kidney,Renal pelvis,Adrenal cortex,Liver,Ovary,Liver,Retroperitoneal lymph node,Uterus,|;  ,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-3350|11|2437|Degeneration,Failure,Peritoneal fluid,Hyperplasia,Degeneration,Deposition, calcium,|Liver,Liver,Peritoneum,Adrenal cortex,Liver,Liver,|MINERALIZATION, MULTIFOCAL,;   MODERATE,|
1003-6-11|12.8 rad/day, total rad dose 1500 (22 hrs/7 days) mean age 463 days,17T2000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1500|19 (19 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-11-3352|11|4990|Lymphoma, malignant,Hemangioendothelioma, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Adenoma, benign,Adenoma, benign,Fistula, acquired,Fibrosis,Inflammation,Edema,Morphologic diagnosis deferred,Inflammation,Deposition, amyloid,Cyst,Congestion,Inflammation,|Topography, multiple sites,Skin,Testis,Thyroid gland,Perianal gland,Small intestine,Prostate,Prostate,Lung,Jejunum,Kidney,Spleen,Skin,Lung,Urinary bladder,|CYSTITIS GLANDULARIS.;   DIFFUSE HYPERPLASIA OF EPITHELIUM AND DOWNWARD GROWTH FORMING MANY VON BRUNNS NESTS.MANY OF THESE NESTS SHOW GLANDULAR CHANGES.CONGESTION,EDEMA AND HEMORRHAGES OF SUBMUCOSA SEEN.,|
1003-6-12|12.8 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,17T4000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (10 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-12-1858|12|2944|Mixed tumor, uncertain whether benign or malignant,Inflamation, acute exudative (suppurative),Inflamation, acute exudative (suppurative),Inflammation, acute,Congestion,Hemorrhage,|Mammary gland #4, right,Lung,Lung,Endocardium,Liver,Topography, multiple sites,|PETECHIAL  (SEPTICEMIA),|
1003-6-12|12.8 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,17T4000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (10 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-12-1861|12|4159|Hemangiosarcoma (Angiosarcoma), malignant,Adenocarcinoma, malignant,Leydig cell tumor, benign,Lipoma, benign,Hemangioendothelioma, benign,Hemangioendothelioma, benign,Fibrosis,Inflammation, pneumonia, septic,Degeneration, fatty,Hypoplasia,Inflammation, chronic,Deposition of foreign crystalline material,Atrophy,Degeneration, fatty,Deposition of foreign crystalline material,Cyst,Inflammation,Hyperplasia,Fibrosis,Hyperplasia,Hemorrhage,|Spleen,Lung,Testis,Kidney,Liver, left lobe,Liver,Kidney,Lung,Myocardium,Femur,Mucous membrane of urinary bladder,Liver,Testis,Liver,Brain,Pituitary gland,Liver, left lobe,Liver, left lobe,Glomerulus,Liver,Spleen,|HEMATOMA,|
1003-6-12|12.8 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,17T4000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (10 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-12-1867|12|4903|Mixed tumor, uncertain whether benign or malignant,Sebaceous adenoma, benign,Leiomyoma, benign,Bile duct adenoma, benign,Hemangioendothelioma, benign,Intraductal papilloma, benign,Lipoma, benign,Rupture,Hematoma,Cyst,Cyst,Hypoplasia,Hemorrhage,Degeneration, fatty,Cyst,Congestion,|Mammary gland,Sebaceous gland,Vaginal muscularis,Liver,Subcutaneous tissue of head,Mammary gland,Skin,Spleen,Spleen,Liver,Sebaceous gland,Adrenal gland,Spleen,Liver,Ovary,Lung,|,|
1003-6-12|12.8 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,17T4000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (10 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-12-1871|12|4295|Carcinoma, malignant,Carcinoma, w/evidence of metastasis,Carcinoma, malignant,Bile duct adenoma, benign,Adenoma, benign,Intraductal adenoma, benign,Inflammation, acute,Infarct,Necrosis,Necrosis,Abscess,Hemorrhage,Hyperplasia,Cyst,Inflammation, chronic,Congestion,Hyperplasia,Pigmentation,Deposition, calcium,Fibrosis,Hemorrhage,Hyperplasia,Hyperplasia,Atrophy,Inflamation, acute exudative (suppurative),|Subcutaneous tissue of flank,PERIANAL GLAND,Lung,Liver,Perianal gland,Prepuce of penis,Abdomen, peritoneum and retroperitoneum,Liver,Small intestine mucous membrane,Spleen,Epidermis,Lung,Liver,Eye,Kidney,Liver,Testis,Spleen,Pulmonary alveoli,Mitral valve,Spleen,Renal pelvis,Adrenal gland,Testis,Visceral peritoneum,| PERITONITIS,|
1003-6-12|12.8 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,17T4000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (10 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-12-1873|12|4027|Carcinoma, undifferentiated type, malignant,Adenocarcinoma, malignant,Carcinoma, undifferentiated type, malignant,Carcinoma, undifferentiated type, malignant,Carcinoma, undifferentiated type, malignant,Carcinoma, undifferentiated type, malignant,Basal cell carcinoma, malignant,Sebaceous adenoma, benign,Leiomyoma, benign,Adenoma, benign,Adenoma, benign,Hemangioendothelioma, benign,Leiomyoma, benign,Intraductal papilloma, benign,Inflammation,Hyperplasia,|Mammary gland,Mammary gland #4, left,Intercostal muscle,Pleura,Mediastinum,Lymph node,Eyelid,Eyelid,Vaginal muscularis,Thyroid gland,Parathyroid gland,Spleen,Vaginal muscularis,Mammary gland #4, right,Kidney,Liver,|NOD. & FOCI ALTERED CS,|
1003-6-12|12.8 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,17T4000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (10 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-12-1891|12|4807|Carcinoma, malignant,Carcinoma, malignant,Melanoma, (Pigmented nevus), benign,Leydig cell tumor, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Fibroma, benign,Synovioma, benign,Inflammation, chronic,Inflammation, chronic,Inflammation, chronic,Congestion,Hemorrhage,Inflammation,|Thyroid gland, right lobe,Lung,Tarsal gland,Testis, left,Testis, right,Retropharyngeal lymph node,Knee joint,Lung,Lung,Kidney,Liver,Spleen,Mesenteric lymph node,| LYMPHADENITIS,|
1003-6-12|12.8 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,17T4000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (10 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-12-1959|12|2682|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Inflamation, acute exudative (suppurative),Hemorrhage,Inflammation, acute,Inflammation,Atrophy,Inflammation, acute,Inflammation,Inflamation, acute exudative (suppurative),Pigmentation,Fibrosis,Cyst,Degeneration,|Gastric fundus,Abdomen,Mesenteric lymph node,Lung,Spleen,Visceral pleura,Mucosa of gallbladder,Testis,Pericardium,Prostate,Lung,Spleen,Pancreas (Exocrine Pancreas),Thyroid gland,Kidney,|NEPHROSIS,|
1003-6-12|12.8 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,17T4000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (10 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-12-1970|12|4560|Adenocarcinoma, malignant,Mixed tumor, uncertain whether benign or malignant,Intraductal carcinoma, non-infiltrating,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Mastocytoma, uncertain whether benign or malignant,Intraductal papilloma, benign,Adenoma, benign,Papillary adenoma, benign,Leiomyoma, benign,Epulis,Fibroma, benign,Inflammation, pleuritis,Lipoma, benign,Hyperplasia,Hyperplasia,Inflamation, acute exudative (suppurative),|Mammary gland #3, left,Mammary gland #3, right,Mammary gland #5, left,Mammary gland #4, right,Diaphragm,Muscle of thorax,Mediastinum,Lung,Tracheobronchial lymph node,Thyroid gland, left lobe,Mediastinal lymph node,Aorta,Subcutaneous tissue of lower extremity,Mammary chain, right,Perianal gland,Gastric mucous membrane,Vaginal muscularis,Oral mucous membrane,Cortex of kidney,Pleural cavity,Skin,Uterus,Mammary chain, right,Uterus,|ENDOMETRITIS,|
1003-6-12|12.8 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,17T4000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (10 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-12-1971|12|3304|Sarcoma, malignant,Sarcoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Adenoma, benign,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Tubular androblastoma (Sertoli Cell Tumor), benign,Hemangioendothelioma, benign,Inflammation, acute,Atrophy,Atelectasis,Deposition, calcium,|Trabecula of spleen,Liver,Thyroid gland,Mandibular lymph node,Skin appendage (Adnexal structure),Testis,Mesenteric lymph node,Liver,Lung,Bone marrow,Testis,Spleen,Lung,Testis,Lung,Pulmonary alveoli,|MICROLITHIASIS,|
1003-6-12|12.8 rad/day, total rad dose 3000 (22 hrs/7 days) mean age 463 days,17T4000|1| 463|gamma-rays Co-60|12.8|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 3000|20 (10 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-12-2074|12|2936|Hemangiosarcoma (Angiosarcoma), malignant,Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,Adenoma, benign,Inflammation, acute,Hyperplasia,Hemorrhage,Atrophy,|Subcutaneous tissue of neck,Trabecula of spleen,Topography, multiple sites,Thyroid gland,Lung,Adrenal gland,Spleen,Testis,|,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3133|13|4350|Adenocarcinoma, w/evidence of metastasis,Mixed tumor (Pleomorphic adenoma), benign,Carcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Leiomyoma, benign,Leiomyoma, benign,Fibroma, benign,Heart failure, (Congestive),Inflammation, acute,Hemorrhage,Congestion,Hyperplasia,Hemorrhage,Metaplasia, myeloid  (extramedulary hematopoesis),Inflammation,Inflammation, chronic,Congestion,Degeneration,|Mammary gland #2, left,Mammary gland,Mammary gland,Lung,Iliac lymph node,Vagina,Vagina,Vagina,Heart,Uterus,Brain,Liver,Adrenal gland,Liver,Spleen,Kidney,Kidney,Retropharyngeal lymph node,Liver,|AREAS OF HEPATOCELL. DEGE.(GLYCOGEN,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3136|13|1201|Suffocation,Hemorrhage,Fibrosis,Hypoplasia,Atrophy,Hyperplasia,Hyperplasia,Hemorrhage,Fibrosis,Congestion,|Tongue,Lung,Bone marrow,Testis,Lymph node,Spleen,Tongue,Biceps femoris muscle,Liver,|,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3139|13|2251|Injury, recent,Hyperplasia,Pigmentation, hemosiderin,Pigmentation, hemosiderin,Atrophy,Degeneration, fatty,Undetermined manner of death,Deposition, calcium,Inflammation,Congestion,|Skin,Testis,Spleen,Lymph node,Testis,Liver,Topography, multiple sites,Kidney,Thyroid gland,Lung,|MILD CONGESTION.,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3144|13|5147|Mixed tumor, uncertain whether benign or malignant,Mixed tumor, malignant (AFIP 80850),Adenoma, benign,Adenoma, benign,Fibroma, benign,Papilloma, benign,Congestion,Hyperplasia,Hematoma,Autolysis,Hyperplasia,Hyperplasia,|Mammary gland #4, right,Topography, multiple sites,Pituitary gland,Adrenal gland,Vagina,Skin of axilla,Brain,Atrioventricular valve,Spleen,Topography, multiple sites,Liver,Adrenal gland,|CORTICAL,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3164|13|2797|Seizure syndrome,|Brain,| / Brain, NOS, Seizure (Epileptic episode), NOSEPILEPSY.,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3165|13|3517|Sarcoma, malignant,Sarcoma, malignant,Carcinoma, undifferentiated type, malignant,Infarct,Inflammation,Hyperplasia,Degeneration, fatty,Degeneration, fatty,Deposition, calcium,Polyp,Inflammation,|Spleen,Topography, multiple sites,Skin,Mesentery,Mesentery,Bone marrow,Liver,Liver,Brain,Uterus,Thyroid gland,|LYMPHOCYTIC THYROIDITIS.MILD.,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3166|13|5445|Bronchiolo-alveolar adenocarcinoma, malignant,Transitional cell carcinoma, malignant,Leydig cell tumor, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Leiomyoma, benign,Lipoma, benign,Adenoma, benign,Hyperplasia,Undetermined manner of death,Hyperplasia,Pigmentation, hemosiderin,Degeneration,Adenoma, benign,Inflammation,Hyperplasia,Pigmentation, hemosiderin,Hemorrhage,Hyperplasia,|Lung,Topography, multiple sites,Testis, right,Testis, right,Stomach,Mediastinum,Thyroid gland,Spleen,Topography, multiple sites,Prescapular lymph node,Spleen,Liver,Adrenal gland,Prostate,Adrenal cortex,Liver,Spleen,Prostate,|MODERATE,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3167|13|5389|Leiomyoma, benign,Leydig cell tumor, benign,Inflammation, chronic,Hyperplasia,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Fibrosis,Degeneration,Fibrosis,Pigmentation, hemosiderin,Inflammation,Undetermined manner of death,|Stomach,Testis,Vertebrae, lumbar,Adrenal cortex,Spleen,Spleen,Kidney,Liver,Prostate,Spleen,Prostate,Topography, multiple sites,|NO COD ASSIGNED.,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3174|13|1021|Inflammation, acute,Hyperplasia,Degeneration,Inflammation,Inflammation,Inflammation,Atrophy,Hyperplasia,Congestion,Congestion,Inflammation, chronic,|Intestine,Lymph node,Kidney,Colonic mucous membrane,Small intestine mucous membrane,Gastric mucous membrane,Testis,Lymph node,Spleen,Liver,Lung,|INTERSTIT. LYMPHOS.,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3183|13|3914|Carcinoma, malignant,Leydig cell tumor, benign,Renal failure syndrome,Inflammation, chronic, glomerulonephritis,Hemorrhage,Constriction injury,Hyperplasia,Inflammation, chronic,Hyperplasia, lymphoid,Atrophy,Hyperplasia,Hyperplasia,Congestion,Pigmentation, hemosiderin,Hyperplasia,Degeneration,Hyperplasia,Congestion,Autolysis,Morphology not assigned in SNOMED or SNODOG,Congestion,Hemorrhage,|Salivary gland,Testis,Kidney,Kidney,Subdural space,Spleen,Iliac lymph node,Kidney,Prescapular lymph node,Testis,Parathyroid gland,Atrioventricular valve,Lung,Spleen,Prostate,Liver,Adrenal gland,Pituitary gland,Gallbladder,Tonsil,Liver,Brain,|SUBDURAL HEMO.-SPCORD,BRAINSTEM,A   LITTLE OVER CEREBRUM,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3185|13|4951|Oligodendroglioma, malignant,Oligodendroglioma, malignant,Leydig cell tumor, benign,Congestion,Hematoma,Autolysis,Congestion,Degeneration,Fibrosis,Congestion,Inflammation,Congestion,Pigmentation, hemosiderin,Hyperplasia,|Brain,Pituitary gland,Testis,Lung,Spleen,Topography, multiple sites,Prescapular lymph node,Liver,Kidney,Liver,Kidney,Mandibular lymph node,Iliac lymph node,Adrenal gland,|CORTICAL,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3188|13|4136|Carcinoma, malignant,Adenocarcinoma, malignant,Papillary carcinoma, malignant,Papilloma, benign,Fibroma, benign,Degeneration,Cyst,Hyperplasia,Hyperplasia,Hyperplasia, lymphoid,Edema,Hyperplasia,|Mammary gland #1, right,Mammary gland,Mammary gland #3, right,Skin,Vagina,Liver,Pituitary gland,Adrenal gland,Parathyroid gland,Lymph node,Lung,Bone marrow,|LEFT SHIFT,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3189|13|4835|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Adenocarcinoma, malignant,Hemangioendothelioma, benign,Adenoma, benign,Adenoma, benign,Leiomyoma, benign,Inflammation,Degeneration,Infarct,Hyperplasia,Fibrosis,Cyst,Regeneration,|Mammary gland #3, right,Mammary gland #4, right,Axillary lymph node,Mammary gland #1, left,Lung,Subcutaneous tissue,Adrenal gland,Thyroid gland,Uterus,Myocardium,Liver,Kidney,Adrenal gland,Heart,Ovary,Liver,|,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3190|13|4871|Neuroblastoma, malignant,Carcinoma, malignant,Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mastocytoma, uncertain whether benign or malignant,Adenoma, benign,Adenoma, benign,Adenoma, benign,Leiomyoma, benign,Leiomyoma, benign,Neurofibroma, benign,Hyperplasia,Hyperplasia,Inflammation,Hyperplasia,Edema,Cyst,Hyperplasia,Degeneration,Atrophy,Inflammation,Inflammation,Metaplasia, myeloid  (extramedulary hematopoesis),Cyst,|Cerebellum,Colon,Mammary gland,Mammary gland,Topography, multiple sites,Skin,Parathyroid gland,Pituitary gland,Adrenal gland,Vagina,Stomach,Corpus uteri,Adrenal gland,Salivary gland,Kidney,Iliac lymph node,Epiglottis,Thyroid gland,Bone marrow,Liver,Heart,Uterus,Lung,Spleen,Ovary,|SIMPLE CYSTS+CORPUS LUTEI,BILATERAL,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3191|13|4823|Hemangiosarcoma (Angiosarcoma), malignant,Hemangiosarcoma (Angiosarcoma), malignant,Hemangiosarcoma (Angiosarcoma), malignant,Carcinoma, malignant,Hemangiosarcoma (Angiosarcoma), w/evidence of metastasis,Leydig cell tumor, benign,Adenoma, benign,Adenoma, benign,Hyperplasia,Congestion,Inflammation, chronic,Hemorrhage,Inflammation,|Spleen,Lung,Liver,Perianal gland,Spleen,Testis,Skin,Parathyroid gland,Adrenal gland,Lymph node,Kidney,Brain,Prostate,|MODERATE SUBACTUE,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3195|13|5343|Adenocarcinoma, malignant,Adenocarcinoma, malignant,Fibrosarcoma, malignant,Transitional cell carcinoma, malignant,Fibroma, benign,Undetermined manner of death,Degeneration,Hyperplasia,Inflammation,Inflammation,Hematoma,Regeneration,Pigmentation, hemosiderin,|Mammary gland #4, right,Lung,Muscle,Topography, multiple sites,Vagina,Topography, multiple sites,Liver,Adrenal cortex,Uterus,Kidney,Spleen,Liver,Liver,|MODERATE,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3198|13|2438|Seizure syndrome,Pigmentation, hemosiderin,Hemorrhage,Deposition, calcium,Pigmentation, hemosiderin,Inflammation,Hemorrhage,Atrophy,Hyperplasia,Hemorrhage,Atrophy,Degeneration,|Brain,Liver,Lung,Kidney,Spleen,Lung,Urinary bladder,Cerebellum,Prostate,Heart,Testis,Heart,|AREA OF DEGE?INFARCT EARLY?INFLAMMA;   AREAS SHOWING LOSS OF STRIATIONS,EDEMA,FIBRE NECROSIS AND EARLY INFLAMMATORY RESPONSE ?EARLY ISCHEMIC CHANGES?EARLY MYOCARDITIS.,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3202|13|4425|Carcinoma, w/evidence of metastasis,Mixed tumor, malignant (AFIP 80850),Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Fibroma, benign,Fibrous histiocytoma, benign,Fibroma, benign,Dysplasia,Cyst,Cyst,Inflammation,Metaplasia, myeloid  (extramedulary hematopoesis),Degeneration,|Mammary gland,Mammary gland #2, left,Adrenal gland,Liver,Axillary lymph node,Bone marrow,Jejunum,Prescapular lymph node,Pituitary gland,Lung,Iliac lymph node,Vagina,Skin,Jejunum,Mammary gland,Tail,Ovary,Uterus,Spleen,Liver,|GLYCOGEN;  ,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3208|13|3677|Glioma, malignant,Glioma, malignant,Pigmentation, hemosiderin,Hyperplasia,Degeneration, fatty,Hyperplasia,Regeneration,Hyperplasia,Hyperplasia,Fibrosis,Inflammation,Atelectasis,Pigmentation, hemosiderin,Fibrosis,Hyperplasia,|Cerebellum,Spinal cord,Spleen,Spleen,Liver,Lymph node,Liver,Thyroid gland,Bone marrow,Lung,Kidney,Lung,Liver,Atrioventricular valve,Prostate,|CYSTIC HYPERPLASIA &PROSTATITIS.;  ,|
1003-6-13|26.3 rad/day, total rad dose 450 (22 hrs/7 days) mean age 463 days,35T0600|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 450|21 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-13-3209|13|4537|Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Adenoma, benign,Hemangioma, benign,Fibroma, benign,Adenoma, benign,Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia,Inflammation, chronic,Degeneration,Inflammation,Degeneration,|Mammary gland,Pericardium,Retropharyngeal lymph node,Iliac lymph node,Axillary lymph node,Prescapular lymph node,Muscle,Adrenal gland,Liver,Vaginal muscularis,Parathyroid gland,Spleen,Bone marrow,Kidney,Liver,Lung,Liver,|GLYCOGEN;  ,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1526|14|2321|Toxic state,Adenocarcinoma, malignant,Inflammation, pneumonia, septic,Adenoma, benign,Inflammation,Adenoma, benign,Shock,Adenoma, benign,Inflammation,Congestion,Hyperplasia,Inflammation,Edema,Inflamation, acute exudative (suppurative),Osteoblastic osteosarcoma, malignant,Neoplastic disease, malignant,Osteoblastic osteosarcoma, malignant,Neoplastic disease, malignant,Osteoporosis,Osteoporosis,Degeneration, focal,Degeneration, focal,|Mammary gland #2, right,Lung,Mammary gland #2, left,Uterus,Mammary gland #3, right,Mammary gland #2, right,Spleen,Liver,Parathyroid gland,Parasternal lymph node,Lung,Uterus,Lumbar vertebra, sixth,Lumbar vertebra, sixth,Frontal bone,Frontal bone,Hepatic parenchymal cell,Hepatic parenchymal cell,|Pathology performed at ITRI! DEGENERATION, FOCAL/LIVER, HEPATOCYTES (incidental disease02),|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1544|14|3114|Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Lymphoma, lymphocytic, malignant, well differentiated,Deposition, calcium,Inflammation,Atrophy,Hyperplasia,Pigmentation,Inflammation, chronic,Inflammation,Congestion,Fibrosis,Hyperplasia,Hyperplasia,Inflammation, acute,Hyperplasia,Edema,|Small intestine,Mesenteric lymph node,Abdomen,Heart,Pulmonary alveoli,Kidney,Testis,Prostate,Spleen,Myocardium,Parasternal lymph node,Liver,Visceral peritoneum,Mucous membrane of urinary bladder,Adrenal gland,Visceral peritoneum,Pituitary anterior lobe (Pars Glandularis),Lung,|C CONGESTION,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1554|14|1823|Toxic state,Inflammation,Shock,Inflammation,Inflammation,Infarct,Undetermined manner of death,|Uterus,Uterus,Kidney,Spleen,Topography, multiple sites,|NO COD COULD BE DETERMINED BY HISTO X   EXAMINATION OF TISSUES SUBMITTED.,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1582|14|4132|Adenoma, benign,Sebaceous adenoma, benign,Inflammation, acute,Hyperplasia,Inflammation,Inflammation,Inflammation,Inflammation,Hyperplasia,Inflammation,Inflammation,Necrosis,Congestion,Hemorrhage,Inflammation,Hyperplasia,Inflammation,Atrophy,Cyst,Inflammation,Inflammation, acute,Degeneration,|Perianal gland,Sebaceous gland,Intestine,Small intestine mucous membrane,Spleen,Liver,Lung,Parasternal lymph node,Parasternal lymph node,Small intestine mucous membrane,Kidney,Gastric mucous membrane,Liver,Myocardium,Colonic mucous membrane,Gastric mucous membrane,Brain,Testis,Mammary gland #2, right,Kidney,Small intestine mucous membrane,Mucous membrane of urinary bladder,|VACUOLAT. EP & I.N. IN BO,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1584|14|3786|Carcinoma, undifferentiated type, malignant,Carcinoma, undifferentiated type, malignant,Adenoma, benign,Leiomyoma, benign,Squamous cell papilloma, benign,Papillary adenoma, benign,Adenoma, benign,Inflammation, chronic,|Mammary gland,Topography, multiple sites,Thyroid gland,Vaginal muscularis,Sebaceous gland,Pylorus,Mammary gland,Uterus,|CYSTIC ENDOMETRITIS,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1597|14|3802|Mixed tumor, malignant (AFIP 80850),Mixed tumor, malignant (AFIP 80850),Osteosarcoma, malignant,Transitional cell papilloma, benign,Leiomyoma, benign,Papilloma, benign,Atrophy,Atrophy,Inflammation,|Mammary chain, right,Topography, multiple sites,Mucous membrane of urinary bladder,Horn of uterus, right,Ovary,Uterus,Ovary,Lung,|INTERSTITIAL,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1600|14|4587|Carcinoma, malignant,Carcinoma, malignant,Fibroma, benign,Leiomyoma, benign,Hemangiopericytoma, uncertain whether benign or malignant,Leydig cell tumor, benign,Lipoma, benign,Adenoma, benign,Lipoma, benign,Lipoma, benign,Sebaceous adenoma, benign,Inflammation, acute,Hyperplasia,Inflammation, chronic,Inflammation, chronic,Hyperplasia,Infarct,|Perianal gland,Thyroid gland,Kidney,Gallbladder,Subcutaneous tissue of eyelid,Testis, left,Spleen,Perianal gland,Subcutaneous tissue of chest,Subcutaneous tissue of axilla,Skin appendage (Adnexal structure),Skin,Prostate,Kidney,Prostate,Testis, right,Kidney,|,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1601|14|4796|Melanoma, (Pigmented nevus), benign,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Tubular androblastoma (Sertoli Cell Tumor), benign,Lipoma, benign,Leiomyoma, benign,Adenoma, benign,Inflammation, pneumonia, septic,Hyperplasia,Congestion,Congestion,Hemorrhage,|Skin,Heart,Lung,Testis,Spleen,Esophagus,Perianal gland,Lung,Bone marrow,Lymph node,Liver,Spleen,|HEMATOMA                            +,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1611|14|3247|Hemangiosarcoma (Angiosarcoma), malignant,Hemangiosarcoma (Angiosarcoma), malignant,Hemangiosarcoma (Angiosarcoma), malignant,Carcinoma, malignant,Mastocytoma, uncertain whether benign or malignant,Papillary adenoma, benign,Transitional cell papilloma, benign,Adenoma, benign,Inflammation, chronic,Atelectasis,Inflammation,Degeneration,Inflammation, chronic,Inflammation, chronic,Hyperplasia,Atrophy,Inflammation,Inflammation, chronic,|Abdomen,Liver,Skin appendage (Adnexal structure),Perianal gland,Subcutaneous tissue of chest,Gastric mucous membrane,Mucous membrane of urinary bladder,Perianal gland,Mucosa of gallbladder,Lung,Pulmonary alveoli,Liver,Testis,Prostate,Pituitary anterior lobe (Pars Glandularis),Testis,Spleen,Mucous membrane of urinary bladder,|PSEUDOPOLYPOID,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1617|14|805|n/a|n/a|n/a|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1669|14|4193|Cholangiocarcinoma (Bile duct carcinoma), malignant,Degeneration,Inflammation,Inflammation, chronic,Hyperplasia,Inflammation, chronic,Inflammation, chronic,Atrophy,Hemorrhage,Inflammation, chronic,Degeneration, fatty,Ulcer,Atrophy,Degeneration,Deposition, calcium,Hyperplasia,Inflammation, chronic,Fibrosis,Inflammation, acute,|Intestine,Liver,Stomach,Liver,Lymphatic follicle of spleen (Spleenic white pulp),Kidney,Gastric fundus,Testis,Spleen,Mucosa of gallbladder,Skeletal muscle,Gastric mucous membrane,Skeletal muscle,Skeletal muscle,Lung,Adrenal cortex,Small intestine mucous membrane,Skeletal muscle,Lung,|INTERSTITIAL,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1682|14|5619|Carcinoma, malignant,Adenocarcinoma, malignant,Carcinoma, malignant,Carcinoma, malignant,Adenocarcinoma, malignant,Adenocarcinoma, malignant,Adenoma, benign,Mixed tumor, uncertain whether benign or malignant,Papillary cystadenoma, benign,Adenocarcinoma, malignant,Granulosa cell tumor, uncertain whether benign or malignant,Adenoma, benign,Leiomyoma, benign,Intraductal papilloma, benign,Osteodystrophy,Inflammation, chronic, glomerulonephritis,Cyst,Cyst,Hyperplasia,Inflammation, chronic,Hemorrhage,Hyperplasia,Inflammation, chronic,Hyperplasia,Atrophy,Inflammation, chronic,|Adrenal gland, left,Lung,Liver,Diaphragm,Lymph node of thorax,Mammary chain, right,Mammary gland #2, left,Mammary gland #2, left,Ovary, left,Thyroid gland,Ovary, right,Liver,Vaginal muscularis,Mammary gland #1, left,Kidney,Kidney,Mammary chain, right,Mammary chain, right,Mammary chain, right,Endometrium,Spleen,Bone marrow,Kidney,Parathyroid gland,Bony tissue (bone),Mucous membrane of urinary bladder,|CH LYMPHOCYTIC CYSTITIS.,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1694|14|4006|Reticulosarcoma (Histocytic Lymphosarcoma), malignant,Reticulosarcoma (Histocytic Lymphosarcoma), malignant,Lymphosarcoma, malignant,Melanoma, (Pigmented nevus), benign,Leydig cell tumor, benign,Lipoma, benign,Tubular androblastoma (Sertoli Cell Tumor), benign,Adenoma, benign,Intraductal adenoma, benign,Fibrosis,Hyperplasia,Inflammation,Hyperplasia,Inflammation, chronic,Cyst,Inflammation, chronic,|Skeletal muscle,Topography, multiple sites,Skin,Tarsal gland,Testis, left,Subcutaneous tissue of eyelid,Testis, right,Thyroid gland,Sebaceous gland,Visceral peritoneum,Sebaceous gland,Kidney,Liver,Prostate,Epidermis,Mucous membrane of urinary bladder,|HYPERPLASTIC,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1699|14|3357|Inflammation, acute,Sebaceous adenoma, benign,Pyometra,Hemangioendothelioma, benign,Lipoma, benign,Transitional cell papilloma, benign,Inflamation, acute exudative (suppurative),Degeneration,Inflammation, chronic,Hemorrhage,Hyperplasia,Inflamation, acute exudative (suppurative),|Peritoneum,Sebaceous gland,Uterus,Skin of foot,Subcutaneous tissue of chest,Mucous membrane of urinary bladder,Visceral peritoneum,Liver,Kidney,Spleen,Endometrium,Uterus,|ENDOMETRITIS, GLS ATROPHI           C,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1725|14|4093|Carcinoma, malignant,Carcinoma, malignant,Adenoma, benign,|Perianal gland,Lung,Perianal gland,|,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1775|14|3430|Mastocytoma, uncertain whether benign or malignant,Mastocytoma, uncertain whether benign or malignant,Ulcer,Hemorrhage,|Subcutaneous tissue,Topography, multiple sites,Duodenal mucous membrane,Lung,|MASSIVE,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1776|14|3848|Adenoma, benign,Papillary adenoma, benign,Inflammation, chronic,Inflammation, acute,Inflammation,Inflammation, chronic,Abscess,Ulcer,Abscess,Inflammation, acute,Degeneration,Inflammation, acute,Infarct,Inflammation,|Testis,Gastric mucous membrane,Prostate,Intestine,Myocardium,Prostate,Skin of knee,Jejunal mucous membrane,Skeletal muscle,Kidney,Thyroid gland, left lobe,Small intestine serosa,Kidney,Parasternal lymph node,|LYMPHADENITIS,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1857|14|2312|Cholangiocarcinoma (Bile duct carcinoma), malignant,Aplasia,Hyperplasia,Atrophy,Aplasia,Hemorrhage,|Intestine,Bone marrow,Lymph node,Small intestine mucous membrane,Bone marrow,Lung,|MULT HEMOR&BONE FORMATION,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1860|14|2373|Hemorrhage,Atelectasis,Inflammation, chronic,Inflammation, chronic,Inflammation, chronic,Hemorrhage,Atrophy,Hyperplasia,Hyperplasia,Inflammation,Hemorrhage,Inflammation, chronic,Hyperplasia,|Spleen,Lung,Kidney,Liver,Lung,Pancreas (Exocrine Pancreas),Testis,Liver,Adrenal gland,Kidney,Spleen,Duodenal mucous membrane,Prostate,|,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1864|14|5650|Carcinoma, malignant,Papillary carcinoma, malignant,Squamous cell carcinoma, malignant (epidermoid carcinoma),Mixed tumor, malignant (AFIP 80850),Chronic lymphoproliferative disease, uncertain whether benig,Papillary adenoma, benign,Adenoma, benign,Papillary adenoma, benign,Fibroma, benign,Fibroma, benign,Leiomyoma, benign,Cyst,Inflammation, acute,Hyperplasia,Infarct,Atrophy,Hyperplasia,Deposition, calcium,Degeneration,Fibrosis,Fibrosis,Hyperplasia,Hyperplasia,Cyst,Inflammation, chronic,Cyst,Hyperplasia,|Mammary gland #1, left,Mammary chain, right,Mammary gland #4, left,Topography, multiple sites,Adrenal gland,Small intestine mucous membrane,Adrenal gland, right,Colonic mucous membrane,Ear, external, right,Vagina,Esophagus,Pituitary gland,Lymph node,Femur,Kidney,Skeletal muscle,Mammary gland #4, left,Lung,Endocardium,Lung,Myocardium,Adrenal gland,Spleen,Ovary,Pylorus,Parathyroid gland,Liver,|REGENERATING NODULES.,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-1870|14|2931|Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,Neurilemmona (Schwannoma), malignant,|Trabecula of spleen,Liver,Lung,Abdomen,|,|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-2727|14|2173|n/a|n/a|n/a|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-2732|14|2165|n/a|n/a|n/a|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-2741|14|2153|n/a|n/a|n/a|
1003-6-14|26.3 rad/day, total rad dose 1050 (22 hrs/7 days) mean age 463 days,35T1400|1| 463|gamma-rays Co-60|26.3|rads per day|External exposure| Exposed 22 hours per day, 7 days per week until total dose = 1050|21 (25 in ERA)|Dog|Dog, Beagle|Both|need def 11|Dogs were provided with life-time clinical care, including annual physical examination and blood work-ups. At necropsy, a thorough gross examination was conducted, and a preliminary cause of death was determined. After histopathological examination of tissues from suspected lesions and an extensive suite of representative tissues, a "final" cause of death was entered into the database. |1003-6-14-2746|14|2125|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1459|99|1575|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1525|99|553|Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,Hypoplasia,Hemorrhage,Hyperplasia,Hemorrhage,Hemorrhage,Pigmentation, hemosiderin,|Retropharyngeal lymph node,Tracheobronchial lymph node,Iliac lymph node,Conjunctiva,Lung,Spleen,Bronchus,Thyroid gland,Mesenteric lymph node,Testis,Spleen,|MILD,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1533|99|796|Degeneration,Hypoplasia,Inflammation, acute,Hemorrhage,Hypoplasia,Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,|Testis,Spleen,Prostate,Colic lymph node,Iliac lymph node,Retropharyngeal lymph node,Mesenteric lymph node,Spleen,Lung,Iliac lymph node,|MARKED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1536|99|533|Melanoma, malignant, w/evidence of metastasis,Neoplastic disease, malignant w/evidence of metastasis,Melanoma, malignant, w/evidence of metastasis,Neoplastic disease, malignant w/evidence of metastasis,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Hyperplasia, lobular,Hyperplasia, lobular,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Neoplastic disease, benign,Adenoma, complex, benign,Adenoma, complex, benign,Neoplastic disease, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Adenoma, complex, benign,Neoplastic disease, benign,Hyperplasia,Hyperplasia,Hyperplasia, lobular,Hyperplasia, lobular,Neoplastic disease, malignant,Tubular adenocarcinoma, complex, malignant,Tubular adenocarcinoma, complex, malignant,Neoplastic disease, malignant,Hyperplasia,Hyperplasia,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Intraductal papilloma, benign,Neoplastic disease, benign,Intraductal papilloma, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Mixed tumor (Pleomorphic adenoma), benign,Neoplastic disease, benign,Mixed tumor (Pleomorphic adenoma), benign,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Dilatation,Dilatation,Hyperplasia, lobular,Hyperplasia, lobular,Sclerosis,Sclerosis,Hyperplasia,Hyperplasia,Adenoma, complex, benign,Neoplastic disease, benign,Adenoma, complex, benign,Neoplastic disease, benign,Neoplastic disease, benign,Adenoma, complex, benign,Adenoma, complex, benign,Neoplastic disease, benign,Metaplasia, myeloid  (extramedulary hematopoesis),Metaplasia, myeloid  (extramedulary hematopoesis),Metaplasia, myeloid  (extramedulary hematopoesis),Metaplasia, myeloid  (extramedulary hematopoesis),Hyperplasia, focal,Hyperplasia, focal,Fibrosis,Fibrosis,Polyp,Polyp,Fibrosis, focal,Fibrosis, focal,Cyst, follicular,Cyst, follicular,Hyperplasia,Hyperplasia,Spondylosis,Disease or syndrome of skeletal system,Disease or syndrome of skeletal system,Spondylosis,Cataract,Eye disease or syndrome,Eye disease or syndrome,Cataract,Fibroma, benign,Neoplastic disease, benign,Fibroma, benign,Neoplastic disease, benign,Hypoplasia,Hypoplasia,Hypoplasia,Hemorrhage,Hemorrhage,Hemorrhage,Pigmentation, hemosiderin,Hemorrhage,|Oral mucous membrane,Oral mucous membrane,Mammary gland #2, right,Mammary gland #2, right,Mammary gland #3, right,Mammary gland #3, right,Mammary gland #3, right,Mammary gland #3, right,Mammary gland #3, right,Mammary gland #3, right,Mammary gland #3, right,Mammary gland #3, right,Mammary gland #4, right,Mammary gland #4, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #5, right,Mammary gland #3, left,Mammary gland #3, left,Mammary gland #3, left,Mammary gland #3, left,Mammary gland #4, left,Mammary gland #4, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Mammary gland #5, left,Spleen,Spleen,Liver,Liver,Hepatic parenchymal cell,Hepatic parenchymal cell,Pancreas (Exocrine Pancreas),Pancreas (Exocrine Pancreas),Gastric mucous membrane,Gastric mucous membrane,Interstitial tissue of kidney,Interstitial tissue of kidney,Ovary,Ovary,Adrenal cortex,Adrenal cortex,Intervetrebral disc,Intervetrebral disc,Crystalline lens,Crystalline lens,Vagina,Vagina,Spleen,Iliac lymph node,Mesenteric lymph node,Mesenteric lymph node,Urinary bladder,Iliac lymph node,Spleen,Lung,|MARKED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1543|99|578|Pigmentation, hemosiderin,Hemorrhage,Pigmentation, hemosiderin,Hemorrhage,Undetermined manner of death,|Iliac lymph node,Retropharyngeal lymph node,Mesenteric lymph node,Subcutaneous tissue of upper extremity,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1547|99|765|Pigmentation, hemosiderin,Necrosis, coagulative,Hemorrhage,Hypoplasia,Hemorrhage,Hemorrhage,Edema,Pigmentation, hemosiderin,Hypoplasia,Hypoplasia,Undetermined manner of death,Hypoplasia,Hypoplasia,Hemorrhage,Pigmentation, hemosiderin,Hemorrhage,Hyperplasia,|Retropharyngeal lymph node,Liver,Myocardium of right atrium,Tracheobronchial lymph node,Colic lymph node,Mesenteric lymph node,Retropharyngeal lymph node,Tracheobronchial lymph node,Spleen,Iliac lymph node,Topography, multiple sites,Mesenteric lymph node,Colic lymph node,Iliac lymph node,Mandibular lymph node,Colon,Adrenal cortex,|MILD,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1556|99|755|Hemorrhage,Hypoplasia,Hypoplasia,Hemorrhage,Pigmentation, hemosiderin,Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,Undetermined manner of death,|Colon,Spleen,Mesenteric lymph node,Myocardium of left atrium,Iliac lymph node,Mesenteric lymph node,Adrenal gland,Retropharyngeal lymph node,Spleen,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1557|99|541|Hypoplasia,Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,Undetermined manner of death,|Mesenteric lymph node,Iliac lymph node,Mesenteric lymph node,Mandibular lymph node,Colon,Retropharyngeal lymph node,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1574|99|471|Pigmentation, hemosiderin,Pigmentation, hemosiderin,Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,Pigmentation, hemosiderin,Hypoplasia,Undetermined manner of death,|Iliac lymph node,Spleen,Tonsil,Retropharyngeal lymph node,Mesenteric lymph node,Mandibular lymph node,Colon,Mandibular lymph node,Spleen,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1603|99|510|Hypoplasia,Hemorrhage,Hemorrhage,Pigmentation, hemosiderin,Congestion,Congestion,Hemorrhage,Hemorrhage,Hemorrhage,Morphologic diagnosis deferred,Hemorrhage,Undetermined manner of death,Hypoplasia,|Testis,Gastric fundus,Urinary bladder,Spleen,Mesenteric lymph node,Retropharyngeal lymph node,Atrium, right,Iliac lymph node,Mandibular lymph node,Bone marrow,Ileal mucous membrane,Topography, multiple sites,Spleen,|LYMPHOID DEPLETION, MARKED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1629|99|500|Congestion,Hemorrhage,Hemorrhage,Congestion,Pigmentation, hemosiderin,Hemorrhage,Pigmentation, hemosiderin,Morphologic diagnosis deferred,Undetermined manner of death,|Retropharyngeal lymph node,Atrium, right,Lung,Mesenteric lymph node,Mesenteric lymph node,Colon,Retropharyngeal lymph node,Bone marrow,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1632|99|450|Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,Congestion,Hemorrhage,Hemorrhage,Hemorrhage,Congestion,Hemorrhage,Undetermined manner of death,|Colon,Tracheobronchial lymph node,Ileum,Mesenteric lymph node,Retropharyngeal lymph node,Atrium, right,Kidney,Iliac lymph node,Spleen,Mandibular lymph node,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1633|99|552|Pigmentation, hemosiderin,Congestion,Edema,Pigmentation, hemosiderin,Congestion,Hemorrhage,Pigmentation, hemosiderin,Pigmentation, hemosiderin,Congestion,Cyst,Congestion,Undetermined manner of death,|Tonsil,Retropharyngeal lymph node,Lung,Mandibular lymph node,Mandibular lymph node,Colon,Retropharyngeal lymph node,Mesenteric lymph node,Mesenteric lymph node,Pituitary gland,Iliac lymph node,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1665|99|507|Congestion,Hypoplasia,Pigmentation, hemosiderin,Atrophy,Pigmentation, hemosiderin,Hypoplasia,Hypoplasia,Hemorrhage,Congestion,Hemorrhage,Undetermined manner of death,Hemorrhage,Congestion,Congestion,|Mesenteric lymph node,Axillary lymph node,Mandibular lymph node,Thymus,Spleen,Testis,Spleen,Colon,Retropharyngeal lymph node,Muscle of thorax,Topography, multiple sites,Atrium, right,Iliac lymph node,Axillary lymph node,|MODERATE,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1683|99|518|Pigmentation, hemosiderin,Hemorrhage,Hemorrhage,Hypoplasia,Hypoplasia,Hemorrhage,Hemorrhage,Congestion,Hemorrhage,Congestion,Hemorrhage,Undetermined manner of death,Congestion,Hemorrhage,Pigmentation, hemosiderin,Congestion,|Retropharyngeal lymph node,Urinary bladder,Lung,Mandibular lymph node,Mesenteric lymph node,Diaphragm,Ileum,Retropharyngeal lymph node,Tonsil,Mesenteric lymph node,Endocardium,Topography, multiple sites,Iliac lymph node,Kidney,Mandibular lymph node,Mandibular lymph node,|MODERATE,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1687|99|515|Hypoplasia,Inflammation,Hypoplasia,Dilatation,Hemorrhage,Edema,Congestion,Pigmentation, hemosiderin,Congestion,Pigmentation, hemosiderin,Hypoplasia,Undetermined manner of death,Hemorrhage,Hemorrhage,Hypoplasia,Congestion,Hypoplasia,Necrosis, focal,Morphologic diagnosis deferred,|Mesenteric lymph node,Myocardium,Spleen,Kidney,Lung,Lung,Iliac lymph node,Retropharyngeal lymph node,Mesenteric lymph node,Spleen,Testis,Topography, multiple sites,Tonsil,Retropharyngeal lymph node,Iliac lymph node,Retropharyngeal lymph node,Retropharyngeal lymph node,Duodenum,Bone marrow,|CANNOT EVALUATE POOR PREP.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1688|99|605|Hemorrhage,Pigmentation, hemosiderin,Congestion,Hyperplasia,Hemorrhage,Hemorrhage,Hypoplasia,Atrophy,Hypoplasia,Hemorrhage,Hemorrhage,Hemorrhage,Hemorrhage,|Pericardium,Spleen,Mesenteric lymph node,Prostate,Aorta,Colic lymph node,Iliac lymph node,Testis,Mesenteric lymph node,Lung,Retropharyngeal lymph node,Ileum,Iliac lymph node,|MODERATE,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1697|99|671|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1698|99|873|Pigmentation, hemosiderin,Pigmentation, hemosiderin,Congestion,Pigmentation, hemosiderin,Congestion,Pigmentation, hemosiderin,Congestion,Undetermined manner of death,|Mandibular lymph node,Spleen,Mandibular lymph node,Retropharyngeal lymph node,Mesenteric lymph node,Iliac lymph node,Retropharyngeal lymph node,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1700|99|590|Hemorrhage,Congestion,Congestion,Atrophy,Congestion,Congestion,Undetermined manner of death,|Mandibular lymph node,Retropharyngeal lymph node,Colic lymph node,Testis,Iliac lymph node,Mesenteric lymph node,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1702|99|689|Congestion,Congestion,Congestion,Congestion,Congestion,Atrophy,Hemorrhage,Pigmentation, hemosiderin,Hemorrhage,Undetermined manner of death,|Colic lymph node,Iliac lymph node,Mesenteric lymph node,Tracheobronchial lymph node,Retropharyngeal lymph node,Testis,Brain,Iliac lymph node,Urinary bladder,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1709|99|567|Hypoplasia,Hypoplasia,Congestion,Hypoplasia,Congestion,Congestion,Hemorrhage,Congestion,Congestion,Hemorrhage,Undetermined manner of death,|Mesenteric lymph node,Iliac lymph node,Colic lymph node,Spleen,Iliac lymph node,Tonsil,Urinary bladder,Retropharyngeal lymph node,Mesenteric lymph node,Adrenal gland,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1714|99|633|Autolysis,Autolysis,Edema,Autolysis,Autolysis,Hypoplasia,Hypoplasia,Hemorrhage,Hemorrhage,Morphologic diagnosis deferred,Hemorrhage,Undetermined manner of death,Cyst,Autolysis,Congestion,Atrophy,|Liver,Stomach,Lung,Intestine,Adrenal gland,Mesenteric lymph node,Iliac lymph node,Retropharyngeal lymph node,Iliac lymph node,Bone marrow,Mesenteric lymph node,Topography, multiple sites,Prostate,Intestine,Tonsil,Testis,|MARKED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1721|99|578|Hemorrhage,Hemorrhage,Abscess,Hemorrhage,Edema,Hypoplasia,Hemorrhage,Congestion,Congestion,Hemorrhage,Hypoplasia,Hypoplasia,|Lung,Colon,Tonsil,Tongue,Lung,Mesenteric lymph node,Colic lymph node,Retropharyngeal lymph node,Mesenteric lymph node,Iliac lymph node,Iliac lymph node,Colic lymph node,|LYMPHOID DEPLETION, MARKED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1722|99|643|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1723|99|604|Congestion,Inflammation,Hypoplasia,Hypoplasia,Congestion,Cyst,Hemorrhage,Hypoplasia,Hemorrhage,Congestion,Hyperplasia,Undetermined manner of death,Congestion,|Mesenteric lymph node,Thyroid gland,Mesenteric lymph node,Iliac lymph node,Iliac lymph node,Pituitary gland,Colon,Spleen,Lung,Retropharyngeal lymph node,Adrenal cortex,Topography, multiple sites,Lung,|MODERATE,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1732|99|635|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1789|99|635|Pigmentation, hemosiderin,Atrophy,Hypoplasia,Hyperplasia,Hypoplasia,Hypoplasia,Inflammation,Morphologic diagnosis deferred,Undetermined manner of death,|Spleen,Thymus,Mesenteric lymph node,Adrenal cortex,Testes, both,Spleen,Thyroid gland,Bone marrow,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1790|99|636|Hypoplasia,Hypoplasia,Hyperplasia,Pigmentation, hemosiderin,Cyst,Edema,Hyperplasia,|Testis, right,Spleen,Adrenal cortex,Spleen,Parathyroid gland,Mesenteric lymph node,Thyroid gland,|FOLLICULAR CELL, MODERATE,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1794|99|534|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1828|99|495|Hypoplasia,Congestion,Hyperplasia,Hypoplasia,Hyperplasia,Hypoplasia,|Testis, right,Adrenal medulla,Thyroid gland,Spleen,Adrenal cortex,Testis, left,|MODERATE,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1875|99|777|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1877|99|401|Hypoplasia,Hypoplasia,Hyperplasia,Cyst,Congestion,Congestion,Hyperplasia,Hypoplasia,Undetermined manner of death,|Mesenteric lymph node,Spleen,Adrenal cortex,Pituitary gland,Iliac lymph node,Mesenteric lymph node,Thyroid gland,Testis, right,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1885|99|769|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1892|99|967|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1895|99|756|Deposition, amyloid,Deposition, amyloid,Amyloidosis,Amyloidosis,Thrombus,Thrombus,Edema,Edema,Seminoma, benign,Neoplastic disease, benign,Seminoma, benign,Neoplastic disease, benign,Fibrosis,Fibrosis,Inflammation, chronic, focal/circumscribed/local,Inflammation, chronic, focal/circumscribed/local,Hyperplasia, focal,Hyperplasia, focal,Hyperplasia, focal,Hyperplasia, focal,Degeneration, focal,Degeneration, focal,Degeneration, fatty,Degeneration, fatty,Hyperplasia, focal,Hyperplasia, focal,Fibrosis, focal,Fibrosis, focal,Cyst,Cyst,|Kidney,Kidney,Pulmonary artery,Pulmonary artery,Tracheobronchial lymph node,Tracheobronchial lymph node,Spermatogenic epithelium,Spermatogenic epithelium,Portal tract,Portal tract,Portal tract,Portal tract,Intrahepatic bile duct,Intrahepatic bile duct,Hepatic parenchymal cell,Hepatic parenchymal cell,Hepatic parenchymal cell,Hepatic parenchymal cell,Hepatic parenchymal cell,Hepatic parenchymal cell,Prostate,Prostate,Prostate,Prostate,Prostate,Prostate,|Uncertain attribution to ANL! CYST/PROSTATE (incidental disease10),|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1901|99|463|Chondroblastic osteosarcoma, malignant,Chondroblastic osteosarcoma, malignant,Neoplastic disease, malignant,Neoplastic disease, malignant,Disease of liver,Degeneration,Degeneration,Disease of liver,Degeneration,Neoplastic disease, malignant,Hyperplasia, focal,Hyperplasia, focal,Cholangiocarcinoma (Bile duct carcinoma), malignant,Cyst, hemorrhagic,Necrosis, focal,Hemosiderosis, (siderosis),Hyperplasia, focal,Necrosis, focal,Cyst, hemorrhagic,Hemosiderosis, (siderosis),Cholangiocarcinoma (Bile duct carcinoma), malignant,Degeneration,Neoplastic disease, malignant,Hyperplasia, focal,Neoplastic disease, benign,Adenoma, complex, benign,Adenoma, complex, benign,Neoplastic disease, benign,Papillary cystadenoma, benign,Neoplastic disease, benign,Neoplastic disease, benign,Papillary cystadenoma, benign,Cyst,Cyst,Cyst,Cyst,Spondylosis,Disease or syndrome of skeletal system,Spondylosis,Disease or syndrome of skeletal system,Plaque,Eye disease or syndrome,Plaque,Eye disease or syndrome,Tonic-clonic seizure syndrome,Tonic-clonic seizure syndrome,Hypoplasia,Edema,Atrophy,Hypoplasia,Pigmentation, hemosiderin,Inflammation,Hyperplasia,Autolysis,Hemorrhage,Hemorrhage,Hemorrhage,Hypoplasia,Congestion,Hemorrhage,Hypoplasia,Hemorrhage,Autolysis,Congestion,Pigmentation, hemosiderin,Congestion,|Thoracic vertebra, fourth,Thoracic vertebra, fourth,Liver,Liver,Hepatic parenchymal cell,Hepatic parenchymal cell,Kupffer cell,Liver,Liver,Liver,Kupffer cell,Hepatic parenchymal cell,Liver,Liver,Kupffer cell,Liver,Hepatic parenchymal cell,Kupffer cell,Mammary gland #5, left,Mammary gland #5, left,Ovary,Ovary,Ovary,Ovary,Pituitary gland,Pituitary gland,Intervertebral disc of lumbar veterbra,Intervertebral disc of lumbar veterbra,Iris, right eye,Iris, right eye,Brain,Seizure (Epileptic episode),Brain,Seizure (Epileptic episode),Mandibular lymph node,Lung,Thymus,Tonsil,Iliac lymph node,Duodenal mucous membrane,Adrenal cortex,Ileum,Pituitary posterior lobe (Pars Nervosa),Subcutaneous tissue of upper extremity,Thymus,Mesenteric lymph node,Iliac lymph node,Mandibular lymph node,Spleen,Lung,Thyroid gland,Mesenteric lymph node,Retropharyngeal lymph node,Retropharyngeal lymph node,|MILD,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1912|99|892|Neoplastic disease, malignant w/evidence of metastasis,Osteoblastic osteosarcoma, malignant, w/evidence of metastas,Osteoblastic osteosarcoma, malignant, w/evidence of metastas,Neoplastic disease, malignant w/evidence of metastasis,Disease or syndrome of skeletal system,Spondylosis,Spondylosis,Disease or syndrome of skeletal system,Inflammation, chronic exudative, multifocal/multiple/segment,Inflammation, chronic exudative, multifocal/multiple/segment,Hyperplasia, lymphoid,Hyperplasia, lymphoid,Hemosiderosis, (siderosis),Hemosiderosis, (siderosis),Hyperplasia, focal,Hyperplasia, focal,Degeneration, focal,Degeneration, focal,Neoplastic disease, benign,Fibroma, benign,Fibroma, benign,Neoplastic disease, benign,Glomerulosclerosis, focal,Glomerulosclerosis, focal,Hyperplasia, cystic,Hyperplasia, cystic,Inflammation, chronic,Inflammation, chronic,|Femur,Femur,Intervertebral disc of lumbar veterbra,Intervertebral disc of lumbar veterbra,Axillary lymph node,Axillary lymph node,Axillary lymph node,Axillary lymph node,Kupffer cell,Kupffer cell,Hepatic parenchymal cell,Hepatic parenchymal cell,Hepatic parenchymal cell,Hepatic parenchymal cell,Cortex of kidney,Cortex of kidney,Glomerulus,Glomerulus,Prostate,Prostate,Prostate,Prostate,|Uncertain attribution to ANL! PROSTATITIS, CHRONIC/PROSTATE (incidental disease10),|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1915|99|892|Deposition, amyloid,Deposition, amyloid,Deposition, amyloid,Deposition, amyloid,Inflammation,Inflammation,Thrombus,Thrombus,Infarct,Infarct,Infarct,Infarct,Inflammation, chronic exudative,Inflammation, chronic exudative,Neoplastic disease, malignant,Melanoma, malignant,Neoplastic disease, malignant,Melanoma, malignant,Hemosiderosis, (siderosis),Hemosiderosis, (siderosis),Fibrosis, focal,Fibrosis, focal,Inflammation, chronic exudative, multifocal/multiple/segment,Inflammation, chronic exudative, multifocal/multiple/segment,Hyperplasia, cystic,Hyperplasia, cystic,Hyperplasia, multifocal,Hyperplasia, multifocal,|Kidney,Kidney,Glomerulus,Glomerulus,Interstitial tissue of kidney,Interstitial tissue of kidney,Pulmonary artery,Pulmonary artery,Lung,Myocardium of right ventricle,Lung,Myocardium of right ventricle,Endometrium,Endometrium,Ciliary body,Ciliary body,Spleen,Spleen,Spleen,Spleen,Tracheobronchial lymph node,Tracheobronchial lymph node,Mucosa of gallbladder,Mucosa of gallbladder,Adrenal cortex,Adrenal cortex,|Uncertain attribution to ANL! HYPERPLASIA, MULTIFOCAL/ADRENAL CORTEX (incidental disease07),|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1918|99|471|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1925|99|622|Congestion,Pigmentation, hemosiderin,Pigmentation, hemosiderin,Pigmentation, hemosiderin,Undetermined manner of death,|Mesenteric lymph node,Retropharyngeal lymph node,Mesenteric lymph node,Mandibular lymph node,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1927|99|860|Congestion,Atrophy,Hypoplasia,Congestion,Hyperplasia,Inflammation, chronic,Aplasia,|Liver,Testis,Parasternal lymph node,Parasternal lymph node,Mucous membrane of urinary bladder,Prostate,Bone marrow,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1948|99|605|Hemorrhage,Hemorrhage,Congestion,Hemorrhage,Hyperplasia,Hyperplasia,Pigmentation, hemosiderin,Undetermined manner of death,Lymphocytic infiltrate,Lymphocytic infiltrate,Disease or syndrome of digestive system,Disease or syndrome of digestive system,Hypothyroidism,Hypothyroidism,Atrophy,Atrophy,Inflammation, chronic exudative,Inflammation, chronic exudative,Inflammation, chronic exudative,Inflammation, chronic exudative,Inflammation, chronic exudative,Inflammation, chronic exudative,Inflammation, granulomatous,Inflammation, granulomatous,Hyperplasia, multifocal,Hyperplasia, multifocal,Hemosiderosis, (siderosis),Hemosiderosis, (siderosis),Hyperplasia, multifocal,Hyperplasia, multifocal,Inflammation with fibrosis,Inflammation with fibrosis,Hyperplasia,Hyperplasia,Plaque,Eye disease or syndrome,Plaque,Eye disease or syndrome,|Muscle of upper extremity,Lung,Mesenteric lymph node,Colon,Adrenal cortex,Thyroid gland,Mandibular lymph node,Topography, multiple sites,Small intestine,Small intestine,Intestinal absorption, abnormal,Intestinal absorption, abnormal,Thyroid gland,Thyroid gland,Thyroid gland,Thyroid gland,Retropharyngeal lymph node,Retropharyngeal lymph node,Hepatic lymph node,Hepatic lymph node,Mesenteric lymph node,Mesenteric lymph node,Myocardium,Myocardium,Kupffer cell,Kupffer cell,Kupffer cell,Kupffer cell,Hepatic parenchymal cell,Hepatic parenchymal cell,Prostate,Prostate,Prostate,Prostate,Iris, right eye,Iris, right eye,|Uncertain attribution to ANL! PLAQUE, MELANOTIC/EYE, IRIS, RIGHT/EYE DISEASE/ (incidental disease10),|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1950|99|603|Aplasia,Edema,|Bone marrow,Lung,|C HEMORR & CONGESTION,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1952|99|697|Hyperplasia,Congestion,Cyst,Hypoplasia,Pigmentation, hemosiderin,Pigmentation, hemosiderin,Pigmentation, hemosiderin,Hyperplasia,Hemorrhage,Pigmentation, hemosiderin,Undetermined manner of death,|Adrenal cortex,Mesenteric lymph node,Pituitary gland,Testis,Iliac lymph node,Retropharyngeal lymph node,Mandibular lymph node,Thyroid gland,Duodenal mucous membrane,Mesenteric lymph node,Topography, multiple sites,|NO COD ASSIGNED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1969|99|643|Hypoplasia,Hemorrhage,Hypoplasia,Aplasia,|Parasternal lymph node,Topography, multiple sites,Spleen,Bone marrow,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-1978|99|686|Aplasia,Atelectasis,Hypoplasia,Congestion,Hypoplasia,|Bone marrow,Lung,Spleen,Parasternal lymph node,Parasternal lymph node,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2070|99|887|Congestion,Deposition, calcium,Abscess,Inflammation, chronic,Inflammation, chronic,Hypoplasia,Hypoplasia,Edema,Aplasia,Inflammation, chronic,Congestion,Deposition, calcium,Congestion,|Spleen,Skeletal muscle,Buccal mucosa,Endometrium,Kidney,Parasternal lymph node,Spleen,Lung,Bone marrow,Duodenal mucous membrane,Parasternal lymph node,Coronary artery,Liver,|CHRONIC PASSIVE,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2073|99|577|Congestion,Hemorrhage,Hyperplasia,Edema,Hypoplasia,Hypoplasia,Hypoplasia,Hypoplasia,Hypoplasia,Hemorrhage,Undetermined manner of death,Congestion,Hypoplasia,|Iliac lymph node,Mesenteric lymph node,Adrenal cortex,Colic lymph node,Spleen,Tonsil,Colic lymph node,Iliac lymph node,Mesenteric lymph node,Colic lymph node,Topography, multiple sites,Spleen,Testis,|MARKED,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2075|99|688|Hemorrhage,Inflammation,Inflammation,Aplasia,Hypoplasia,Hypoplasia,Developmental malformation,|Myocardium,Parasternal lymph node,Kidney,Bone marrow,Parasternal lymph node,Spleen,Parathyroid gland,|THYROGLOSSAL DUCT,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2076|99|627|Hemorrhage,Hypoplasia,Aplasia,Edema,|Topography, multiple sites,Parasternal lymph node,Bone marrow,Lung,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2077|99|556|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2078|99|713|Congestion,Atrophy,Hypoplasia,Hypoplasia,Aplasia,|Liver,Testis,Parasternal lymph node,Spleen,Bone marrow,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2083|99|558|Hemorrhage,Hypoplasia,Aplasia,|Topography, multiple sites,Parasternal lymph node,Bone marrow,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2087|99|687|Hemorrhage,Aplasia,Hypoplasia,Congestion,Hypoplasia,|Topography, multiple sites,Bone marrow,Spleen,Liver,Parasternal lymph node,|LYMPHOID,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2089|99|664|Atrophy,Hypoplasia,Hemorrhage,Aplasia,Congestion,Hypoplasia,|Testis,Parasternal lymph node,Topography, multiple sites,Bone marrow,Topography, multiple sites,Spleen,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2090|99|588|Aplasia,|Bone marrow,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2091|99|787|Aplasia,Hemorrhage,|Bone marrow,Topography, multiple sites,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2092|99|546|Hemorrhage,Sepsis,|Lung,Whole body,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2139|99|786|Hypoplasia,Hemorrhage,Hemorrhage,Inflammation, chronic,Hemorrhage,Hemorrhage,Developmental malformation,Atrophy,Inflammation, acute,Aplasia,|Spleen,Heart,Lung,Spleen,Adrenal cortex,Skin of breast,Parathyroid gland,Myocardium of ventricle,Kidney,Bone marrow,|BASED ON PM FINDINGS.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2143|99|796|Hemorrhage,Necrosis,Hemorrhage,|Heart,Liver,Whole body,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2146|99|800|Hemorrhage,Hypoplasia,Edema,Fibrosis,Aplasia,Hypoplasia,Atrophy,|Topography, multiple sites,Parasternal lymph node,Lung,Spleen,Bone marrow,Spleen,Testis,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2147|99|726|Hypoplasia,Inflammation, chronic,Aplasia,|Lymph node,Thyroid gland,Bone marrow,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2241|99|500|Hypoplasia,Hemorrhage,Inflammation, chronic,Hypoplasia,|Iliac lymph node,Lung,Iliac lymph node,Mesenteric lymph node,|HEMORR, EDEMA, HEMOSIDERI           N,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2248|99|538|Hemorrhage,Hypoplasia,Inflammation,Undetermined manner of death,|Topography, multiple sites,Parasternal lymph node,Parasternal lymph node,Whole body,|NO COD ASSIGNED.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2249|99|501|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2250|99|551|Inflammation, acute,Inflammation, acute,Disease of pancreas,Disease of pancreas,Thrombus,Necrosis, fat,Inflammation, ulcerative,Inflammation, ulcerative,Thrombus,Necrosis, fat,Shock,Shock,Atrophy,Atrophy,Hemosiderosis, (siderosis),Hemosiderosis, (siderosis),Tonic-clonic seizure syndrome,Tonic-clonic seizure syndrome,Inflammation, chronic exudative, multifocal/multiple/segment,Inflammation, chronic exudative, multifocal/multiple/segment,Hemosiderosis, (siderosis),Hemosiderosis, (siderosis),Inflammation, chronic exudative, multifocal/multiple/segment,Inflammation, chronic exudative, multifocal/multiple/segment,Inflammation,Inflammation,|Pancreas (Exocrine Pancreas),Pancreas (Exocrine Pancreas),Pulmonary artery,Pancreas (Exocrine Pancreas),Esophagus,Esophagus,Pulmonary artery,Pancreas (Exocrine Pancreas),Cardiovascular system,Cardiovascular system,Lymphatic follicle of spleen (Spleenic white pulp),Lymphatic follicle of spleen (Spleenic white pulp),Hepatic lymph node,Hepatic lymph node,Seizure (Epileptic episode),Brain,Brain,Seizure (Epileptic episode),Hepatic lymph node,Hepatic lymph node,Mesenteric lymph node,Mesenteric lymph node,Mesenteric lymph node,Mesenteric lymph node,Glomerulus,Glomerulus,|Uncertain attribution to ANL! GLOMERULONEPHRITIS, MINIMAL/KIDNEY, GLOMERULI (incidental disease07),|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2251|99|880|Hemorrhage,Aplasia,Inflammation, acute,Hypoplasia,Disease of liver,Necrosis,Obstruction,Necrosis,Obstruction,Edema,Hyperplasia, focal,Hemosiderosis, (siderosis),Cyst, epithelial,Infiltration, fatty,|Topography, multiple sites,Bone marrow,Kidney,Parasternal lymph node,Centrilobular region of liver,Liver function failure,Hepatic parenchymal cell,Common bile duct,Hepatic parenchymal cell,Common bile duct,Lung,Kupffer cell,Kupffer cell,Parathyroid gland,Hepatic parenchymal cell,|Uncertain attribution to ANL! INFILTRATION, FATTY/LIVER, HEPATOCYTES (incidental disease04),|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2252|99|534|Hypoplasia,Hypoplasia,Edema,Undetermined manner of death,|Parasternal lymph node,Spleen,Lung,Whole body,|NO COD ASSIGNED.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2253|99|880|Hypoplasia,Aplasia,Fibrosis,Traumatic abnormality,Hypoplasia,Edema,Congestion,Necrosis,Hemorrhage,|Lymph node,Bone marrow,Adrenal gland,Pulmonary alveoli,Spleen,Lung,Topography, multiple sites,Adrenal gland,Topography, multiple sites,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2283|99|876|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2285|99|654|Atrophy,Developmental malformation,Hemorrhage,Inflammation,Hemorrhage,|Testis, left,Jejunal mucous membrane,Topography, multiple sites,Lymph node,Whole body,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2286|99|867|Hypoplasia,Aplasia,Hypoplasia,Hemorrhage,Edema,Congestion,Inflammation, diffuse,Inflammation, diffuse,Inflammation, acute exudative, confluent/disseminated/global,Inflammation, acute exudative, multifocal/multiple/segmental,Inflamation, acute exudative (suppurative),Inflammation, acute exudative, multifocal/multiple/segmental,Necrosis, diffuse/massive,Inflamation, acute exudative (suppurative),Necrosis, diffuse/massive,Inflammation, acute exudative, confluent/disseminated/global,Glomerulosclerosis, diffuse,Glomerulosclerosis, diffuse,|Spleen,Bone marrow,Parasternal lymph node,Topography, multiple sites,Lung,Topography, multiple sites,Skin of back,Skin of back,Axillary lymph node,Retropharyngeal lymph node,Skin of trunk, lateral region,Retropharyngeal lymph node,Skin of trunk, lateral region,Skin of trunk, lateral region,Skin of trunk, lateral region,Axillary lymph node,Glomerulus,Glomerulus,|Pathology performed at ITRI! GLOMERULOSCLEROSIS, DIFFUSE/KIDNEY, GLOMERULI (incidental disease01),|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2288|99|636|Aplasia,Congestion,Hemorrhage,Ulcer,|Bone marrow,Liver,Topography, multiple sites,Colonic mucous membrane,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2289|99|680|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2291|99|718|Hypoplasia,Hemorrhage,Congestion,Aplasia,|Testis,Topography, multiple sites,Topography, multiple sites,Bone marrow,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2292|99|807|Aplasia,Hemorrhage,Edema,|Bone marrow,Topography, multiple sites,Lung,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2294|99|680|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2318|99|753|Aplasia,Hemorrhage,Edema,|Bone marrow,Topography, multiple sites,Lung,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2325|99|595|Abscess,Atrophy,|Subcutaneous tissue of lower extremity,Testis,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2338|99|571|Hypoplasia,Aplasia,Atrophy,|Retropharyngeal lymph node,Bone marrow,Testis,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2346|99|732|Hemorrhage,Aplasia,Hypoplasia,Hypoplasia,|Topography, multiple sites,Bone marrow,Lymph node,Spleen,|LY. C CONG., SIDEROCYTES,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2347|99|649|Hemorrhage,Edema,Aplasia,Hypoplasia,Hypoplasia,|Topography, multiple sites,Lung,Bone marrow,Retropharyngeal lymph node,Spleen,|LYMPHOID,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2350|99|627|Aplasia,Hyperplasia,|Bone marrow,Pituitary anterior lobe (Pars Glandularis),|CHROMOPHOBE CELLS,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2374|99|332|Inflammation, acute,Inflammation,Inflammation,Fibrosis,Inflammation, acute,Congestion,Inflammation,Infarct,Hemorrhage,Necrosis,Edema,|Abdomen, peritoneum and retroperitoneum,Prostate,Urinary bladder,Urethra,Visceral peritoneum,Liver,Lymph node,Prostate,Urinary bladder,Prostate,Lung,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2378|99|593|Edema,Hemorrhage,|Lung,Lung,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2379|99|508|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2384|99|571|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2385|99|573|Edema,|Lung,|HEMORR. & BACT. COLONIES,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2386|99|684|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2394|99|667|Edema,|Lung,| C CONGESTION,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2397|99|717|Hemorrhage,Aplasia,Hypoplasia,Hypoplasia,|Heart,Bone marrow,Spleen,Lymph node,|LYMPHOID,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2459|99|462|Hypoplasia,Inflammation,Hemorrhage,Hypoplasia,Congestion,|Spleen,Lymph node,Topography, multiple sites,Lymph node,Topography, multiple sites,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2470|99|565|Atrophy,Hypoplasia,Hypoplasia,Hemorrhage,|Testis,Spleen,Lymph node,Topography, multiple sites,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2471|99|547|Hemorrhage,|Topography, multiple sites,|SEVERE IN GL.BL.& STOM.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2476|99|555|Edema,|Lung,|C MASSIVE HEMORRHAGE,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2478|99|567|Hemorrhage,Atrophy,|Topography, multiple sites,Testis,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2479|99|588|Atrophy,Hemorrhage,Edema,|Testis,Topography, multiple sites,Lung,|C MARKED CONGESTION,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2490|99|519|Developmental malformation,Undetermined manner of death,|Parathyroid gland,Whole body,|NO COD ASSIGNED.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2497|99|485|Hemorrhage,|Topography, multiple sites,|GLBL, COLON,LNS,ADR,TONSI           L,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2538|99|628|Hemorrhage,Aplasia,Hypoplasia,Hypoplasia,|Myocardium,Bone marrow,Spleen,Lymph node,|LYMPHOID C RBC-PHAGOCYTOS,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2554|99|617|Hypoplasia,Aplasia,Hemorrhage,|Spleen,Bone marrow,Topography, multiple sites,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2555|99|622|Hemorrhage,Atrophy,Undetermined manner of death,|Thyroid gland,Testis,Whole body,|NO COD ASSIGNED.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2556|99|620|Atrophy,Undetermined manner of death,|Testis,Whole body,|NO COD ASSIGNED.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2563|99|541|Atrophy,Undetermined manner of death,|Testis,Topography, multiple sites,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2564|99|544|Atrophy,Undetermined manner of death,|Testis,Topography, multiple sites,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2565|99|555|Atrophy,Edema,Inflammation, chronic,Undetermined manner of death,|Testis,Lung,Thyroid gland,Topography, multiple sites,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2566|99|536|Congestion,Hemorrhage,Aplasia,Hypoplasia,Edema,Hypoplasia,Atrophy,|Topography, multiple sites,Topography, multiple sites,Bone marrow,Spleen,Lung,Lymph node,Testis,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2597|99|541|Fibrosis,Hemorrhage,Edema,|Mesenteric lymph node,Myocardium of right atrium,Lung,|C MASSIVE HEMORR.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2633|99|497|Hypoplasia,Hypoplasia,Hemorrhage,Edema,|Spleen,Lymph node,Topography, multiple sites,Lung,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2649|99|590|Congestion,Congestion,Hemorrhage,Hypoplasia,Undetermined manner of death,|Spleen,Lymph node,Lymph node,Spleen,Topography, multiple sites,|NO COD ASSIGNED.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2689|99|546|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2692|99|550|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2693|99|648|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2705|99|539|Hypoplasia,Hemorrhage,Undetermined manner of death,|Spleen,Spleen,Topography, multiple sites,|NO COD ASSIGNED.,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2714|99|523|n/a|n/a|n/a|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2716|99|636|Aplasia,Hemorrhage,|Bone marrow,Heart,|MYO, EPI & ENDO-CARDIUM,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2721|99|567|Pigmentation,Infarct,Hemorrhage,Aplasia,|Spleen,Urinary bladder,Endocardium of right ventricle,Bone marrow,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2881|99|618|Inflammation, acute,Hemorrhage,Edema,Abscess,|Lung,Topography, multiple sites,Lung,Kidney,| C AMYLOIDOSIS,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2883|99|625|Edema,Hypoplasia,Hemorrhage,Congestion,Hypoplasia,Inflammation, acute,Pigmentation,Aplasia,|Lung,Spleen,Topography, multiple sites,Spleen,Lymph node,Lung,Spleen,Bone marrow,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-2911|99|546|Atrophy,Congestion,Hemorrhage,Aplasia,|Testis,Topography, multiple sites,Topography, multiple sites,Bone marrow,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-3149|99|556|Hemorrhage,Congestion,Aplasia,Inflammation, acute,Hypoplasia,Hypoplasia,Congestion,|Topography, multiple sites,Liver,Bone marrow,Lung,Spleen,Lymph node,Topography, multiple sites,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-3151|99|548|Hemorrhage,Hypoplasia,Aplasia,Hypoplasia,Atrophy,Inflammation, acute,|Topography, multiple sites,Lymph node,Bone marrow,Spleen,Testis,Lung,|INTERSTITIAL,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-3157|99|517|Hypoplasia,Inflammation, acute,Hypoplasia,Hemorrhage,Aplasia,Edema,|Spleen,Lung,Lymph node,Topography, multiple sites,Bone marrow,Lung,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-3159|99|527|Edema,Inflammation, acute,Hypoplasia,Hypoplasia,Hemorrhage,Inflammation, acute,|Lung,Lung,Lymph node,Spleen,Topography, multiple sites,Tongue,|ULC. GLOSSITIS,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-3160|99|548|Pigmentation,Inflammation, acute,Edema,Congestion,Hypoplasia,Hemorrhage,Hypoplasia,Hemorrhage,Atrophy,|Spleen,Tongue,Lung,Liver,Retropharyngeal lymph node,Topography, multiple sites,Spleen,Lung,Testis,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-3161|99|508|Hemorrhage,Pigmentation,Edema,Inflammation, chronic,Hypoplasia,Hypoplasia,Hemorrhage,Congestion,|Topography, multiple sites,Spleen,Lung,Mandibular lymph node,Mesenteric lymph node,Spleen,Pericardium,Liver,|,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-3162|99|498|Inflammation, acute,Hemorrhage,Hypoplasia,Atrophy,|Tongue,Topography, multiple sites,Lymph node,Testis,| CRYPTORCHID,|
1003-6-99|n/a,n/a|n/a| n/a|n/a||n/a|n/a| n/a|19 (129 in ERA)|Dog|Dog, Beagle|Both|need def 11|Supplementary animals|1003-6-99-3349|99|531|Aplasia,Inflammation, acute,Inflammation, acute,Inflammation, acute,Hemorrhage,Inflammation, chronic,|Bone marrow,Endometrium,Tongue,Lymph node,Topography, multiple sites,Lung,| FIBROUS;  ,|
		
